action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
,,2214610,[],CHEMBL984306,Promotion of flag-tagged cIAP1 degradation in human HT1080 cells assessed as decrease in cIAPI production after 3 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1,,,CHEMBL1149858,Bioorg Med Chem,2008,"{'bei': '19.11', 'le': '0.37', 'lle': '5.54', 'sei': '6.06'}",CHEMBL457092,BESTATIN METHYL ESTER,CHEMBL457092,6.16,0,http://www.openphacts.org/units/Nanomolar,742184,=,1,1,=,,IC50,nM,,690.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.69
,,2214616,[],CHEMBL984306,Promotion of flag-tagged cIAP1 degradation in human HT1080 cells assessed as decrease in cIAPI production after 3 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCN(CCCC)[C@H](CC(=O)NO)C(=O)N[C@@H](CC(C)C)C(=O)OC,,,CHEMBL1149858,Bioorg Med Chem,2008,"{'bei': '13.00', 'le': '0.25', 'lle': '3.18', 'sei': '4.66'}",CHEMBL458777,,CHEMBL458777,5.04,0,http://www.openphacts.org/units/Nanomolar,742228,=,1,1,=,,IC50,nM,,9200.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,9.2
,,2214617,[],CHEMBL984306,Promotion of flag-tagged cIAP1 degradation in human HT1080 cells assessed as decrease in cIAPI production after 3 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCN[C@H](CC(=O)NO)C(=O)N[C@@H](CC(C)C)C(=O)OC,,,CHEMBL1149858,Bioorg Med Chem,2008,"{'bei': '16.08', 'le': '0.32', 'lle': '4.99', 'sei': '4.56'}",CHEMBL458594,,CHEMBL458594,5.33,0,http://www.openphacts.org/units/Nanomolar,742227,=,1,1,=,,IC50,nM,,4690.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,4.69
,,2214619,[],CHEMBL984306,Promotion of flag-tagged cIAP1 degradation in human HT1080 cells assessed as decrease in cIAPI production after 3 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](Cc1ccccc1)C(=O)OC,,,CHEMBL1149858,Bioorg Med Chem,2008,"{'bei': '16.67', 'le': '0.32', 'lle': '4.10', 'sei': '5.80'}",CHEMBL458592,,CHEMBL458592,6.08,0,http://www.openphacts.org/units/Nanomolar,742225,=,1,1,=,,IC50,nM,,840.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.84
,,2214620,[],CHEMBL984306,Promotion of flag-tagged cIAP1 degradation in human HT1080 cells assessed as decrease in cIAPI production after 3 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCC[C@H](CC(=O)NO)C(=O)N[C@H](C(=O)OC)C(C)(C)C,,,CHEMBL1149858,Bioorg Med Chem,2008,,CHEMBL458586,,CHEMBL458586,,0,http://www.openphacts.org/units/Nanomolar,742224,>,1,1,>,,IC50,nM,,20000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,20.0
,,2214621,[],CHEMBL984306,Promotion of flag-tagged cIAP1 degradation in human HT1080 cells assessed as decrease in cIAPI production after 3 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCC[C@H](CC(=O)NO)C(=O)N[C@H](C(=O)OC)C(C)C,,,CHEMBL1149858,Bioorg Med Chem,2008,"{'bei': '18.66', 'le': '0.37', 'lle': '4.51', 'sei': '5.64'}",CHEMBL457293,,CHEMBL457293,5.90,0,http://www.openphacts.org/units/Nanomolar,742204,=,1,1,=,,IC50,nM,,1250.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,1.25
,,2214622,[],CHEMBL984306,Promotion of flag-tagged cIAP1 degradation in human HT1080 cells assessed as decrease in cIAPI production after 3 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C)C(=O)OC,,,CHEMBL1149858,Bioorg Med Chem,2008,"{'bei': '21.77', 'le': '0.43', 'lle': '5.52', 'sei': '5.99'}",CHEMBL457292,,CHEMBL457292,6.28,0,http://www.openphacts.org/units/Nanomolar,742203,=,1,1,=,,IC50,nM,,530.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.53
,,2214623,[],CHEMBL984306,Promotion of flag-tagged cIAP1 degradation in human HT1080 cells assessed as decrease in cIAPI production after 3 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCC[C@H](CC(=O)NO)C(=O)NCC(=O)OC,,,CHEMBL1149858,Bioorg Med Chem,2008,"{'bei': '21.19', 'le': '0.42', 'lle': '5.44', 'sei': '5.55'}",CHEMBL457060,,CHEMBL457060,5.81,0,http://www.openphacts.org/units/Nanomolar,742202,=,1,1,=,,IC50,nM,,1540.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,1.54
,,2214624,[],CHEMBL984306,Promotion of flag-tagged cIAP1 degradation in human HT1080 cells assessed as decrease in cIAPI production after 3 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)[C@H](CC(C)C)NC(=O)CCC(=O)NO,,,CHEMBL1149858,Bioorg Med Chem,2008,"{'bei': '18.06', 'le': '0.36', 'lle': '4.72', 'sei': '4.49'}",CHEMBL457291,,CHEMBL457291,4.70,0,http://www.openphacts.org/units/Nanomolar,742201,=,1,1,=,,IC50,nM,,19900.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,19.9
,,2214625,[],CHEMBL984306,Promotion of flag-tagged cIAP1 degradation in human HT1080 cells assessed as decrease in cIAPI production after 3 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(=O)NO)Cc1ccccc1,,,CHEMBL1149858,Bioorg Med Chem,2008,"{'bei': '12.40', 'le': '0.24', 'lle': '2.90', 'sei': '4.15'}",CHEMBL458564,,CHEMBL458564,4.34,0,http://www.openphacts.org/units/Nanomolar,742200,=,1,1,=,,IC50,nM,,45200.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,45.2
,,2214626,[],CHEMBL984306,Promotion of flag-tagged cIAP1 degradation in human HT1080 cells assessed as decrease in cIAPI production after 3 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](CC(=O)NO)C(=O)N[C@@H](CC(C)C)C(=O)OC,,,CHEMBL1149858,Bioorg Med Chem,2008,"{'bei': '16.02', 'le': '0.32', 'lle': '4.01', 'sei': '4.41'}",CHEMBL458563,,CHEMBL458563,4.62,0,http://www.openphacts.org/units/Nanomolar,742199,=,1,1,=,,IC50,nM,,24100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,24.1
,,2214627,[],CHEMBL984306,Promotion of flag-tagged cIAP1 degradation in human HT1080 cells assessed as decrease in cIAPI production after 3 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCC[C@@H](CC(=O)NO)C(=O)N[C@@H](CC(C)C)C(=O)OC,,,CHEMBL1149858,Bioorg Med Chem,2008,"{'bei': '14.88', 'le': '0.29', 'lle': '3.14', 'sei': '4.70'}",CHEMBL457466,,CHEMBL457466,4.92,0,http://www.openphacts.org/units/Nanomolar,742198,=,1,1,=,,IC50,nM,,12100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,12.1
,,2214628,[],CHEMBL984306,Promotion of flag-tagged cIAP1 degradation in human HT1080 cells assessed as decrease in cIAPI production after 3 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](CC(C)C)C(=O)OC,,,CHEMBL1149858,Bioorg Med Chem,2008,"{'bei': '18.08', 'le': '0.35', 'lle': '4.19', 'sei': '5.70'}",CHEMBL457093,,CHEMBL457093,5.97,0,http://www.openphacts.org/units/Nanomolar,742185,=,1,1,=,,IC50,nM,,1060.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,1.06
,,3439242,[],CHEMBL1248007,Displacement of fluorescent SM5F peptide from His-tagged human cIAP1 BIR3 domain expressed in Escherichia coli BL21(DE3) cells by fluorescence polarization-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H](C)C(=O)N[C@H]1CC[C@@H](NC(=O)Cc2ccccc2)C[C@H]2CC[C@@H](C(=O)N[C@@H]3CCCc4ccccc43)N2C1=O,,,CHEMBL1240488,J Med Chem,2010,"{'bei': '14.96', 'le': '0.28', 'lle': '6.05', 'sei': '7.18'}",CHEMBL1241426,,CHEMBL1241426,8.59,0,http://www.openphacts.org/units/Nanomolar,952154,=,1,1,=,,IC50,nM,,2.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.6
,,3439243,[],CHEMBL1248007,Displacement of fluorescent SM5F peptide from His-tagged human cIAP1 BIR3 domain expressed in Escherichia coli BL21(DE3) cells by fluorescence polarization-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H](C)C(=O)N[C@H]1CC[C@H](NC(=O)Cc2ccccc2)C[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL1240488,J Med Chem,2010,"{'bei': '11.60', 'le': '0.21', 'lle': '3.82', 'sei': '5.91'}",CHEMBL1241425,,CHEMBL1241425,7.08,0,http://www.openphacts.org/units/Nanomolar,952153,=,1,1,=,,IC50,nM,,84.1,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,84.1
,,3439244,[],CHEMBL1248007,Displacement of fluorescent SM5F peptide from His-tagged human cIAP1 BIR3 domain expressed in Escherichia coli BL21(DE3) cells by fluorescence polarization-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H](C)C(=O)N[C@H]1CC[C@@H](NC(=O)Cc2ccccc2)C[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL1240488,J Med Chem,2010,"{'bei': '13.06', 'le': '0.24', 'lle': '4.70', 'sei': '6.66'}",CHEMBL1241424,,CHEMBL1241424,7.96,0,http://www.openphacts.org/units/Nanomolar,952152,=,1,1,=,,IC50,nM,,10.9,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,10.9
,,3439245,[],CHEMBL1248007,Displacement of fluorescent SM5F peptide from His-tagged human cIAP1 BIR3 domain expressed in Escherichia coli BL21(DE3) cells by fluorescence polarization-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H](C)C(=O)N[C@H]1CC[C@H](O)C[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL1240488,J Med Chem,2010,"{'bei': '14.90', 'le': '0.28', 'lle': '5.45', 'sei': '6.63'}",CHEMBL1242922,,CHEMBL1242922,7.34,0,http://www.openphacts.org/units/Nanomolar,954326,=,1,1,=,,IC50,nM,,45.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,45.5
,,3439246,[],CHEMBL1248007,Displacement of fluorescent SM5F peptide from His-tagged human cIAP1 BIR3 domain expressed in Escherichia coli BL21(DE3) cells by fluorescence polarization-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H](C)C(=O)N[C@H]1CC[C@@H](O)C[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL1240488,J Med Chem,2010,"{'bei': '14.74', 'le': '0.28', 'lle': '5.37', 'sei': '6.56'}",CHEMBL1243385,,CHEMBL1243385,7.26,0,http://www.openphacts.org/units/Nanomolar,954959,=,1,1,=,,IC50,nM,,54.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,54.5
,,3439247,[],CHEMBL1248007,Displacement of fluorescent SM5F peptide from His-tagged human cIAP1 BIR3 domain expressed in Escherichia coli BL21(DE3) cells by fluorescence polarization-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Cc2ccccc2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL1240488,J Med Chem,2010,"{'bei': '13.51', 'le': '0.25', 'lle': '5.23', 'sei': '7.26'}",CHEMBL504559,,CHEMBL504559,8.05,0,http://www.openphacts.org/units/Nanomolar,952151,=,1,1,=,,IC50,nM,,9.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,9.0
,,3439248,[],CHEMBL1248007,Displacement of fluorescent SM5F peptide from His-tagged human cIAP1 BIR3 domain expressed in Escherichia coli BL21(DE3) cells by fluorescence polarization-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL1240488,J Med Chem,2010,"{'bei': '15.39', 'le': '0.29', 'lle': '4.42', 'sei': '8.10'}",CHEMBL481422,,CHEMBL481422,7.33,0,http://www.openphacts.org/units/Nanomolar,954960,=,1,1,=,,IC50,nM,,46.2,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,46.2
,,6196239,[],CHEMBL1777015,Competitive inhibition of human cIAP1 BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCc4ccc(CCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.85', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774157,,CHEMBL1774157,8.59,0,http://www.openphacts.org/units/Nanomolar,1422015,=,1,1,=,,IC50,nM,,2.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.6
,,6196241,[],CHEMBL1777015,Competitive inhibition of human cIAP1 BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCCCCCCCn4cc([C@@H](NC(=O)[C@@H]5CC[C@@H]6CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N65)c5ccccc5)nn4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.97', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774031,,CHEMBL1774031,8.55,0,http://www.openphacts.org/units/Nanomolar,1421824,=,1,1,=,,IC50,nM,,2.8,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.8
,,6196252,[],CHEMBL1777015,Competitive inhibition of human cIAP1 BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCCCCCCCCCn4cc([C@@H](NC(=O)[C@@H]5CC[C@@H]6CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N65)c5ccccc5)nn4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.71', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774160,,CHEMBL1774160,8.49,0,http://www.openphacts.org/units/Nanomolar,1422018,=,1,1,=,,IC50,nM,,3.2,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3.2
,,6196254,[],CHEMBL1777017,Competitive inhibition of human cIAP1BIR2-BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCc4ccc(CCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.72', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774157,,CHEMBL1774157,8.44,0,http://www.openphacts.org/units/Nanomolar,1422015,=,1,1,=,,IC50,nM,,3.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3.6
,,6196258,[],CHEMBL1777015,Competitive inhibition of human cIAP1 BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCc4ccc(CCCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.43', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774154,,CHEMBL1774154,8.34,0,http://www.openphacts.org/units/Nanomolar,1422011,=,1,1,=,,IC50,nM,,4.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4.6
,,6196259,[],CHEMBL1777015,Competitive inhibition of human cIAP1 BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCCOCCCCCn4cc([C@@H](NC(=O)[C@@H]5CC[C@@H]6CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N65)c5ccccc5)nn4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.63', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774163,,CHEMBL1774163,8.31,0,http://www.openphacts.org/units/Nanomolar,1422021,=,1,1,=,,IC50,nM,,4.9,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4.9
,,6196265,[],CHEMBL1777015,Competitive inhibition of human cIAP1 BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCCCc4ccc(CCCCCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.02', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774158,,CHEMBL1774158,8.27,0,http://www.openphacts.org/units/Nanomolar,1422016,=,1,1,=,,IC50,nM,,5.4,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,5.4
,,6196266,[],CHEMBL1777017,Competitive inhibition of human cIAP1BIR2-BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCc4ccc(CCCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.35', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774154,,CHEMBL1774154,8.24,0,http://www.openphacts.org/units/Nanomolar,1422011,=,1,1,=,,IC50,nM,,5.7,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,5.7
,,6196267,[],CHEMBL1777017,Competitive inhibition of human cIAP1BIR2-BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCc4ccc(CCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.74', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774156,,CHEMBL1774156,8.24,0,http://www.openphacts.org/units/Nanomolar,1422014,=,1,1,=,,IC50,nM,,5.7,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,5.7
,,6196272,[],CHEMBL1777015,Competitive inhibition of human cIAP1 BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCc4ccc(CCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.70', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774156,,CHEMBL1774156,8.21,0,http://www.openphacts.org/units/Nanomolar,1422014,=,1,1,=,,IC50,nM,,6.2,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,6.2
,,6196273,[],CHEMBL1777015,Competitive inhibition of human cIAP1 BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCc4cn(CCCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)nn4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.38', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774161,,CHEMBL1774161,8.21,0,http://www.openphacts.org/units/Nanomolar,1422019,=,1,1,=,,IC50,nM,,6.2,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,6.2
,,6196275,[],CHEMBL1777017,Competitive inhibition of human cIAP1BIR2-BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCc4cn(CCCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)nn4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.36', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774161,,CHEMBL1774161,8.19,0,http://www.openphacts.org/units/Nanomolar,1422019,=,1,1,=,,IC50,nM,,6.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,6.5
,,6196278,[],CHEMBL1777015,Competitive inhibition of human cIAP1 BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCNC(=O)NCCCCn4cc([C@@H](NC(=O)[C@@H]5CC[C@@H]6CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N65)c5ccccc5)nn4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.40', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774162,,CHEMBL1774162,8.17,0,http://www.openphacts.org/units/Nanomolar,1422020,=,1,1,=,,IC50,nM,,6.8,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,6.8
,,6196281,[],CHEMBL1777017,Competitive inhibition of human cIAP1BIR2-BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCCCCCc4ccc(CCCCCCCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '6.60', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774159,,CHEMBL1774159,8.14,0,http://www.openphacts.org/units/Nanomolar,1422017,=,1,1,=,,IC50,nM,,7.3,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,7.3
,,6196283,[],CHEMBL1777017,Competitive inhibition of human cIAP1BIR2-BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCNC(=O)NCCCCn4cc([C@@H](NC(=O)[C@@H]5CC[C@@H]6CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N65)c5ccccc5)nn4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.37', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774162,,CHEMBL1774162,8.13,0,http://www.openphacts.org/units/Nanomolar,1422020,=,1,1,=,,IC50,nM,,7.4,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,7.4
,,6196284,[],CHEMBL1777017,Competitive inhibition of human cIAP1BIR2-BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCCOCCCCCn4cc([C@@H](NC(=O)[C@@H]5CC[C@@H]6CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N65)c5ccccc5)nn4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.46', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774163,,CHEMBL1774163,8.13,0,http://www.openphacts.org/units/Nanomolar,1422021,=,1,1,=,,IC50,nM,,7.4,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,7.4
,,6196286,[],CHEMBL1777015,Competitive inhibition of human cIAP1 BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCOCCCCOCCn4cc([C@@H](NC(=O)[C@@H]5CC[C@@H]6CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N65)c5ccccc5)nn4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.54', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774164,,CHEMBL1774164,8.12,0,http://www.openphacts.org/units/Nanomolar,1422022,=,1,1,=,,IC50,nM,,7.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,7.5
,,6196294,[],CHEMBL1777017,Competitive inhibition of human cIAP1BIR2-BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(Cc4ccc(Cn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.77', 'le': None, 'lle': None, 'sei': None}",CHEMBL1773083,,CHEMBL1773083,8.06,0,http://www.openphacts.org/units/Nanomolar,1422013,=,1,1,=,,IC50,nM,,8.8,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,8.8
,,6196295,[],CHEMBL1777017,Competitive inhibition of human cIAP1BIR2-BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCCCCCCCn4cc([C@@H](NC(=O)[C@@H]5CC[C@@H]6CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N65)c5ccccc5)nn4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.50', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774031,,CHEMBL1774031,8.05,0,http://www.openphacts.org/units/Nanomolar,1421824,=,1,1,=,,IC50,nM,,9.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,9.0
,,6196296,[],CHEMBL1777017,Competitive inhibition of human cIAP1BIR2-BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCCCCCCCCCn4cc([C@@H](NC(=O)[C@@H]5CC[C@@H]6CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N65)c5ccccc5)nn4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.30', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774160,,CHEMBL1774160,8.04,0,http://www.openphacts.org/units/Nanomolar,1422018,=,1,1,=,,IC50,nM,,9.2,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,9.2
,,6196297,[],CHEMBL1777017,Competitive inhibition of human cIAP1BIR2-BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCCCc4ccc(CCCCCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '6.81', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774158,,CHEMBL1774158,8.02,0,http://www.openphacts.org/units/Nanomolar,1422016,=,1,1,=,,IC50,nM,,9.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,9.5
,,6196298,[],CHEMBL1777017,Competitive inhibition of human cIAP1BIR2-BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCOCCCCOCCn4cc([C@@H](NC(=O)[C@@H]5CC[C@@H]6CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N65)c5ccccc5)nn4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.43', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774164,,CHEMBL1774164,8.01,0,http://www.openphacts.org/units/Nanomolar,1422022,=,1,1,=,,IC50,nM,,9.8,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,9.8
,,6196300,[],CHEMBL1777015,Competitive inhibition of human cIAP1 BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(Cc4ccc(Cn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.71', 'le': None, 'lle': None, 'sei': None}",CHEMBL1773083,,CHEMBL1773083,8.00,0,http://www.openphacts.org/units/Nanomolar,1422013,=,1,1,=,,IC50,nM,,10.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,10.0
,,6196306,[],CHEMBL1777015,Competitive inhibition of human cIAP1 BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCCCCCc4ccc(CCCCCCCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '6.39', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774159,,CHEMBL1774159,7.89,0,http://www.openphacts.org/units/Nanomolar,1422017,=,1,1,=,,IC50,nM,,13.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,13.0
,,6196307,[],CHEMBL1777015,Competitive inhibition of human cIAP1 BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCOCCOCCOCCn4cc([C@@H](NC(=O)[C@@H]5CC[C@@H]6CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N65)c5ccccc5)nn4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.21', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774165,,CHEMBL1774165,7.89,0,http://www.openphacts.org/units/Nanomolar,1422023,=,1,1,=,,IC50,nM,,13.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,13.0
,,6196310,[],CHEMBL1777017,Competitive inhibition of human cIAP1BIR2-BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCOCCOCCOCCn4cc([C@@H](NC(=O)[C@@H]5CC[C@@H]6CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N65)c5ccccc5)nn4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '7.18', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774165,,CHEMBL1774165,7.85,0,http://www.openphacts.org/units/Nanomolar,1422023,=,1,1,=,,IC50,nM,,14.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,14.0
,,6196313,[],CHEMBL1777015,Competitive inhibition of human cIAP1 BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCc4ccc(CCCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](Cc8c[nH]c9ccccc89)NC(C)=O)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '6.16', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774166,,CHEMBL1774166,7.80,0,http://www.openphacts.org/units/Nanomolar,1422024,=,1,1,=,,IC50,nM,,16.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,16.0
,,6196320,[],CHEMBL1777017,Competitive inhibition of human cIAP1BIR2-BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCc4ccc(CCCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](Cc8c[nH]c9ccccc89)NC(C)=O)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '6.04', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774166,,CHEMBL1774166,7.64,0,http://www.openphacts.org/units/Nanomolar,1422024,=,1,1,=,,IC50,nM,,23.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,23.0
,,6196325,[],CHEMBL1777015,Competitive inhibition of human cIAP1 BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '15.57', 'le': '0.29', 'lle': '4.50', 'sei': '8.20'}",CHEMBL481422,,CHEMBL481422,7.42,0,http://www.openphacts.org/units/Nanomolar,1421823,=,1,1,=,,IC50,nM,,38.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,38.0
,,6196335,[],CHEMBL1777017,Competitive inhibition of human cIAP1BIR2-BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,"{'bei': '15.15', 'le': '0.28', 'lle': '4.30', 'sei': '7.98'}",CHEMBL481422,,CHEMBL481422,7.22,0,http://www.openphacts.org/units/Nanomolar,1421823,=,1,1,=,,IC50,nM,,60.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,60.0
,,6196385,[],CHEMBL1777017,Competitive inhibition of human cIAP1BIR2-BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCc4ccc(CCCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](Cc8c[nH]c9ccccc89)NC(C)=O)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,,CHEMBL1774155,,CHEMBL1774155,,0,http://www.openphacts.org/units/Nanomolar,1422012,>,1,1,>,,IC50,nM,,10000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,10000.0
,,6196391,[],CHEMBL1777015,Competitive inhibition of human cIAP1 BIR3 domain after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCc4ccc(CCCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](Cc8c[nH]c9ccccc89)NC(C)=O)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL1772970,J Med Chem,2011,,CHEMBL1774155,,CHEMBL1774155,,0,http://www.openphacts.org/units/Nanomolar,1422012,>,1,1,>,,IC50,nM,,50000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,50000.0
,,8032994,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1C[C@@H]2CC[C@H]1N(CCc1ccccc1)C2)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950864,,CHEMBL1950864,8.40,0,http://www.openphacts.org/units/Nanomolar,1578246,=,1,1,=,,IC50,nM,,4.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4.0
,,8032995,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2c[nH]c3ccccc23)C1)C(C)(C)C,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950863,,CHEMBL1950863,6.94,0,http://www.openphacts.org/units/Nanomolar,1578245,=,1,1,=,,IC50,nM,,115.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.115
,,8032996,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccncc2)C1)C(C)(C)C,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950862,,CHEMBL1950862,6.23,0,http://www.openphacts.org/units/Nanomolar,1578244,=,1,1,=,,IC50,nM,,593.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.593
,,8032997,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccccn2)C1)C(C)(C)C,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950861,,CHEMBL1950861,6.52,0,http://www.openphacts.org/units/Nanomolar,1578243,=,1,1,=,,IC50,nM,,301.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.301
,,8032998,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccc(C(F)(F)F)cc2)C1)C(C)(C)C,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950860,,CHEMBL1950860,7.31,0,http://www.openphacts.org/units/Nanomolar,1578242,=,1,1,=,,IC50,nM,,49.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.049
,,8032999,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccc([N+](=O)[O-])cc2)C1)C(C)(C)C,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950859,,CHEMBL1950859,7.50,0,http://www.openphacts.org/units/Nanomolar,1578241,=,1,1,=,,IC50,nM,,32.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.032
,,8033000,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccc(O)cc2)C1)C(C)(C)C,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950858,,CHEMBL1950858,7.38,0,http://www.openphacts.org/units/Nanomolar,1578240,=,1,1,=,,IC50,nM,,42.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.042
,,8033001,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccc(C)cc2)C1)C(C)(C)C,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950857,,CHEMBL1950857,7.52,0,http://www.openphacts.org/units/Nanomolar,1578239,=,1,1,=,,IC50,nM,,30.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.03
,,8033002,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccc(Br)cc2)C1)C(C)(C)C,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950856,,CHEMBL1950856,7.62,0,http://www.openphacts.org/units/Nanomolar,1578238,=,1,1,=,,IC50,nM,,24.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.024
,,8033003,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccc(Cl)cc2)C1)C(C)(C)C,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950855,,CHEMBL1950855,7.62,0,http://www.openphacts.org/units/Nanomolar,1578237,=,1,1,=,,IC50,nM,,24.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.024
,,8033004,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccc(OC)cc2)C1)C(C)(C)C,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950854,,CHEMBL1950854,7.05,0,http://www.openphacts.org/units/Nanomolar,1578236,=,1,1,=,,IC50,nM,,90.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.09
,,8033005,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2cccc(OC)c2)C1)C(C)(C)C,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950853,,CHEMBL1950853,7.28,0,http://www.openphacts.org/units/Nanomolar,1578235,=,1,1,=,,IC50,nM,,52.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.052
,,8033006,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccccc2OC)C1)C(C)(C)C,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950852,,CHEMBL1950852,7.30,0,http://www.openphacts.org/units/Nanomolar,1578234,=,1,1,=,,IC50,nM,,50.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.05
,,8033007,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccc(F)cc2)C1)C(C)(C)C,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950851,,CHEMBL1950851,7.70,0,http://www.openphacts.org/units/Nanomolar,1578233,=,1,1,=,,IC50,nM,,20.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.02
,,8033008,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccc(F)cc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950850,,CHEMBL1950850,7.75,0,http://www.openphacts.org/units/Nanomolar,1578232,=,1,1,=,,IC50,nM,,18.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.018
,,8033009,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2cccc(F)c2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950849,,CHEMBL1950849,7.17,0,http://www.openphacts.org/units/Nanomolar,1578231,=,1,1,=,,IC50,nM,,68.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.068
,,8033010,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccccc2F)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950848,,CHEMBL1950848,7.48,0,http://www.openphacts.org/units/Nanomolar,1578230,=,1,1,=,,IC50,nM,,33.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.033
,,8033011,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(S(=O)(=O)Cc2ccccc2)C1)C(C)(C)C,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950847,,CHEMBL1950847,5.41,0,http://www.openphacts.org/units/Nanomolar,1578229,=,1,1,=,,IC50,nM,,3890.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,3.89
,,8033012,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(S(=O)(=O)c2ccccc2)C1)C(C)(C)C,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950846,,CHEMBL1950846,5.24,0,http://www.openphacts.org/units/Nanomolar,1578228,=,1,1,=,,IC50,nM,,5750.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,5.75
,,8033013,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN([C@@H]2CCCc3ccccc32)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950845,,CHEMBL1950845,5.70,0,http://www.openphacts.org/units/Nanomolar,1578227,=,1,1,=,,IC50,nM,,1990.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,1.99
,,8033014,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CC(c2ccccc2)c2ccccc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950844,,CHEMBL1950844,7.21,0,http://www.openphacts.org/units/Nanomolar,1578226,=,1,1,=,,IC50,nM,,62.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.062
,,8033015,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N(C)[C@H]1CCCN(CCc2ccccc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950843,,CHEMBL1950843,7.36,0,http://www.openphacts.org/units/Nanomolar,1578225,=,1,1,=,,IC50,nM,,44.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.044
,,8033016,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccccc2)C1)C(C)(C)C,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950842,,CHEMBL1950842,7.58,0,http://www.openphacts.org/units/Nanomolar,1578224,=,1,1,=,,IC50,nM,,26.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.026
,,8033017,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCCN(CCc2ccccc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950841,,CHEMBL1950841,7.10,0,http://www.openphacts.org/units/Nanomolar,1578223,=,1,1,=,,IC50,nM,,80.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.08
,,8033018,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCCN(Cc2ccccc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950732,,CHEMBL1950732,6.57,0,http://www.openphacts.org/units/Nanomolar,1578063,=,1,1,=,,IC50,nM,,270.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.27
,,8033019,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(C(=O)OCc2ccccc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950731,,CHEMBL1950731,6.35,0,http://www.openphacts.org/units/Nanomolar,1578062,=,1,1,=,,IC50,nM,,450.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.45
,,8033020,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(C(=O)Cc2ccccc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950730,,CHEMBL1950730,6.89,0,http://www.openphacts.org/units/Nanomolar,1578061,=,1,1,=,,IC50,nM,,130.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.13
,,8033021,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(C(=O)c2ccccc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950729,,CHEMBL1950729,5.47,0,http://www.openphacts.org/units/Nanomolar,1578060,=,1,1,=,,IC50,nM,,3360.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,3.36
,,8033022,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCCc2ccccc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950728,,CHEMBL1950728,6.10,0,http://www.openphacts.org/units/Nanomolar,1578059,=,1,1,=,,IC50,nM,,790.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.79
,,8033023,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(Cc2ccccc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950727,,CHEMBL1950727,5.77,0,http://www.openphacts.org/units/Nanomolar,1578058,=,1,1,=,,IC50,nM,,1690.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,1.69
,,8033024,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCN(C(=O)OCc2ccccc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950726,,CHEMBL1950726,6.13,0,http://www.openphacts.org/units/Nanomolar,1578057,=,1,1,=,,IC50,nM,,740.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.74
,,8033025,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCN(C(=O)Cc2ccccc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950725,,CHEMBL1950725,6.11,0,http://www.openphacts.org/units/Nanomolar,1578056,=,1,1,=,,IC50,nM,,780.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.78
,,8033026,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCN(C(=O)c2ccccc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950724,,CHEMBL1950724,5.30,0,http://www.openphacts.org/units/Nanomolar,1578055,=,1,1,=,,IC50,nM,,5020.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,5.02
,,8033027,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCN(CCCc2ccccc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950723,,CHEMBL1950723,6.13,0,http://www.openphacts.org/units/Nanomolar,1578054,=,1,1,=,,IC50,nM,,740.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.74
,,8033028,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCN(CCc2ccccc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950722,,CHEMBL1950722,6.30,0,http://www.openphacts.org/units/Nanomolar,1578053,=,1,1,=,,IC50,nM,,500.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.5
,,8033029,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCN(Cc2ccccc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1950721,,CHEMBL1950721,5.47,0,http://www.openphacts.org/units/Nanomolar,1578052,=,1,1,=,,IC50,nM,,3380.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,3.38
,,8033030,[],CHEMBL1952922,Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assay,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccccc2)C1)C1CCCCC1,,,CHEMBL1949628,Bioorg Med Chem Lett,2012,,CHEMBL1949685,,CHEMBL1949685,7.40,0,http://www.openphacts.org/units/Nanomolar,1578051,=,1,1,=,,IC50,nM,,40.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.04
,,8059973,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1ccc(N)cc1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,,CHEMBL1957107,,CHEMBL1957107,,0,http://www.openphacts.org/units/Nanomolar,1581598,<,1,1,<,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,8059974,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1ccc(C(=O)OC)cc1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,,CHEMBL1957106,,CHEMBL1957106,,0,http://www.openphacts.org/units/Nanomolar,1581597,<,1,1,<,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,8059975,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1ccc([N+](=O)[O-])cc1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,,CHEMBL1957105,,CHEMBL1957105,,0,http://www.openphacts.org/units/Nanomolar,1581596,<,1,1,<,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,8059976,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1ccc(OC)cc1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,,CHEMBL1957026,,CHEMBL1957026,,0,http://www.openphacts.org/units/Nanomolar,1581497,<,1,1,<,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,8059977,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1ccc(C(C)(C)C)cc1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,"{'bei': '12.74', 'le': '0.24', 'lle': '2.86', 'sei': '8.27'}",CHEMBL1957025,,CHEMBL1957025,8.48,0,http://www.openphacts.org/units/Nanomolar,1581496,=,1,1,=,,IC50,nM,,3.3,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3.3
,,8059978,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1ccc(C(F)(F)F)cc1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,,CHEMBL1957024,,CHEMBL1957024,,0,http://www.openphacts.org/units/Nanomolar,1581495,<,1,1,<,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,8059979,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1cc(F)cc(F)c1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,,CHEMBL1957023,,CHEMBL1957023,,0,http://www.openphacts.org/units/Nanomolar,1581494,<,1,1,<,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,8059980,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1cc(Cl)cc(Cl)c1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,"{'bei': '12.65', 'le': '0.25', 'lle': '2.96', 'sei': '8.37'}",CHEMBL1957022,,CHEMBL1957022,8.59,0,http://www.openphacts.org/units/Nanomolar,1581493,=,1,1,=,,IC50,nM,,2.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.6
,,8059981,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1ccc(F)cc1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,,CHEMBL1957021,,CHEMBL1957021,,0,http://www.openphacts.org/units/Nanomolar,1581492,<,1,1,<,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,8059982,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1cccc(F)c1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,,CHEMBL1957020,,CHEMBL1957020,,0,http://www.openphacts.org/units/Nanomolar,1581491,<,1,1,<,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,8059983,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1ccccc1F)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,,CHEMBL1957019,,CHEMBL1957019,,0,http://www.openphacts.org/units/Nanomolar,1581490,<,1,1,<,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,8059984,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1ccc(Cl)cc1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,,CHEMBL1957018,,CHEMBL1957018,,0,http://www.openphacts.org/units/Nanomolar,1581489,<,1,1,<,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,8059985,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1cccc(Cl)c1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,,CHEMBL1957017,,CHEMBL1957017,,0,http://www.openphacts.org/units/Nanomolar,1581488,<,1,1,<,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,8059986,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1ccccc1Cl)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,,CHEMBL1957016,,CHEMBL1957016,,0,http://www.openphacts.org/units/Nanomolar,1581487,<,1,1,<,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,8059987,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1ccc(C)cc1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,,CHEMBL1957015,,CHEMBL1957015,,0,http://www.openphacts.org/units/Nanomolar,1581486,<,1,1,<,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,8059988,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1cccc(C)c1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,,CHEMBL1957014,,CHEMBL1957014,,0,http://www.openphacts.org/units/Nanomolar,1581485,<,1,1,<,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,8059989,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1ccccc1C)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,,CHEMBL1957013,,CHEMBL1957013,,0,http://www.openphacts.org/units/Nanomolar,1581483,<,1,1,<,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,8059990,[],CHEMBL1958905,Displacement of AbuRPF-K(5-Fam)-NH2 from human recombinant His-tagged-cIAP1 BIR3 domain after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNCc1ccccc1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL1955754,Bioorg Med Chem Lett,2012,,CHEMBL575256,,CHEMBL575256,,0,http://www.openphacts.org/units/Nanomolar,1581484,<,1,1,<,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,12070911,[],CHEMBL2162884,Competitive inhibition of human cIAP1 BIR3 domain expressed in Escherichia coli BL21(DE3) after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(N)=O,,,CHEMBL2157893,J Med Chem,2011,"{'bei': '15.09', 'le': '0.29', 'lle': '6.52', 'sei': '4.06'}",CHEMBL365059,,CHEMBL365059,6.00,0,http://www.openphacts.org/units/Nanomolar,1732876,=,1,1,=,,IC50,nM,,999.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,999.0
,,12070912,[],CHEMBL2162884,Competitive inhibition of human cIAP1 BIR3 domain expressed in Escherichia coli BL21(DE3) after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CC(C)C)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2157893,J Med Chem,2011,"{'bei': '14.08', 'le': '0.26', 'lle': '5.29', 'sei': '7.14'}",CHEMBL2158051,XEVINAPANT,CHEMBL2158051,7.91,0,http://www.openphacts.org/units/Nanomolar,1732877,=,1,1,=,,IC50,nM,,12.3,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,12.3
,,12070913,[],CHEMBL2162884,Competitive inhibition of human cIAP1 BIR3 domain expressed in Escherichia coli BL21(DE3) after 2 to 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H]1CN(C(=O)CC(C)C)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2157893,J Med Chem,2011,"{'bei': '6.52', 'le': '0.12', 'lle': '0.08', 'sei': '3.48'}",CHEMBL2158052,,CHEMBL2158052,4.41,0,http://www.openphacts.org/units/Nanomolar,1732878,=,1,1,=,,IC50,nM,,38900.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,38900.0
,,12077983,[],CHEMBL2160288,Binding affinity to BIR3 domain of cIAP1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2157891,J Med Chem,2012,"{'bei': '15.39', 'le': '0.29', 'lle': '4.42', 'sei': '8.10'}",CHEMBL481422,,CHEMBL481422,7.33,1,http://www.openphacts.org/units/Nanomolar,1733561,=,1,1,=,,IC50,nM,,46.2,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,46.2
,,12077984,[],CHEMBL2160288,Binding affinity to BIR3 domain of cIAP1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(C)=O)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2157891,J Med Chem,2012,"{'bei': '15.62', 'le': '0.29', 'lle': '6.52', 'sei': '7.32'}",CHEMBL456400,,CHEMBL456400,8.12,0,http://www.openphacts.org/units/Nanomolar,1733563,=,1,1,=,,IC50,nM,,7.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,7.6
,,12077985,[],CHEMBL2160288,Binding affinity to BIR3 domain of cIAP1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCc4ccc(CCCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL2157891,J Med Chem,2012,"{'bei': '7.43', 'le': None, 'lle': None, 'sei': None}",CHEMBL1774154,,CHEMBL1774154,8.34,1,http://www.openphacts.org/units/Nanomolar,1733564,=,1,1,=,,IC50,nM,,4.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4.6
,,12077986,[],CHEMBL2160288,Binding affinity to BIR3 domain of cIAP1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCCCCCn4cc([C@@H](NC(=O)[C@@H]5CC[C@@H]6CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N65)c5ccccc5)nn4)nn3)N2C1=O,,,CHEMBL2157891,J Med Chem,2012,"{'bei': '8.18', 'le': None, 'lle': None, 'sei': None}",CHEMBL2158599,,CHEMBL2158599,8.55,0,http://www.openphacts.org/units/Nanomolar,1733565,=,1,1,=,,IC50,nM,,2.8,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.8
,,12077987,[],CHEMBL2160288,Binding affinity to BIR3 domain of cIAP1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CCC(=O)N2CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2157891,J Med Chem,2012,"{'bei': '7.92', 'le': None, 'lle': None, 'sei': None}",CHEMBL2158600,,CHEMBL2158600,8.21,0,http://www.openphacts.org/units/Nanomolar,1733566,=,1,1,=,,IC50,nM,,6.1,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,6.1
,,12077988,[],CHEMBL2160288,Binding affinity to BIR3 domain of cIAP1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CCCCC(=O)N2CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2157891,J Med Chem,2012,"{'bei': '7.83', 'le': None, 'lle': None, 'sei': None}",CHEMBL2158601,,CHEMBL2158601,8.35,0,http://www.openphacts.org/units/Nanomolar,1733567,=,1,1,=,,IC50,nM,,4.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4.5
,,12077989,[],CHEMBL2160288,Binding affinity to BIR3 domain of cIAP1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CCCCCCC(=O)N2CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2157891,J Med Chem,2012,"{'bei': '7.38', 'le': None, 'lle': None, 'sei': None}",CHEMBL2158602,,CHEMBL2158602,8.07,0,http://www.openphacts.org/units/Nanomolar,1733568,=,1,1,=,,IC50,nM,,8.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,8.6
,,12077990,[],CHEMBL2160288,Binding affinity to BIR3 domain of cIAP1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CCCCCCCCC(=O)N2CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2157891,J Med Chem,2012,"{'bei': '7.04', 'le': None, 'lle': None, 'sei': None}",CHEMBL2158603,,CHEMBL2158603,7.89,0,http://www.openphacts.org/units/Nanomolar,1733569,=,1,1,=,,IC50,nM,,12.9,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,12.9
,,12077991,[],CHEMBL2160288,Binding affinity to BIR3 domain of cIAP1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CCCCCCCCCCC(=O)N2CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2157891,J Med Chem,2012,"{'bei': '6.88', 'le': None, 'lle': None, 'sei': None}",CHEMBL2158604,,CHEMBL2158604,7.91,0,http://www.openphacts.org/units/Nanomolar,1733570,=,1,1,=,,IC50,nM,,12.4,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,12.4
,,12077992,[],CHEMBL2160288,Binding affinity to BIR3 domain of cIAP1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CCCCc2ccc(CCCCC(=O)N3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2157891,J Med Chem,2012,"{'bei': '6.48', 'le': None, 'lle': None, 'sei': None}",CHEMBL2158605,,CHEMBL2158605,7.76,0,http://www.openphacts.org/units/Nanomolar,1733571,=,1,1,=,,IC50,nM,,17.4,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,17.4
,,12077993,[],CHEMBL2160288,Binding affinity to BIR3 domain of cIAP1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CCCCOCCCCC(=O)N2CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2157891,J Med Chem,2012,"{'bei': '7.10', 'le': None, 'lle': None, 'sei': None}",CHEMBL2158606,,CHEMBL2158606,8.07,0,http://www.openphacts.org/units/Nanomolar,1733572,=,1,1,=,,IC50,nM,,8.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,8.5
,,12077994,[],CHEMBL2160288,Binding affinity to BIR3 domain of cIAP1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)c2ccc(C(=O)N3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2157891,J Med Chem,2012,"{'bei': '7.07', 'le': None, 'lle': None, 'sei': None}",CHEMBL2158607,,CHEMBL2158607,7.67,0,http://www.openphacts.org/units/Nanomolar,1733573,=,1,1,=,,IC50,nM,,21.2,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,21.2
,,12178346,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CO)CC[C@H]2C(=O)N[C@H](C(=O)NCCCCCNc1c(NCCCCCNC(=O)[C@@H](NC(=O)[C@@H]2CC[C@@H]3CC[C@H](CO)[C@H](NC(=O)[C@H](CC)NC)C(=O)N32)c2ccccc2)c(=O)c1=O)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '7.18', 'le': None, 'lle': None, 'sei': None}",CHEMBL2205247,,CHEMBL2220310,8.59,0,http://www.openphacts.org/units/Nanomolar,1758298,=,1,1,=,,IC50,nM,,2.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.6
,,12178347,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CO)CC[C@H]2C(=O)N[C@H](C(=O)NCCNC(=O)CCC#CC#CCCC(=O)NCCNC(=O)[C@@H](NC(=O)[C@@H]1CC[C@@H]2CC[C@H](CO)[C@H](NC(=O)[C@H](CC)NC)C(=O)N21)c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '7.52', 'le': None, 'lle': None, 'sei': None}",CHEMBL2205248,,CHEMBL2220133,8.96,0,http://www.openphacts.org/units/Nanomolar,1758299,=,1,1,=,,IC50,nM,,1.1,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.1
,,12178348,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNCc1ccccc1)CC[C@H]2C(=O)N[C@@H](c1ccccc1)c1cn(CCCCc2ccc(CCCCn3cc([C@@H](NC(=O)[C@@H]4CC[C@@H]5CC[C@H](CNCc6ccccc6)[C@H](NC(=O)[C@H](CC)NC)C(=O)N54)c4ccccc4)nn3)cc2)nn1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '5.70', 'le': None, 'lle': None, 'sei': None}",CHEMBL2205249,,CHEMBL2220076,7.75,0,http://www.openphacts.org/units/Nanomolar,1758300,=,1,1,=,,IC50,nM,,17.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,17.6
,,12178349,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCN)CC[C@H]2C(=O)N[C@H](C(=O)NCCCOCCOCCOCCCNC(=O)[C@@H](NC(=O)[C@@H]1CC[C@@H]2CC[C@H](CCN)[C@H](NC(=O)[C@H](CC)NC)C(=O)N21)c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,,CHEMBL2204566,,CHEMBL2220233,,0,http://www.openphacts.org/units/Nanomolar,1757380,<=,1,1,<=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,,12178350,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CCNC(=O)CCc1cn(CCOCCOCCOCCNC(=O)[C@@H](NC(=O)[C@@H]3CC[C@@H]4CC[C@H](CO)[C@H](NC(=O)[C@H](CC)NC)C(=O)N43)c3ccccc3)nn1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '6.92', 'le': None, 'lle': None, 'sei': None}",CHEMBL2204567,,CHEMBL2220204,8.82,0,http://www.openphacts.org/units/Nanomolar,1757381,=,1,1,=,,IC50,nM,,1.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.5
,,12178351,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1Cn1cc(CCC(=O)NCCOCCOCCOCCNC(=O)[C@@H](NC(=O)[C@@H]3CC[C@@H]4CC[C@H](CO)[C@H](NC(=O)[C@H](CC)NC)C(=O)N43)c3ccccc3)nn1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '6.59', 'le': None, 'lle': None, 'sei': None}",CHEMBL2204568,,CHEMBL2220339,8.30,0,http://www.openphacts.org/units/Nanomolar,1757382,=,1,1,=,,IC50,nM,,5.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,5.0
,,12178352,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNC(=O)COCC(=O)NCCOCCOCCOCCNC(=O)[C@@H](NC(=O)[C@@H]1CC[C@@H]3CC[C@H](CO)[C@H](NC(=O)[C@H](CC)NC)C(=O)N31)c1ccccc1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '6.78', 'le': None, 'lle': None, 'sei': None}",CHEMBL2204569,,CHEMBL2220018,8.49,0,http://www.openphacts.org/units/Nanomolar,1757383,=,1,1,=,,IC50,nM,,3.2,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3.2
,,12178353,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](N)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1Cn1cc(CO[C@H](C)[C@H](NC(=O)[C@H](C)NC)C(=O)N3CCC[C@H]3Cn3nnnc3Sc3ccccc3)nn1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL2203032,Bioorg Med Chem,2012,,CHEMBL2204570,,CHEMBL2204570,,0,http://www.openphacts.org/units/Nanomolar,1757384,<=,1,1,<=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,,12178402,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1Cn1nnnc1Sc1ccccc1)[C@H](C)OCC#CC#CCO[C@@H](C)[C@H](NC(=O)[C@H](C)NC)C(=O)N1CCC[C@H]1Cn1nnnc1Sc1ccccc1,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '8.15', 'le': '0.16', 'lle': '6.25', 'sei': '3.46'}",CHEMBL2204571,,CHEMBL2204571,7.90,0,http://www.openphacts.org/units/Nanomolar,1757385,=,1,1,=,,IC50,nM,,12.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,12.6
,,12178403,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCc4ccc(CCCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,,,CHEMBL2203032,Bioorg Med Chem,2012,,CHEMBL1774154,,CHEMBL1774154,,0,http://www.openphacts.org/units/Nanomolar,1757386,<=,1,1,<=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,,12178404,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNC(=O)c1cn(C[C@H]3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@H]3NC(=O)[C@H](CC)NC)nn1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '8.05', 'le': None, 'lle': None, 'sei': None}",CHEMBL2204572,,CHEMBL2220313,8.77,0,http://www.openphacts.org/units/Nanomolar,1757387,=,1,1,=,,IC50,nM,,1.7,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.7
,,12178405,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNC(=O)CCc1cn(C[C@H]3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@H]3NC(=O)[C@H](CC)NC)nn1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '7.64', 'le': None, 'lle': None, 'sei': None}",CHEMBL2204573,,CHEMBL2220038,8.54,0,http://www.openphacts.org/units/Nanomolar,1757388,=,1,1,=,,IC50,nM,,2.9,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.9
,,12178406,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNC(=O)CCCC#CC#CCCCC(=O)NC[C@H]1CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@H]1NC(=O)[C@H](CC)NC)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '7.39', 'le': None, 'lle': None, 'sei': None}",CHEMBL2204574,,CHEMBL2220039,8.85,0,http://www.openphacts.org/units/Nanomolar,1757389,=,1,1,=,,IC50,nM,,1.4,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.4
,,12178407,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNC(=O)CCCCCCCCC(=O)NC[C@H]1CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@H]1NC(=O)[C@H](CC)NC)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '7.52', 'le': None, 'lle': None, 'sei': None}",CHEMBL2204575,,CHEMBL2220296,8.85,0,http://www.openphacts.org/units/Nanomolar,1757390,=,1,1,=,,IC50,nM,,1.4,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.4
,,12178408,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNC(=O)COCCOCCOCC(=O)NC[C@H]1CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@H]1NC(=O)[C@H](CC)NC)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '7.32', 'le': None, 'lle': None, 'sei': None}",CHEMBL2204576,,CHEMBL2220292,8.77,0,http://www.openphacts.org/units/Nanomolar,1757391,=,1,1,=,,IC50,nM,,1.7,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.7
,,12178409,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNC(=O)COCCOCCOCCOCC(=O)NC[C@H]1CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@H]1NC(=O)[C@H](CC)NC)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,,CHEMBL2204577,,CHEMBL2220200,,0,http://www.openphacts.org/units/Nanomolar,1757392,<=,1,1,<=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,,12178410,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNC(=O)CCCCC#CC#CCCCCCC(=O)NC[C@H]1CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@H]1NC(=O)[C@H](CC)NC)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '6.79', 'le': None, 'lle': None, 'sei': None}",CHEMBL2204578,,CHEMBL2219999,8.42,0,http://www.openphacts.org/units/Nanomolar,1757393,=,1,1,=,,IC50,nM,,3.8,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3.8
,,12178411,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNC(=O)CCCCc1cn(CCCCc3ccc(CCCCn4cc(CCCCC(=O)NC[C@H]5CC[C@H]6CC[C@@H](C(=O)NC(c7ccccc7)c7ccccc7)N6C(=O)[C@H]5NC(=O)[C@H](CC)NC)nn4)cc3)nn1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '5.64', 'le': None, 'lle': None, 'sei': None}",CHEMBL2204579,,CHEMBL2220019,8.46,0,http://www.openphacts.org/units/Nanomolar,1757394,=,1,1,=,,IC50,nM,,3.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3.5
,,12178412,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNC(=O)CCNc1c(NCCC(=O)NC[C@H]3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@H]3NC(=O)[C@H](CC)NC)c(=O)c1=O)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,,CHEMBL2204580,,CHEMBL2220295,,0,http://www.openphacts.org/units/Nanomolar,1757395,<=,1,1,<=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,,12178413,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CO)CC[C@H]2C(=O)N[C@@H](c1ccccc1)c1cn(CCCCc2ccc(CCCCn3cc([C@@H](NC(=O)[C@@H]4CC[C@@H]5CC[C@H](CO)[C@H](NC(=O)[C@H](CC)NC)C(=O)N54)c4ccccc4)nn3)cc2)nn1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '7.00', 'le': None, 'lle': None, 'sei': None}",CHEMBL2204581,,CHEMBL2220359,8.27,0,http://www.openphacts.org/units/Nanomolar,1757396,=,1,1,=,,IC50,nM,,5.4,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,5.4
,,12178414,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CO)CC[C@H]2C(=O)N[C@H](C(=O)NCCCCCCCCNC(=O)[C@@H](NC(=O)[C@@H]1CC[C@@H]2CC[C@H](CO)[C@H](NC(=O)[C@H](CC)NC)C(=O)N21)c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '8.25', 'le': None, 'lle': None, 'sei': None}",CHEMBL2204582,,CHEMBL2220294,8.72,0,http://www.openphacts.org/units/Nanomolar,1757397,=,1,1,=,,IC50,nM,,1.9,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.9
,,12178415,[],CHEMBL2216052,Displacement of FITC-Smac from human recombinant His-tagged cIAP-1 BIR3 domain (245 to 357 residues) after 3 hrs by fluorescent polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CO)CC[C@H]2C(=O)N[C@H](C(=O)NCCCOCCOCCOCCCNC(=O)[C@@H](NC(=O)[C@@H]1CC[C@@H]2CC[C@H](CO)[C@H](NC(=O)[C@H](CC)NC)C(=O)N21)c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F,,,CHEMBL2203032,Bioorg Med Chem,2012,"{'bei': '7.79', 'le': None, 'lle': None, 'sei': None}",CHEMBL2205246,,CHEMBL2220057,8.82,0,http://www.openphacts.org/units/Nanomolar,1758297,=,1,1,=,,IC50,nM,,1.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.5
,,12727024,[],CHEMBL2351926,Binding affinity to cIAP1 BIR3 domain (unknown origin) after 3 hrs by competitive fluorescence polarization assay in presence of Smac-2F,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CCc2ccc(CCC(=O)N3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2346602,J Med Chem,2013,"{'bei': '6.24', 'le': None, 'lle': None, 'sei': None}",CHEMBL2348613,,CHEMBL2348613,7.13,0,http://www.openphacts.org/units/Nanomolar,1876670,=,1,1,=,,IC50,nM,,74.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,74.6
,,12727025,[],CHEMBL2351926,Binding affinity to cIAP1 BIR3 domain (unknown origin) after 3 hrs by competitive fluorescence polarization assay in presence of Smac-2F,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Cc2ccc(CC(=O)N3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2346602,J Med Chem,2013,"{'bei': '6.78', 'le': None, 'lle': None, 'sei': None}",CHEMBL2348614,,CHEMBL2348614,7.54,0,http://www.openphacts.org/units/Nanomolar,1876671,=,1,1,=,,IC50,nM,,28.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,28.5
,,12727026,[],CHEMBL2351926,Binding affinity to cIAP1 BIR3 domain (unknown origin) after 3 hrs by competitive fluorescence polarization assay in presence of Smac-2F,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2346602,J Med Chem,2013,"{'bei': '6.35', 'le': None, 'lle': None, 'sei': None}",CHEMBL2348615,,CHEMBL2348615,7.31,0,http://www.openphacts.org/units/Nanomolar,1876672,=,1,1,=,,IC50,nM,,48.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,48.6
,,12727027,[],CHEMBL2351926,Binding affinity to cIAP1 BIR3 domain (unknown origin) after 3 hrs by competitive fluorescence polarization assay in presence of Smac-2F,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2346602,J Med Chem,2013,"{'bei': '6.98', 'le': None, 'lle': None, 'sei': None}",CHEMBL2348616,,CHEMBL2348616,7.64,0,http://www.openphacts.org/units/Nanomolar,1876673,=,1,1,=,,IC50,nM,,22.9,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,22.9
,,12727028,[],CHEMBL2351926,Binding affinity to cIAP1 BIR3 domain (unknown origin) after 3 hrs by competitive fluorescence polarization assay in presence of Smac-2F,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)N2CCN(C(=O)N3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)CC2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2346602,J Med Chem,2013,"{'bei': '6.85', 'le': None, 'lle': None, 'sei': None}",CHEMBL2348617,,CHEMBL2348617,7.49,0,http://www.openphacts.org/units/Nanomolar,1876674,=,1,1,=,,IC50,nM,,32.7,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,32.7
,,12727029,[],CHEMBL2351926,Binding affinity to cIAP1 BIR3 domain (unknown origin) after 3 hrs by competitive fluorescence polarization assay in presence of Smac-2F,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)N[C@H]2CC[C@H](NC(=O)N3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)CC2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2346602,J Med Chem,2013,"{'bei': '6.70', 'le': None, 'lle': None, 'sei': None}",CHEMBL2348618,,CHEMBL2348618,7.51,0,http://www.openphacts.org/units/Nanomolar,1876675,=,1,1,=,,IC50,nM,,30.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,30.6
,,12727030,[],CHEMBL2351926,Binding affinity to cIAP1 BIR3 domain (unknown origin) after 3 hrs by competitive fluorescence polarization assay in presence of Smac-2F,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(Oc3ccc(NC(=O)N4CC[C@H]5CC[C@@H](C(=O)NC(c6ccccc6)c6ccccc6)N5C(=O)[C@@H](NC(=O)[C@H](C)NC)C4)cc3)cc2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2346602,J Med Chem,2013,"{'bei': '6.62', 'le': None, 'lle': None, 'sei': None}",CHEMBL2348619,,CHEMBL2348619,8.00,0,http://www.openphacts.org/units/Nanomolar,1876676,=,1,1,=,,IC50,nM,,10.1,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,10.1
,,12727031,[],CHEMBL2351926,Binding affinity to cIAP1 BIR3 domain (unknown origin) after 3 hrs by competitive fluorescence polarization assay in presence of Smac-2F,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(Cc3ccc(NC(=O)N4CC[C@H]5CC[C@@H](C(=O)NC(c6ccccc6)c6ccccc6)N5C(=O)[C@@H](NC(=O)[C@H](C)NC)C4)cc3)cc2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2346602,J Med Chem,2013,"{'bei': '6.26', 'le': None, 'lle': None, 'sei': None}",CHEMBL2348620,,CHEMBL2348620,7.55,0,http://www.openphacts.org/units/Nanomolar,1876677,=,1,1,=,,IC50,nM,,28.4,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,28.4
,,12727032,[],CHEMBL2351926,Binding affinity to cIAP1 BIR3 domain (unknown origin) after 3 hrs by competitive fluorescence polarization assay in presence of Smac-2F,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCc2cccc(CNC(=O)N3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)c2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2346602,J Med Chem,2013,"{'bei': '6.61', 'le': None, 'lle': None, 'sei': None}",CHEMBL2348621,,CHEMBL2348621,7.56,0,http://www.openphacts.org/units/Nanomolar,1876678,=,1,1,=,,IC50,nM,,27.4,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,27.4
,,12727033,[],CHEMBL2351926,Binding affinity to cIAP1 BIR3 domain (unknown origin) after 3 hrs by competitive fluorescence polarization assay in presence of Smac-2F,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2cccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)c2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2346602,J Med Chem,2013,"{'bei': '6.62', 'le': None, 'lle': None, 'sei': None}",CHEMBL2348622,,CHEMBL2348622,7.38,0,http://www.openphacts.org/units/Nanomolar,1876679,=,1,1,=,,IC50,nM,,41.7,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,41.7
,,12727034,[],CHEMBL2351926,Binding affinity to cIAP1 BIR3 domain (unknown origin) after 3 hrs by competitive fluorescence polarization assay in presence of Smac-2F,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL2346602,J Med Chem,2013,"{'bei': '6.87', 'le': None, 'lle': None, 'sei': None}",CHEMBL2348623,,CHEMBL2348623,7.66,0,http://www.openphacts.org/units/Nanomolar,1876680,=,1,1,=,,IC50,nM,,21.7,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,21.7
,,13421520,[],CHEMBL2421322,Displacement of biotinyl-Smac from His-tagged human recombinant cIAP-1 BIR3 domain (250-350) after overnight incubation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@H]2CCCN2C[C@H]1C(=O)N[C@@H]1CCOc2ccccc21)C1CCCCC1.Cl.Cl,,,CHEMBL2417358,Bioorg Med Chem,2013,"{'bei': '16.51', 'le': '0.31', 'lle': '6.71', 'sei': '8.42'}",CHEMBL3142652,,CHEMBL2365533,8.68,0,http://www.openphacts.org/units/Nanomolar,1913586,=,1,1,=,,IC50,nM,,2.1,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.1
,,13421521,[],CHEMBL2421322,Displacement of biotinyl-Smac from His-tagged human recombinant cIAP-1 BIR3 domain (250-350) after overnight incubation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@H]2C[C@@H]3C[C@@H]3N2C[C@H]1C(=O)N[C@@H]1CCOc2ccccc21)C1CCCCC1.Cl.Cl,,,CHEMBL2417358,Bioorg Med Chem,2013,"{'bei': '15.73', 'le': '0.30', 'lle': '6.49', 'sei': '8.21'}",CHEMBL3216147,,CHEMBL3039743,8.46,0,http://www.openphacts.org/units/Nanomolar,1913587,=,1,1,=,,IC50,nM,,3.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3.5
,,13421522,[],CHEMBL2421322,Displacement of biotinyl-Smac from His-tagged human recombinant cIAP-1 BIR3 domain (250-350) after overnight incubation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@H]2C[C@H]3C[C@H]3N2C[C@H]1C(=O)N[C@@H]1CCOc2ccccc21)C1CCCCC1.Cl.Cl,,,CHEMBL2417358,Bioorg Med Chem,2013,"{'bei': '14.05', 'le': '0.26', 'lle': '5.58', 'sei': '7.33'}",CHEMBL3216595,,CHEMBL3040848,7.55,0,http://www.openphacts.org/units/Nanomolar,1913588,=,1,1,=,,IC50,nM,,28.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,28.0
,,13469286,[],CHEMBL2434143,Inhibition of His-thrombin-TEV-tagged cIAP1 BIR3 domain (260 to 352) (unknown origin) after 1 hr by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H]1C(=O)N(Cc2c(C#N)n(-c3ccccc3C#N)c3ccccc23)c2ccccc2OC12CCOCC2.Cl,,,CHEMBL2429856,J Med Chem,2013,,CHEMBL2431755,,CHEMBL2436227,,0,http://www.openphacts.org/units/Nanomolar,1922700,>,1,1,>,,IC50,nM,,55000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,55.0
,,13469287,[],CHEMBL2434143,Inhibition of His-thrombin-TEV-tagged cIAP1 BIR3 domain (260 to 352) (unknown origin) after 1 hr by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1,,,CHEMBL2429856,J Med Chem,2013,"{'bei': '14.45', 'le': '0.28', 'lle': '3.39', 'sei': '7.92'}",CHEMBL2431768,LCL-161,CHEMBL2431768,7.24,0,http://www.openphacts.org/units/Nanomolar,1922713,=,1,1,=,,IC50,nM,,58.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.058
,,13469360,[],CHEMBL2434144,Inhibition of His-thrombin-TEV-tagged cIAP1 BIR2 domain (174 to 256) (unknown origin) after 1 hr by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H]1C(=O)N(Cc2c(C#N)n(-c3ccccc3C#N)c3ccccc23)c2ccccc2OC12CCOCC2.Cl,,,CHEMBL2429856,J Med Chem,2013,"{'bei': '11.16', 'le': '0.20', 'lle': '2.63', 'sei': '4.96'}",CHEMBL2431755,,CHEMBL2436227,6.57,0,http://www.openphacts.org/units/Nanomolar,1922700,=,1,1,=,,IC50,nM,,271.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.271
,,13469361,[],CHEMBL2434144,Inhibition of His-thrombin-TEV-tagged cIAP1 BIR2 domain (174 to 256) (unknown origin) after 1 hr by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1,,,CHEMBL2429856,J Med Chem,2013,"{'bei': '11.12', 'le': '0.22', 'lle': '1.72', 'sei': '6.09'}",CHEMBL2431768,LCL-161,CHEMBL2431768,5.57,0,http://www.openphacts.org/units/Nanomolar,1922713,=,1,1,=,,IC50,nM,,2720.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,2.72
,,13482556,[],CHEMBL2439930,Displacement of AVPIAQKSEK (epsilon-biotin)-OH from 6xhistidine-thrombin-TEV-tagged cIAP1 BIR3 domain (260 to 352) (unknown origin) after 45 mins by TR-FRET Assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H]1C(=O)N(Cc2c(C)ccc3ccccc23)c2ccc(C#N)cc2N(C(C)=O)[C@H]1C.Cl,,,CHEMBL2434833,J Med Chem,2013,,CHEMBL2436226,,CHEMBL3040443,,0,http://www.openphacts.org/units/Nanomolar,1924663,>,1,1,>,,IC50,nM,,54800.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,54.8
,,13482641,[],CHEMBL2439931,Displacement of AVPIAQKSEK (epsilon-biotin)-OH from 6xhistidine-thrombin-TEV-tagged cIAP1 BIR2 domain (174 to 256) (unknown origin) after 45 mins by TR-FRET Assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H]1C(=O)N(Cc2c(C)ccc3ccccc23)c2ccc(C#N)cc2N(C(C)=O)[C@H]1C.Cl,,,CHEMBL2434833,J Med Chem,2013,"{'bei': '11.21', 'le': '0.21', 'lle': '2.18', 'sei': '5.29'}",CHEMBL2436226,,CHEMBL3040443,5.58,0,http://www.openphacts.org/units/Nanomolar,1924663,=,1,1,=,,IC50,nM,,2640.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,2.64
,,13482645,[],CHEMBL2437638,Inhibition of cIAP1 BIR2 domain (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1,,,CHEMBL2434833,J Med Chem,2013,"{'bei': '11.32', 'le': '0.22', 'lle': '1.82', 'sei': '6.20'}",CHEMBL2431768,LCL-161,CHEMBL2431768,5.67,0,http://www.openphacts.org/units/Nanomolar,1924664,=,1,1,=,,IC50,nM,,2140.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,2.14
,,13482675,[],CHEMBL2437639,Inhibition of cIAP1 BIR3 domain (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1,,,CHEMBL2434833,J Med Chem,2013,"{'bei': '14.41', 'le': '0.28', 'lle': '3.36', 'sei': '7.89'}",CHEMBL2431768,LCL-161,CHEMBL2431768,7.21,0,http://www.openphacts.org/units/Nanomolar,1924664,=,1,1,=,,IC50,nM,,61.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.061
,,13841510,[],CHEMBL3097971,Inhibition of human recombinant His-tagged cIAP-1 BIR3 domain (250 to 350) using AVPIAQ-K(biotin)-NH2 as substrate after overnight incubation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@H](C(=O)N1C[C@@H]2Cc3cc(Cl)cc(Cl)c3N2C[C@H]1C(=O)N[C@@H]1CCOc2ccccc21)C1CCCCC1,,,CHEMBL3091457,Bioorg Med Chem,2013,"{'bei': '13.48', 'le': '0.27', 'lle': '4.21', 'sei': '8.60'}",CHEMBL3094403,,CHEMBL3094403,8.85,0,http://www.openphacts.org/units/Nanomolar,1954682,=,1,1,=,,IC50,nM,,1.4,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.4
,,13841511,[],CHEMBL3097971,Inhibition of human recombinant His-tagged cIAP-1 BIR3 domain (250 to 350) using AVPIAQ-K(biotin)-NH2 as substrate after overnight incubation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@H](C(=O)N1C[C@@H]2Cc3cc(Cl)ccc3N2C[C@H]1C(=O)N[C@@H]1CCOc2ccccc21)C1CCCCC1,,,CHEMBL3091457,Bioorg Med Chem,2013,"{'bei': '14.40', 'le': '0.28', 'lle': '4.97', 'sei': '8.70'}",CHEMBL3094404,,CHEMBL3094404,8.96,0,http://www.openphacts.org/units/Nanomolar,1954683,=,1,1,=,,IC50,nM,,1.1,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.1
,,13841512,[],CHEMBL3097971,Inhibition of human recombinant His-tagged cIAP-1 BIR3 domain (250 to 350) using AVPIAQ-K(biotin)-NH2 as substrate after overnight incubation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@H](C(=O)N1C[C@@H]2Cc3cc(C#N)ccc3N2C[C@H]1C(=O)N[C@@H]1CCOc2ccccc21)C1CCCCC1,,,CHEMBL3091457,Bioorg Med Chem,2013,"{'bei': '14.69', 'le': '0.27', 'lle': '5.80', 'sei': '7.10'}",CHEMBL3094405,,CHEMBL3094405,9.00,0,http://www.openphacts.org/units/Nanomolar,1954684,=,1,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,,13841513,[],CHEMBL3097971,Inhibition of human recombinant His-tagged cIAP-1 BIR3 domain (250 to 350) using AVPIAQ-K(biotin)-NH2 as substrate after overnight incubation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H]2CCCN2C[C@H]1C(=O)N[C@@H]1CCOc2ccccc21)C1CCCCC1,,,CHEMBL3091457,Bioorg Med Chem,2013,"{'bei': '16.47', 'le': '0.31', 'lle': '6.69', 'sei': '8.40'}",CHEMBL3094406,,CHEMBL3094406,8.66,0,http://www.openphacts.org/units/Nanomolar,1954685,=,1,1,=,,IC50,nM,,2.2,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.2
,,13841514,[],CHEMBL3097971,Inhibition of human recombinant His-tagged cIAP-1 BIR3 domain (250 to 350) using AVPIAQ-K(biotin)-NH2 as substrate after overnight incubation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@H](C(=O)N1C[C@H]2CCCN2C[C@H]1C(=O)N[C@@H]1CCOc2ccccc21)C1CCCCC1,,,CHEMBL3091457,Bioorg Med Chem,2013,"{'bei': '16.53', 'le': '0.31', 'lle': '6.56', 'sei': '8.66'}",CHEMBL3094407,,CHEMBL3094407,8.92,0,http://www.openphacts.org/units/Nanomolar,1954687,=,1,1,=,,IC50,nM,,1.2,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.2
,,13841515,[],CHEMBL3097971,Inhibition of human recombinant His-tagged cIAP-1 BIR3 domain (250 to 350) using AVPIAQ-K(biotin)-NH2 as substrate after overnight incubation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@H]2CCCN2C[C@H]1C(=O)N[C@@H]1CCOc2ccccc21)C1CCCCC1,,,CHEMBL3091457,Bioorg Med Chem,2013,"{'bei': '16.51', 'le': '0.31', 'lle': '6.71', 'sei': '8.42'}",CHEMBL2365533,,CHEMBL2365533,8.68,0,http://www.openphacts.org/units/Nanomolar,1954686,=,1,1,=,,IC50,nM,,2.1,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.1
,,13841516,[],CHEMBL3097971,Inhibition of human recombinant His-tagged cIAP-1 BIR3 domain (250 to 350) using AVPIAQ-K(biotin)-NH2 as substrate after overnight incubation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@H](C(=O)N1C[C@@H]2Cc3ccccc3N2C[C@H]1C(=O)N[C@@H]1CCOc2ccccc21)C1CCCCC1,,,CHEMBL3091457,Bioorg Med Chem,2013,"{'bei': '15.06', 'le': '0.28', 'lle': '5.52', 'sei': '8.60'}",CHEMBL3094408,,CHEMBL3094408,8.85,0,http://www.openphacts.org/units/Nanomolar,1954688,=,1,1,=,,IC50,nM,,1.4,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.4
,,13841517,[],CHEMBL3097971,Inhibition of human recombinant His-tagged cIAP-1 BIR3 domain (250 to 350) using AVPIAQ-K(biotin)-NH2 as substrate after overnight incubation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC)C(=O)N[C@H](C(=O)N1C[C@H]2Cc3ccccc3N2C[C@H]1C(=O)N[C@@H]1CCOc2ccccc21)C1CCCCC1,,,CHEMBL3091457,Bioorg Med Chem,2013,"{'bei': '14.92', 'le': '0.28', 'lle': '5.44', 'sei': '8.51'}",CHEMBL3094409,,CHEMBL3094409,8.77,0,http://www.openphacts.org/units/Nanomolar,1954689,=,1,1,=,,IC50,nM,,1.7,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.7
,,13841518,[],CHEMBL3097971,Inhibition of human recombinant His-tagged cIAP-1 BIR3 domain (250 to 350) using AVPIAQ-K(biotin)-NH2 as substrate after overnight incubation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@H]2Cc3ccccc3N2C[C@H]1C(=O)N[C@@H]1CCOc2ccccc21)C1CCCCC1,,,CHEMBL3091457,Bioorg Med Chem,2013,"{'bei': '14.91', 'le': '0.28', 'lle': '5.61', 'sei': '8.30'}",CHEMBL3091493,,CHEMBL3091493,8.55,0,http://www.openphacts.org/units/Nanomolar,1954690,=,1,1,=,,IC50,nM,,2.8,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.8
,,13893603,[],CHEMBL3112066,Displacement of AbuRPFK-5FAM from GST-tagged cIAP1 BIR3 domain (L250 to G350) (unknown origin) after 20 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H]1c2ccccc2C[C@H]1OCC#CC#CCO[C@@H]1Cc2ccccc2[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC)C1CCCCC1)C1CCCCC1,,,CHEMBL3108710,J Med Chem,2013,"{'bei': '7.71', 'le': None, 'lle': None, 'sei': None}",CHEMBL3108827,,CHEMBL3108827,7.82,0,http://www.openphacts.org/units/Nanomolar,1961295,=,1,1,=,,IC50,nM,,15.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,15.0
,,13893604,[],CHEMBL3112066,Displacement of AbuRPFK-5FAM from GST-tagged cIAP1 BIR3 domain (L250 to G350) (unknown origin) after 20 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,C#CCO[C@@H]1CCc2ccccc2[C@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C,,,CHEMBL3108710,J Med Chem,2013,"{'bei': '13.16', 'le': '0.25', 'lle': '4.60', 'sei': '6.55'}",CHEMBL3108926,,CHEMBL3108926,6.54,0,http://www.openphacts.org/units/Nanomolar,1961420,=,1,1,=,,IC50,nM,,290.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,290.0
,,13893605,[],CHEMBL3112066,Displacement of AbuRPFK-5FAM from GST-tagged cIAP1 BIR3 domain (L250 to G350) (unknown origin) after 20 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,C#CCO[C@H]1CCc2ccccc2[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C,,,CHEMBL3108710,J Med Chem,2013,"{'bei': '15.81', 'le': '0.30', 'lle': '5.91', 'sei': '7.87'}",CHEMBL3108925,,CHEMBL3108925,7.85,0,http://www.openphacts.org/units/Nanomolar,1961419,=,1,1,=,,IC50,nM,,14.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,14.0
,,13893606,[],CHEMBL3112066,Displacement of AbuRPFK-5FAM from GST-tagged cIAP1 BIR3 domain (L250 to G350) (unknown origin) after 20 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,C#CCO[C@H]1CCc2ccccc2[C@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C,,,CHEMBL3108710,J Med Chem,2013,"{'bei': '14.90', 'le': '0.28', 'lle': '5.46', 'sei': '7.41'}",CHEMBL3108924,,CHEMBL3108924,7.40,0,http://www.openphacts.org/units/Nanomolar,1961418,=,1,1,=,,IC50,nM,,40.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,40.0
,,13893607,[],CHEMBL3112066,Displacement of AbuRPFK-5FAM from GST-tagged cIAP1 BIR3 domain (L250 to G350) (unknown origin) after 20 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,C#CCO[C@@H]1CCc2ccccc2[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C,,,CHEMBL3108710,J Med Chem,2013,"{'bei': '16.11', 'le': '0.30', 'lle': '6.06', 'sei': '8.02'}",CHEMBL3108923,,CHEMBL3108923,8.00,0,http://www.openphacts.org/units/Nanomolar,1961417,=,1,1,=,,IC50,nM,,10.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,10.0
,,14584440,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2SC(C)(C)C(C(=O)Nc3cc(C)nn3-c3ccccc3)N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '14.64', 'le': '0.28', 'lle': '4.86', 'sei': '6.74'}",CHEMBL3236070,,CHEMBL3236070,7.30,0,http://www.openphacts.org/units/Nanomolar,2085113,=,1,1,=,,IC50,nM,,50.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.05
,,14584441,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@H]2CCN(CCc3ccccc3)C[C@H]21)C1CCCCC1,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '16.65', 'le': '0.31', 'lle': '4.75', 'sei': '11.70'}",CHEMBL1950720,,CHEMBL1950720,7.57,0,http://www.openphacts.org/units/Nanomolar,2085114,=,1,1,=,,IC50,nM,,27.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.027
,,14584442,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4ccccc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '17.96', 'le': '0.34', 'lle': '5.61', 'sei': '11.45'}",CHEMBL3233043,,CHEMBL3233043,7.41,0,http://www.openphacts.org/units/Nanomolar,2085115,=,1,1,=,,IC50,nM,,39.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.039
,,14584443,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4ccc(Br)cc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '15.50', 'le': '0.34', 'lle': '5.06', 'sei': '11.78'}",CHEMBL3236071,,CHEMBL3236071,7.62,0,http://www.openphacts.org/units/Nanomolar,2085116,=,1,1,=,,IC50,nM,,24.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.024
,,14584444,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4ccccc4F)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '17.32', 'le': '0.33', 'lle': '5.52', 'sei': '11.53'}",CHEMBL3236072,,CHEMBL3236072,7.46,0,http://www.openphacts.org/units/Nanomolar,2085117,=,1,1,=,,IC50,nM,,35.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.035
,,14584445,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4ccc(F)cc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '17.83', 'le': '0.34', 'lle': '5.74', 'sei': '11.87'}",CHEMBL3236073,,CHEMBL3236073,7.68,0,http://www.openphacts.org/units/Nanomolar,2085118,=,1,1,=,,IC50,nM,,21.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.021
,,14584446,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4ccccc4OC)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '16.62', 'le': '0.31', 'lle': '5.55', 'sei': '9.95'}",CHEMBL3236074,,CHEMBL3236074,7.36,0,http://www.openphacts.org/units/Nanomolar,2085119,=,1,1,=,,IC50,nM,,44.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.044
,,14584447,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4cccc(OC)c4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '16.17', 'le': '0.31', 'lle': '5.34', 'sei': '9.68'}",CHEMBL3236075,,CHEMBL3236075,7.16,0,http://www.openphacts.org/units/Nanomolar,2085120,=,1,1,=,,IC50,nM,,70.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.07
,,14584448,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4ccc(OC)cc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '15.35', 'le': '0.29', 'lle': '4.99', 'sei': '9.19'}",CHEMBL3236076,,CHEMBL3236076,6.80,0,http://www.openphacts.org/units/Nanomolar,2085121,=,1,1,=,,IC50,nM,,160.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.16
,,14584449,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4ccc(O)cc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '16.94', 'le': '0.32', 'lle': '5.76', 'sei': '8.55'}",CHEMBL3236077,,CHEMBL3236077,7.26,0,http://www.openphacts.org/units/Nanomolar,2085122,=,1,1,=,,IC50,nM,,55.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.055
,,14584450,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4ccccc4C)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '17.45', 'le': '0.33', 'lle': '5.33', 'sei': '11.51'}",CHEMBL3236078,,CHEMBL3236078,7.44,0,http://www.openphacts.org/units/Nanomolar,2085123,=,1,1,=,,IC50,nM,,36.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.036
,,14584451,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4cccc(C)c4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '16.41', 'le': '0.31', 'lle': '4.89', 'sei': '10.82'}",CHEMBL3236079,,CHEMBL3236079,7.00,0,http://www.openphacts.org/units/Nanomolar,2085124,=,1,1,=,,IC50,nM,,100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.1
,,14584452,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4ccc(C)cc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '16.73', 'le': '0.31', 'lle': '5.03', 'sei': '11.03'}",CHEMBL3236080,,CHEMBL3236080,7.14,0,http://www.openphacts.org/units/Nanomolar,2085125,=,1,1,=,,IC50,nM,,73.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.073
,,14584453,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4ccc(Cl)cc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '16.63', 'le': '0.33', 'lle': '4.98', 'sei': '11.49'}",CHEMBL3236081,,CHEMBL3236081,7.43,0,http://www.openphacts.org/units/Nanomolar,2085126,=,1,1,=,,IC50,nM,,37.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.037
,,14584454,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4ccc(Cl)c(Cl)c4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '15.32', 'le': '0.31', 'lle': '4.28', 'sei': '11.40'}",CHEMBL3236366,,CHEMBL3236366,7.38,0,http://www.openphacts.org/units/Nanomolar,2085484,=,1,1,=,,IC50,nM,,42.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.042
,,14584455,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4ccc([N+](=O)[O-])cc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '16.08', 'le': '0.30', 'lle': '5.65', 'sei': '6.82'}",CHEMBL3236367,,CHEMBL3236367,7.36,0,http://www.openphacts.org/units/Nanomolar,2085485,=,1,1,=,,IC50,nM,,44.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.044
,,14584456,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4ccc(C(F)(F)F)cc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '14.67', 'le': '0.28', 'lle': '4.23', 'sei': '10.90'}",CHEMBL3233046,,CHEMBL3233046,7.05,0,http://www.openphacts.org/units/Nanomolar,2085486,=,1,1,=,,IC50,nM,,89.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.089
,,14584457,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CC(C)c4ccccc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '15.81', 'le': '0.30', 'lle': '4.38', 'sei': '10.43'}",CHEMBL3236368,,CHEMBL3236368,6.75,0,http://www.openphacts.org/units/Nanomolar,2085487,=,1,1,=,,IC50,nM,,180.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.18
,,14584458,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4c[nH]c5ccccc45)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '15.94', 'le': '0.30', 'lle': '4.92', 'sei': '8.95'}",CHEMBL3236369,,CHEMBL3236369,7.20,0,http://www.openphacts.org/units/Nanomolar,2085488,=,1,1,=,,IC50,nM,,63.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.063
,,14584459,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4scnc4C)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '15.08', 'le': '0.30', 'lle': '4.98', 'sei': '8.43'}",CHEMBL3236370,,CHEMBL3236370,6.54,0,http://www.openphacts.org/units/Nanomolar,2085489,=,1,1,=,,IC50,nM,,290.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.29
,,14584460,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4ccccn4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '15.47', 'le': '0.29', 'lle': '5.21', 'sei': '8.25'}",CHEMBL3236371,,CHEMBL3236371,6.40,0,http://www.openphacts.org/units/Nanomolar,2085490,=,1,1,=,,IC50,nM,,400.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.4
,,14584461,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCC4=C(C)OCN4C)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '13.19', 'le': '0.25', 'lle': '4.62', 'sei': '7.42'}",CHEMBL3236372,,CHEMBL3236372,5.72,0,http://www.openphacts.org/units/Nanomolar,2085491,=,1,1,=,,IC50,nM,,1900.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,1.9
,,14584462,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCc4nc5cc(C)ccc5[nH]4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '12.01', 'le': '0.23', 'lle': '3.62', 'sei': '6.00'}",CHEMBL3236373,,CHEMBL3236373,5.60,0,http://www.openphacts.org/units/Nanomolar,2085492,=,1,1,=,,IC50,nM,,2500.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,2.5
,,14584463,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(Cc4ccccc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '15.92', 'le': '0.30', 'lle': '4.60', 'sei': '9.81'}",CHEMBL3236374,,CHEMBL3236374,6.35,0,http://www.openphacts.org/units/Nanomolar,2085493,=,1,1,=,,IC50,nM,,450.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.45
,,14584464,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCCc4ccccc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '13.80', 'le': '0.26', 'lle': '3.70', 'sei': '9.10'}",CHEMBL3236375,,CHEMBL3236375,5.89,0,http://www.openphacts.org/units/Nanomolar,2085494,=,1,1,=,,IC50,nM,,1300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,1.3
,,14584465,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CCC4CCCCC4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '15.51', 'le': '0.30', 'lle': '3.97', 'sei': '10.04'}",CHEMBL3236376,,CHEMBL3236376,6.50,0,http://www.openphacts.org/units/Nanomolar,2085495,=,1,1,=,,IC50,nM,,320.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.32
,,14584466,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CC4CCCCC4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '15.55', 'le': '0.30', 'lle': '4.16', 'sei': '9.73'}",CHEMBL3236377,,CHEMBL3236377,6.29,0,http://www.openphacts.org/units/Nanomolar,2085496,=,1,1,=,,IC50,nM,,510.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.51
,,14584467,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(CC(C)C)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '15.23', 'le': '0.29', 'lle': '4.34', 'sei': '8.59'}",CHEMBL3236378,,CHEMBL3236378,5.55,0,http://www.openphacts.org/units/Nanomolar,2085497,=,1,1,=,,IC50,nM,,2800.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,2.8
,,14584468,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(C(c4ccccc4)c4ccccc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '10.58', 'le': '0.20', 'lle': '1.68', 'sei': '7.76'}",CHEMBL3236379,,CHEMBL3236379,5.02,0,http://www.openphacts.org/units/Nanomolar,2085498,=,1,1,=,,IC50,nM,,9500.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,9.5
,,14584469,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCN1CC[C@@H]2C[C@@H]3CCC[C@H](NC(=O)[C@H](C)NC)C(=O)N3[C@@H]2C1,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '16.24', 'le': '0.31', 'lle': '4.57', 'sei': '9.15'}",CHEMBL3236380,,CHEMBL3236380,5.92,0,http://www.openphacts.org/units/Nanomolar,2085499,=,1,1,=,,IC50,nM,,1200.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,1.2
,,14584470,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(C(=O)Cc4ccccc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '16.83', 'le': '0.32', 'lle': '5.86', 'sei': '8.78'}",CHEMBL3236381,,CHEMBL3236381,7.18,0,http://www.openphacts.org/units/Nanomolar,2085500,=,1,1,=,,IC50,nM,,66.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.066
,,14584471,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(C(=O)C(c4ccccc4)c4ccccc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '12.80', 'le': '0.24', 'lle': '3.52', 'sei': '7.87'}",CHEMBL3236382,,CHEMBL3236382,6.43,0,http://www.openphacts.org/units/Nanomolar,2085501,=,1,1,=,,IC50,nM,,370.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.37
,,14584472,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,C#CCOCC(C(=O)N1CC[C@@H]2C[C@@H]3CCC[C@H](NC(=O)[C@H](C)NC)C(=O)N3[C@@H]2C1)c1ccccc1,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '13.54', 'le': '0.25', 'lle': '5.19', 'sei': '7.36'}",CHEMBL3236383,,CHEMBL3236383,6.70,0,http://www.openphacts.org/units/Nanomolar,2085502,=,1,1,=,,IC50,nM,,200.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.2
,,14584473,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,C#CCOCC(C(=O)N1CC[C@@H]2C[C@@H]3CCC[C@H](NC(=O)[C@H](C)NC)C(=O)N3[C@@H]2C1)c1ccccc1,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '12.18', 'le': '0.23', 'lle': '4.52', 'sei': '6.62'}",CHEMBL3236383,,CHEMBL3236383,6.03,0,http://www.openphacts.org/units/Nanomolar,2085503,=,1,1,=,,IC50,nM,,940.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.94
,,14584474,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(C(=O)c4ccccc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,,CHEMBL3236384,,CHEMBL3236384,,0,http://www.openphacts.org/units/Nanomolar,2085504,>,1,1,>,,IC50,nM,,10000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,10.0
,,14584475,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(C(=O)OCc4ccccc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '15.04', 'le': '0.28', 'lle': '4.77', 'sei': '7.32'}",CHEMBL3236385,,CHEMBL3236385,6.66,0,http://www.openphacts.org/units/Nanomolar,2085505,=,1,1,=,,IC50,nM,,220.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.22
,,14584476,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(C(=O)Oc4ccccc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '17.00', 'le': '0.32', 'lle': '5.53', 'sei': '8.01'}",CHEMBL3236386,,CHEMBL3236386,7.28,0,http://www.openphacts.org/units/Nanomolar,2085506,=,1,1,=,,IC50,nM,,52.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.052
,,14584477,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(C(=O)Nc4ccccc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '15.57', 'le': '0.29', 'lle': '4.87', 'sei': '7.10'}",CHEMBL3236387,,CHEMBL3236387,6.66,0,http://www.openphacts.org/units/Nanomolar,2085507,=,1,1,=,,IC50,nM,,220.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.22
,,14584478,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(S(=O)(=O)Cc4ccccc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '12.00', 'le': '0.24', 'lle': '4.47', 'sei': '5.62'}",CHEMBL3236388,,CHEMBL3236388,5.55,0,http://www.openphacts.org/units/Nanomolar,2085508,=,1,1,=,,IC50,nM,,2800.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,2.8
,,14584479,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(S(=O)(=O)c4ccccc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '11.36', 'le': '0.22', 'lle': '4.16', 'sei': '5.16'}",CHEMBL3236389,,CHEMBL3236389,5.10,0,http://www.openphacts.org/units/Nanomolar,2085509,=,1,1,=,,IC50,nM,,8000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,8.0
,,14584480,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(C(=O)C(OCC#CC#CCOC(C(=O)N4CC[C@@H]5C[C@@H]6CCC[C@H](NC(=O)[C@H](C)NC)C(=O)N6[C@@H]5C4)c4ccccc4)c4ccccc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '8.89', 'le': '0.17', 'lle': '5.82', 'sei': '4.68'}",CHEMBL3236390,,CHEMBL3236390,8.52,0,http://www.openphacts.org/units/Nanomolar,2085510,=,1,1,=,,IC50,nM,,3.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.003
,,14584481,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2C[C@H]3CCN(C(=O)C(OCC#CC#CCOC(C(=O)N4CC[C@@H]5C[C@@H]6CCC[C@H](NC(=O)[C@H](C)NC)C(=O)N6[C@@H]5C4)c4ccccc4)c4ccccc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,"{'bei': '8.89', 'le': '0.17', 'lle': '5.82', 'sei': '4.68'}",CHEMBL3236390,,CHEMBL3236390,8.52,0,http://www.openphacts.org/units/Nanomolar,2085511,=,1,1,=,,IC50,nM,,3.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.003
,,14587400,[],CHEMBL3241790,Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CCC[C@@H]2C[C@H]3CCN(CCc4ccccc4)C[C@H]3N2C1=O,,,CHEMBL3232969,Bioorg Med Chem Lett,2014,,CHEMBL3236391,,CHEMBL3236391,,0,http://www.openphacts.org/units/Nanomolar,2085512,>,1,1,>,,IC50,nM,,10000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,10.0
,,15096875,[],CHEMBL3388612,Inhibition of cIAP1 BIR2-3 (unknown origin) assessed as inhibition of polarization activity using N-His-Tb-cBir2-3(154-352) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(NC(=O)c3ccc(C(=O)N[C@H]4C[C@@H](C(=O)N[C@@H]5CCCc6ccccc65)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C4)cc3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3351229,Bioorg Med Chem Lett,2014,"{'bei': '7.07', 'le': None, 'lle': None, 'sei': None}",CHEMBL3339214,,CHEMBL3339214,7.82,0,http://www.openphacts.org/units/Nanomolar,2247556,=,1,1,=,,IC50,nM,,15.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,15.0
,,15096876,[],CHEMBL3388612,Inhibition of cIAP1 BIR2-3 (unknown origin) assessed as inhibition of polarization activity using N-His-Tb-cBir2-3(154-352) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(OCc3ccc(C(=O)N[C@H]4C[C@@H](C(=O)N[C@@H]5CCCc6ccccc65)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C4)cc3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3351229,Bioorg Med Chem Lett,2014,"{'bei': '6.51', 'le': None, 'lle': None, 'sei': None}",CHEMBL3339215,,CHEMBL3339215,7.12,0,http://www.openphacts.org/units/Nanomolar,2247557,=,1,1,=,,IC50,nM,,76.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,76.0
,,15096877,[],CHEMBL3388612,Inhibition of cIAP1 BIR2-3 (unknown origin) assessed as inhibition of polarization activity using N-His-Tb-cBir2-3(154-352) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(C#Cc3ccc(C(=O)N[C@H]4C[C@@H](C(=O)N[C@@H]5CCCc6ccccc65)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C4)cc3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3351229,Bioorg Med Chem Lett,2014,"{'bei': '6.53', 'le': None, 'lle': None, 'sei': None}",CHEMBL3339216,,CHEMBL3339216,7.10,0,http://www.openphacts.org/units/Nanomolar,2247558,=,1,1,=,,IC50,nM,,79.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,79.0
,,15096878,[],CHEMBL3388612,Inhibition of cIAP1 BIR2-3 (unknown origin) assessed as inhibition of polarization activity using N-His-Tb-cBir2-3(154-352) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(CCc3ccc(C(=O)N[C@H]4C[C@@H](C(=O)N[C@@H]5CCCc6ccccc65)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C4)cc3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3351229,Bioorg Med Chem Lett,2014,"{'bei': '6.96', 'le': None, 'lle': None, 'sei': None}",CHEMBL3339217,,CHEMBL3339217,7.60,0,http://www.openphacts.org/units/Nanomolar,2247559,=,1,1,=,,IC50,nM,,25.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,25.0
,,15096879,[],CHEMBL3388612,Inhibition of cIAP1 BIR2-3 (unknown origin) assessed as inhibition of polarization activity using N-His-Tb-cBir2-3(154-352) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(C(=O)Nc3nc4cc(C(=O)N[C@H]5C[C@@H](C(=O)N[C@@H]6CCCc7ccccc76)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C5)ccc4s3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3351229,Bioorg Med Chem Lett,2014,"{'bei': '6.83', 'le': None, 'lle': None, 'sei': None}",CHEMBL3339218,,CHEMBL3339218,7.96,0,http://www.openphacts.org/units/Nanomolar,2247560,=,1,1,=,,IC50,nM,,11.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,11.0
,,15096880,[],CHEMBL3388612,Inhibition of cIAP1 BIR2-3 (unknown origin) assessed as inhibition of polarization activity using N-His-Tb-cBir2-3(154-352) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(C(=O)Nc3ncc(C(=O)N[C@H]4C[C@@H](C(=O)N[C@@H]5CCCc6ccccc65)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C4)o3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3351229,Bioorg Med Chem Lett,2014,"{'bei': '7.92', 'le': None, 'lle': None, 'sei': None}",CHEMBL3339219,,CHEMBL3339219,8.70,0,http://www.openphacts.org/units/Nanomolar,2247561,=,1,1,=,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,15096881,[],CHEMBL3388612,Inhibition of cIAP1 BIR2-3 (unknown origin) assessed as inhibition of polarization activity using N-His-Tb-cBir2-3(154-352) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)c2ccc(CN(C(=O)[C@@H]3Cc4ccccc4CN3C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)[C@H]3CCCc4ccccc43)cc2)C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3351229,Bioorg Med Chem Lett,2014,"{'bei': '7.05', 'le': None, 'lle': None, 'sei': None}",CHEMBL3339220,,CHEMBL3339220,7.60,0,http://www.openphacts.org/units/Nanomolar,2247562,=,1,1,=,,IC50,nM,,25.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,25.0
,,15096882,[],CHEMBL3388612,Inhibition of cIAP1 BIR2-3 (unknown origin) assessed as inhibition of polarization activity using N-His-Tb-cBir2-3(154-352) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)c2ccc(CN(C(=O)[C@@H]3Cc4ccccc4CN3C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)[C@H](C)c3ccccc3F)cc2)C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3351229,Bioorg Med Chem Lett,2014,"{'bei': '7.62', 'le': None, 'lle': None, 'sei': None}",CHEMBL3339221,,CHEMBL3339221,8.15,0,http://www.openphacts.org/units/Nanomolar,2247563,=,1,1,=,,IC50,nM,,7.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,7.0
,,15096883,[],CHEMBL3388612,Inhibition of cIAP1 BIR2-3 (unknown origin) assessed as inhibition of polarization activity using N-His-Tb-cBir2-3(154-352) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)c2ccc(CN(C(=O)[C@@H]3Cc4ccccc4CN3C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)[C@@H](COC)c3ccccc3)cc2)C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3351229,Bioorg Med Chem Lett,2014,"{'bei': '7.67', 'le': None, 'lle': None, 'sei': None}",CHEMBL3339223,,CHEMBL3339223,8.30,0,http://www.openphacts.org/units/Nanomolar,2247565,=,1,1,=,,IC50,nM,,5.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,5.0
,,15096884,[],CHEMBL3388612,Inhibition of cIAP1 BIR2-3 (unknown origin) assessed as inhibition of polarization activity using N-His-Tb-cBir2-3(154-352) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)c2ccc(CN(C(=O)[C@@H]3Cc4ccccc4CN3C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)[C@H](COC)c3ccccc3)cc2)C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3351229,Bioorg Med Chem Lett,2014,"{'bei': '7.48', 'le': None, 'lle': None, 'sei': None}",CHEMBL3339224,,CHEMBL3339224,8.10,0,http://www.openphacts.org/units/Nanomolar,2247566,=,1,1,=,,IC50,nM,,8.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,8.0
,,15204157,[],CHEMBL3411458,Binding affinity to human N-terminal His-tagged cIAP1 BIR2-3 C202A/C213G mutant after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(NC(=O)C3(C(=O)N[C@H]4C[C@@H](C(=O)N[C@@H]5CCCc6ccccc65)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C4)CCC3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3407443,J Med Chem,2015,"{'bei': '7.74', 'le': None, 'lle': None, 'sei': None}",CHEMBL3410871,,CHEMBL3410871,8.40,0,http://www.openphacts.org/units/Nanomolar,2289780,=,1,1,=,,IC50,nM,,4.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4.0
,,15204158,[],CHEMBL3411458,Binding affinity to human N-terminal His-tagged cIAP1 BIR2-3 C202A/C213G mutant after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(NC(=O)C(=O)N[C@H]3C[C@@H](C(=O)N[C@@H]4CCCc5ccccc54)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3407443,J Med Chem,2015,"{'bei': '8.07', 'le': None, 'lle': None, 'sei': None}",CHEMBL3410872,,CHEMBL3410872,8.32,0,http://www.openphacts.org/units/Nanomolar,2289781,=,1,1,=,,IC50,nM,,4.8,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4.8
,,15204159,[],CHEMBL3411458,Binding affinity to human N-terminal His-tagged cIAP1 BIR2-3 C202A/C213G mutant after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(NCC(=O)N[C@H]3C[C@@H](C(=O)N[C@@H]4CCCc5ccccc54)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3407443,J Med Chem,2015,"{'bei': '8.19', 'le': None, 'lle': None, 'sei': None}",CHEMBL3410873,,CHEMBL3410873,8.33,0,http://www.openphacts.org/units/Nanomolar,2289782,=,1,1,=,,IC50,nM,,4.7,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4.7
,,15204160,[],CHEMBL3411458,Binding affinity to human N-terminal His-tagged cIAP1 BIR2-3 C202A/C213G mutant after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(NC(=O)N[C@H]3C[C@@H](C(=O)N[C@@H]4CCCc5ccccc54)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3407443,J Med Chem,2015,"{'bei': '8.22', 'le': None, 'lle': None, 'sei': None}",CHEMBL3410874,,CHEMBL3410874,8.25,0,http://www.openphacts.org/units/Nanomolar,2289783,=,1,1,=,,IC50,nM,,5.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,5.6
,,15204161,[],CHEMBL3411458,Binding affinity to human N-terminal His-tagged cIAP1 BIR2-3 C202A/C213G mutant after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c(-c2[nH]c3cc(F)ccc3c2C[C@@H]2C[C@H](O)CN2C(=O)[C@H](CC)NC(=O)[C@H](C)NC)[nH]c2cc(F)ccc12,,,CHEMBL3407443,J Med Chem,2015,"{'bei': '9.05', 'le': '0.17', 'lle': '4.69', 'sei': '3.75'}",CHEMBL3039522,BIRINAPANT,CHEMBL3039522,7.30,0,http://www.openphacts.org/units/Nanomolar,2289677,=,1,1,=,,IC50,nM,,50.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,50.0
,,15205101,[],CHEMBL3411458,Binding affinity to human N-terminal His-tagged cIAP1 BIR2-3 C202A/C213G mutant after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(NC(=O)[C@H]3C[C@@H](C(=O)N[C@@H]4CCCc5ccccc54)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3407443,J Med Chem,2015,"{'bei': '8.64', 'le': '0.16', 'lle': '3.78', 'sei': '4.06'}",CHEMBL3410875,,CHEMBL3410875,8.54,0,http://www.openphacts.org/units/Nanomolar,2289784,=,1,1,=,,IC50,nM,,2.9,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.9
,,15205102,[],CHEMBL3411458,Binding affinity to human N-terminal His-tagged cIAP1 BIR2-3 C202A/C213G mutant after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(C(=O)N[C@H]3C[C@@H](C(=O)N[C@@H]4CCCc5ccccc54)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3407443,J Med Chem,2015,"{'bei': '8.45', 'le': '0.16', 'lle': '4.05', 'sei': '3.97'}",CHEMBL3410876,,CHEMBL3410876,8.35,0,http://www.openphacts.org/units/Nanomolar,2289785,=,1,1,=,,IC50,nM,,4.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4.5
,,15205103,[],CHEMBL3411458,Binding affinity to human N-terminal His-tagged cIAP1 BIR2-3 C202A/C213G mutant after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(N[C@H]3C[C@@H](C(=O)N[C@@H]4CCCc5ccccc54)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3407443,J Med Chem,2015,"{'bei': '8.82', 'le': '0.17', 'lle': '3.48', 'sei': '4.39'}",CHEMBL3410877,,CHEMBL3410877,8.47,0,http://www.openphacts.org/units/Nanomolar,2289786,=,1,1,=,,IC50,nM,,3.4,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3.4
,,15205104,[],CHEMBL3411458,Binding affinity to human N-terminal His-tagged cIAP1 BIR2-3 C202A/C213G mutant after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(O[C@H]3C[C@@H](C(=O)N[C@@H]4CCCc5ccccc54)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3407443,J Med Chem,2015,"{'bei': '8.78', 'le': '0.16', 'lle': '3.49', 'sei': '4.44'}",CHEMBL3410878,,CHEMBL3410878,8.44,0,http://www.openphacts.org/units/Nanomolar,2289787,=,1,1,=,,IC50,nM,,3.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3.6
,,15205105,[],CHEMBL3411458,Binding affinity to human N-terminal His-tagged cIAP1 BIR2-3 C202A/C213G mutant after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc([C@H]3C[C@@H](C(=O)N[C@@H]4CCCc5ccccc54)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3407443,J Med Chem,2015,"{'bei': '8.79', 'le': '0.16', 'lle': '3.02', 'sei': '4.59'}",CHEMBL3410879,,CHEMBL3410879,8.31,0,http://www.openphacts.org/units/Nanomolar,2289788,=,1,1,=,,IC50,nM,,4.9,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4.9
,,15205106,[],CHEMBL3411458,Binding affinity to human N-terminal His-tagged cIAP1 BIR2-3 C202A/C213G mutant after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(NC(=O)c3ccc(C(=O)N[C@H]4C[C@@H](C(=O)N[C@@H]5CCCc6ccccc65)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C4)cc3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3407443,J Med Chem,2015,"{'bei': '7.22', 'le': None, 'lle': None, 'sei': None}",CHEMBL3339214,,CHEMBL3339214,8.00,0,http://www.openphacts.org/units/Nanomolar,2289678,=,1,1,=,,IC50,nM,,10.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,10.0
,,15205107,[],CHEMBL3411458,Binding affinity to human N-terminal His-tagged cIAP1 BIR2-3 C202A/C213G mutant after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(NC(=O)c3ccc(CCN[C@H]4C[C@@H](C(=O)N[C@@H]5CCCc6ccccc65)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C4)cc3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3407443,J Med Chem,2015,"{'bei': '7.56', 'le': None, 'lle': None, 'sei': None}",CHEMBL3410807,,CHEMBL3410807,8.38,0,http://www.openphacts.org/units/Nanomolar,2289679,=,1,1,=,,IC50,nM,,4.2,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4.2
,,15205108,[],CHEMBL3411458,Binding affinity to human N-terminal His-tagged cIAP1 BIR2-3 C202A/C213G mutant after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(NC(=O)CCCC(=O)N[C@H]3C[C@@H](C(=O)N[C@@H]4CCCc5ccccc54)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3407443,J Med Chem,2015,"{'bei': '7.89', 'le': None, 'lle': None, 'sei': None}",CHEMBL3410808,,CHEMBL3410808,8.47,0,http://www.openphacts.org/units/Nanomolar,2289680,=,1,1,=,,IC50,nM,,3.4,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3.4
,,15205109,[],CHEMBL3411458,Binding affinity to human N-terminal His-tagged cIAP1 BIR2-3 C202A/C213G mutant after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(NC(=O)C(F)(F)C(F)(F)C(F)(F)C(=O)N[C@H]3C[C@@H](C(=O)N[C@@H]4CCCc5ccccc54)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C3)ccc2C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,,,CHEMBL3407443,J Med Chem,2015,"{'bei': '6.58', 'le': None, 'lle': None, 'sei': None}",CHEMBL3410809,,CHEMBL3410809,7.77,0,http://www.openphacts.org/units/Nanomolar,2289681,=,1,1,=,,IC50,nM,,17.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,17.0
,,15229439,[],CHEMBL3420986,Inhibition of cIAP1 BIR2-3 (154 to 352 residues) (unknown origin) fluoresceinated dimeric SMAC peptide based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H]2C[C@H]1C(=O)N[C@@H](Cc1ccc3ccccc3c1)C(=O)N[C@H](C(=O)O)Cc1ccc(cc1)OCc1cn(nn1)[C@H]1C[C@@H](C(=O)N[C@@H](Cc3ccc4ccccc4c3)C(=O)N[C@H](C(=O)O)Cc3ccc(cc3)OCc3cn2nn3)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C2CCCCC2)C1)C1CCCCC1,,,CHEMBL3414571,J Med Chem,2015,"{'bei': '5.23', 'le': None, 'lle': None, 'sei': None}",CHEMBL3414727,,CHEMBL3414727,8.15,0,http://www.openphacts.org/units/Nanomolar,2290125,=,1,1,=,,IC50,nM,,7.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.007
,,15229440,[],CHEMBL3420986,Inhibition of cIAP1 BIR2-3 (154 to 352 residues) (unknown origin) fluoresceinated dimeric SMAC peptide based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H]2C[C@H]1C(=O)N[C@@H](Cc1ccc3ccccc3c1)C(=O)N[C@H](C(=O)O)Cc1ccc(cc1)OCc1cn(nn1)[C@H]1C[C@@H](C(=O)N[C@@H](Cc3ccc4ccccc4c3)C(=O)N[C@H](C(=O)O)Cc3ccc(cc3)OCc3cn2nn3)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C1)C(C)(C)C,,,CHEMBL3414571,J Med Chem,2015,"{'bei': '5.51', 'le': None, 'lle': None, 'sei': None}",CHEMBL3414728,,CHEMBL3414728,8.30,0,http://www.openphacts.org/units/Nanomolar,2290126,=,1,1,=,,IC50,nM,,5.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.005
,,15229441,[],CHEMBL3420986,Inhibition of cIAP1 BIR2-3 (154 to 352 residues) (unknown origin) fluoresceinated dimeric SMAC peptide based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H]2C[C@H]1C(=O)N[C@@H](Cc1ccc3ccccc3c1)C(=O)N[C@H](C(=O)O)Cc1cn(nn1)[C@H]1C[C@@H](C(=O)N[C@@H](Cc3ccc4ccccc4c3)C(=O)N[C@H](C(=O)O)Cc3cn2nn3)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)C)C1)C(C)C,,,CHEMBL3414571,J Med Chem,2015,"{'bei': '6.74', 'le': None, 'lle': None, 'sei': None}",CHEMBL3414729,,CHEMBL3414729,8.52,0,http://www.openphacts.org/units/Nanomolar,2290127,=,1,1,=,,IC50,nM,,3.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.003
,,15229442,[],CHEMBL3420985,Inhibition of XIAP BIR2-3 (125 to 356 residues) C202A/C213G mutant (unknown origin) fluoresceinated dimeric SMAC peptide based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H]2C[C@H]1C(=O)N[C@@H](Cc1ccc3ccccc3c1)C(=O)N[C@H](C(=O)O)Cc1cn(nn1)[C@H]1C[C@@H](C(=O)N[C@@H](Cc3ccc4ccccc4c3)C(=O)N[C@H](C(=O)O)Cc3cn2nn3)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)C)C1)C(C)C,,,CHEMBL3414571,J Med Chem,2015,"{'bei': '6.36', 'le': None, 'lle': None, 'sei': None}",CHEMBL3414729,,CHEMBL3414729,8.05,0,http://www.openphacts.org/units/Nanomolar,2290127,=,1,1,=,,IC50,nM,,9.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.009
,,15229443,[],CHEMBL3420985,Inhibition of XIAP BIR2-3 (125 to 356 residues) C202A/C213G mutant (unknown origin) fluoresceinated dimeric SMAC peptide based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H]2C[C@H]1C(=O)N[C@@H](Cc1ccc3ccccc3c1)C(=O)N[C@H](C(=O)O)Cc1ccc(cc1)OCc1cn(nn1)[C@H]1C[C@@H](C(=O)N[C@@H](Cc3ccc4ccccc4c3)C(=O)N[C@H](C(=O)O)Cc3ccc(cc3)OCc3cn2nn3)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C1)C(C)(C)C,,,CHEMBL3414571,J Med Chem,2015,"{'bei': '5.09', 'le': None, 'lle': None, 'sei': None}",CHEMBL3414728,,CHEMBL3414728,7.66,0,http://www.openphacts.org/units/Nanomolar,2290126,=,1,1,=,,IC50,nM,,22.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.022
,,15229444,[],CHEMBL3420985,Inhibition of XIAP BIR2-3 (125 to 356 residues) C202A/C213G mutant (unknown origin) fluoresceinated dimeric SMAC peptide based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H]2C[C@H]1C(=O)N[C@@H](Cc1ccc3ccccc3c1)C(=O)N[C@H](C(=O)O)Cc1ccc(cc1)OCc1cn(nn1)[C@H]1C[C@@H](C(=O)N[C@@H](Cc3ccc4ccccc4c3)C(=O)N[C@H](C(=O)O)Cc3ccc(cc3)OCc3cn2nn3)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C2CCCCC2)C1)C1CCCCC1,,,CHEMBL3414571,J Med Chem,2015,"{'bei': '4.89', 'le': None, 'lle': None, 'sei': None}",CHEMBL3414727,,CHEMBL3414727,7.62,0,http://www.openphacts.org/units/Nanomolar,2290125,=,1,1,=,,IC50,nM,,24.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.024
,,15667670,[],CHEMBL3603531,Inhibition of cIAP (unknown origin) assessed as inhibition of cIAP-BIR3 interaction by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cc1)C(=O)C2,,,CHEMBL3600357,J Med Chem,2015,,CHEMBL3601398,CGM-097,CHEMBL3601398,,0,http://www.openphacts.org/units/Nanomolar,2492871,>,1,1,>,,IC50,nM,,50000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,50000.0
,,15671599,[],CHEMBL3602896,Antagonist activity at cIAP1-BIR3 domain (unknown origin) assessed as inhibition of interaction with SMAC by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](NC(=O)[C@H](C)N)C(N)=O,,,CHEMBL3600342,J Med Chem,2015,"{'bei': '24.67', 'le': '0.49', 'lle': '5.66', 'sei': '4.70'}",CHEMBL181785,,CHEMBL181785,4.62,0,http://www.openphacts.org/units/Nanomolar,2492063,=,1,1,=,,IC50,nM,,24000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,24.0
,,15671600,[],CHEMBL3602896,Antagonist activity at cIAP1-BIR3 domain (unknown origin) assessed as inhibition of interaction with SMAC by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](N)C(=O)Nc1cccc(N)n1,,,CHEMBL3600342,J Med Chem,2015,"{'bei': '25.35', 'le': '0.48', 'lle': '4.62', 'sei': '4.86'}",CHEMBL3600720,,CHEMBL3600720,4.57,0,http://www.openphacts.org/units/Nanomolar,2492064,=,1,1,=,,IC50,nM,,27000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,27.0
,,15671601,[],CHEMBL3602896,Antagonist activity at cIAP1-BIR3 domain (unknown origin) assessed as inhibition of interaction with SMAC by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3cnc(Cl)cc32)CCN1,,,CHEMBL3600342,J Med Chem,2015,"{'bei': '15.94', 'le': '0.32', 'lle': '3.78', 'sei': '9.69'}",CHEMBL3600732,,CHEMBL3600732,4.70,0,http://www.openphacts.org/units/Nanomolar,2492076,=,1,1,=,,IC50,nM,,20000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,20.0
,,15671602,[],CHEMBL3602896,Antagonist activity at cIAP1-BIR3 domain (unknown origin) assessed as inhibition of interaction with SMAC by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCCC2)CCN1,,,CHEMBL3600342,J Med Chem,2015,"{'bei': '16.03', 'le': '0.31', 'lle': '3.49', 'sei': '9.52'}",CHEMBL3600721,,CHEMBL3600721,3.39,0,http://www.openphacts.org/units/Nanomolar,2492065,=,1,1,=,,IC50,nM,,410000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,410.0
,,15671603,[],CHEMBL3602896,Antagonist activity at cIAP1-BIR3 domain (unknown origin) assessed as inhibition of interaction with SMAC by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ccc(Cl)cc32)CCN1,,,CHEMBL3600342,J Med Chem,2015,"{'bei': '16.88', 'le': '0.34', 'lle': '3.17', 'sei': '15.27'}",CHEMBL3600733,,CHEMBL3600733,5.43,0,http://www.openphacts.org/units/Nanomolar,2492077,=,1,1,=,,IC50,nM,,3700.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,3.7
,,15671604,[],CHEMBL3602896,Antagonist activity at cIAP1-BIR3 domain (unknown origin) assessed as inhibition of interaction with SMAC by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2ccc(Cl)cc21,,,CHEMBL3600342,J Med Chem,2015,"{'bei': '16.91', 'le': '0.34', 'lle': '3.92', 'sei': '13.81'}",CHEMBL3600734,,CHEMBL3600734,6.19,0,http://www.openphacts.org/units/Nanomolar,2492078,=,1,1,=,,IC50,nM,,650.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.65
,,15671605,[],CHEMBL3602896,Antagonist activity at cIAP1-BIR3 domain (unknown origin) assessed as inhibition of interaction with SMAC by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Cl)cc21,,,CHEMBL3600342,J Med Chem,2015,"{'bei': '17.70', 'le': '0.35', 'lle': '4.82', 'sei': '11.26'}",CHEMBL3600735,,CHEMBL3600735,6.50,0,http://www.openphacts.org/units/Nanomolar,2492079,=,1,1,=,,IC50,nM,,320.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.32
,,15671606,[],CHEMBL3602896,Antagonist activity at cIAP1-BIR3 domain (unknown origin) assessed as inhibition of interaction with SMAC by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Cc3ccccc3)cc21,,,CHEMBL3600342,J Med Chem,2015,"{'bei': '18.93', 'le': '0.35', 'lle': '5.39', 'sei': '13.86'}",CHEMBL3600717,,CHEMBL3600717,8.00,0,http://www.openphacts.org/units/Nanomolar,2492060,=,1,1,=,,IC50,nM,,10.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,uM,UO_0000065,,0.01
,298675,16259932,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3cnc(C(F)(F)C4CC4)cc32)[C@@H](CN2CCCC2=O)CN1,,,CHEMBL3639218,,2015,"{'bei': '16.51', 'le': '0.32', 'lle': '5.36', 'sei': '11.42'}",CHEMBL3700080,,CHEMBL3700080,7.85,0,http://www.openphacts.org/units/Nanomolar,2577296,=,37,1,=,,IC50,nM,,14.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,14.0
,298624,16261174,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(-c3cnn(C)c3)cc21,,,CHEMBL3639218,,2015,"{'bei': '15.17', 'le': '0.28', 'lle': '4.84', 'sei': '8.29'}",CHEMBL3700003,,CHEMBL3700003,6.26,0,http://www.openphacts.org/units/Nanomolar,2577219,=,37,1,=,,IC50,nM,,550.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,550.0
,273246,16261437,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(S(=O)(=O)CCC/C=C/CCCS(=O)(=O)N2CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699023,,CHEMBL3699023,,0,http://www.openphacts.org/units/Nanomolar,2576149,<,37,1,<,,IC50,nM,,100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,100.0
,298572,16262327,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cc(F)c(S(=O)(=O)c3ccc(OC)cc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '13.81', 'le': '0.27', 'lle': '4.57', 'sei': '8.14'}",CHEMBL3699947,,CHEMBL3699947,7.17,0,http://www.openphacts.org/units/Nanomolar,2577160,=,37,1,=,,IC50,nM,,67.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,67.0
,298593,16262508,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Cc3cccc(Cl)c3)cc21,,,CHEMBL3639218,,2015,"{'bei': '17.33', 'le': '0.34', 'lle': '4.66', 'sei': '13.73'}",CHEMBL3699967,,CHEMBL3699967,7.92,0,http://www.openphacts.org/units/Nanomolar,2577182,=,37,1,=,,IC50,nM,,12.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,12.0
,298654,16263403,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cnn(C[C@H]2CN[C@H](C)CN2CC(=O)N2CC3(Cc4ccccc4C3)c3ccc(C#N)cc32)c1,,,CHEMBL3639218,,2015,"{'bei': '14.48', 'le': '0.26', 'lle': '4.15', 'sei': '9.01'}",CHEMBL3700038,,CHEMBL3700038,6.96,0,http://www.openphacts.org/units/Nanomolar,2577254,=,37,1,=,,IC50,nM,,110.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,110.0
,298567,16263926,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC3(CCC3)c3ccc(Cl)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '15.23', 'le': '0.30', 'lle': '2.69', 'sei': '14.30'}",CHEMBL3696521,,CHEMBL3696521,5.09,0,http://www.openphacts.org/units/Nanomolar,2573365,=,37,1,=,,IC50,nM,,8200.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,8200.0
,298658,16264142,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1C[C@](C)(COC)c2ccc(Br)cc21,,,CHEMBL3639218,,2015,"{'bei': '13.74', 'le': '0.31', 'lle': '4.04', 'sei': '11.20'}",CHEMBL3700045,,CHEMBL3700045,6.05,0,http://www.openphacts.org/units/Nanomolar,2577261,=,37,1,=,,IC50,nM,,890.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,890.0
,273264,16264535,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)N[C@@H]5C[C@@H]5c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)N[C@@H]3C[C@@H]3c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699041,,CHEMBL3699041,,0,http://www.openphacts.org/units/Nanomolar,2576167,<,37,1,<,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,298619,16264640,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Oc3c(C)cccc3C)cc21,,,CHEMBL3639218,,2015,"{'bei': '15.51', 'le': '0.29', 'lle': '3.60', 'sei': '10.49'}",CHEMBL3699999,,CHEMBL3699999,7.02,0,http://www.openphacts.org/units/Nanomolar,2577214,=,37,1,=,,IC50,nM,,96.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,96.0
,298655,16264689,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ccc(C#N)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '16.33', 'le': '0.30', 'lle': '3.62', 'sei': '8.59'}",CHEMBL3700039,,CHEMBL3700039,5.10,0,http://www.openphacts.org/units/Nanomolar,2577255,=,37,1,=,,IC50,nM,,7900.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,7900.0
,298587,16265440,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Cc3ccccc3F)cc21,,,CHEMBL3639218,,2015,"{'bei': '18.26', 'le': '0.34', 'lle': '5.31', 'sei': '13.94'}",CHEMBL3699960,,CHEMBL3699960,8.05,0,http://www.openphacts.org/units/Nanomolar,2577175,=,37,1,=,,IC50,nM,,9.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,9.0
,298665,16265552,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2nnc(Cl)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.86', 'le': '0.34', 'lle': '5.14', 'sei': '8.78'}",CHEMBL3700054,,CHEMBL3700054,6.20,0,http://www.openphacts.org/units/Nanomolar,2577270,=,37,1,=,,IC50,nM,,630.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,630.0
,273259,16267047,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CNCC(=O)N[C@H]1CN(C(=O)N2CCN(C(=O)N3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)CC2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699036,,CHEMBL3699036,,0,http://www.openphacts.org/units/Nanomolar,2576162,<,37,1,<,,IC50,nM,,300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,300.0
,298676,16267562,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(F)(F)c1cc2c(cn1)C(C)(C)CN2C(=O)CN1C[C@@H](C)NC[C@@H]1CN1CC[C@@H](F)C1,,,CHEMBL3639218,,2015,"{'bei': '16.30', 'le': '0.32', 'lle': '4.71', 'sei': '14.74'}",CHEMBL3700081,,CHEMBL3700081,7.62,0,http://www.openphacts.org/units/Nanomolar,2577297,=,37,1,=,,IC50,nM,,24.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,24.0
,298628,16267911,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Oc3c(F)cccc3F)cc21,,,CHEMBL3639218,,2015,"{'bei': '15.03', 'le': '0.29', 'lle': '3.83', 'sei': '10.34'}",CHEMBL3700007,,CHEMBL3700007,6.92,0,http://www.openphacts.org/units/Nanomolar,2577223,=,37,1,=,,IC50,nM,,120.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,120.0
,298528,16268319,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3ccc(Cl)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '15.44', 'le': '0.31', 'lle': '3.02', 'sei': '12.75'}",CHEMBL3600728,,CHEMBL3600728,4.54,0,http://www.openphacts.org/units/Nanomolar,2573322,=,37,1,=,,IC50,nM,,29000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,29000.0
,298623,16268740,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CCC1(C)CN(C(=O)CN2C[C@@H](C)NC[C@@H]2COC)c2cc(Cl)ccc21,,,CHEMBL3639218,,2015,"{'bei': '16.54', 'le': '0.33', 'lle': '3.62', 'sei': '14.02'}",CHEMBL3700002,,CHEMBL3700002,6.28,0,http://www.openphacts.org/units/Nanomolar,2577218,=,37,1,=,,IC50,nM,,520.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,520.0
,298673,16269338,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(F)(F)c1cc2c(cn1)C(C)(C)CN2C(=O)CN1C[C@@H](C)NC[C@@H]1CN1CCCC1=O,,,CHEMBL3639218,,2015,"{'bei': '16.48', 'le': '0.32', 'lle': '5.15', 'sei': '11.11'}",CHEMBL3700067,,CHEMBL3700067,7.64,0,http://www.openphacts.org/units/Nanomolar,2577283,=,37,1,=,,IC50,nM,,23.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,23.0
,298568,16269351,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cc(F)c(S(=O)(=O)c3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '13.70', 'le': '0.27', 'lle': '5.20', 'sei': '6.97'}",CHEMBL3696522,,CHEMBL3696522,6.89,0,http://www.openphacts.org/units/Nanomolar,2573366,=,37,1,=,,IC50,nM,,130.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,130.0
,298661,16269904,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1C[C@](C)(c2cc(C)no2)c2ccc(Cc3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '13.76', 'le': '0.25', 'lle': '3.18', 'sei': '9.49'}",CHEMBL3700049,,CHEMBL3700049,6.72,0,http://www.openphacts.org/units/Nanomolar,2577265,=,37,1,=,,IC50,nM,,190.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,190.0
,298618,16271960,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(C3CCCCC3)cc21,,,CHEMBL3639218,,2015,"{'bei': '15.97', 'le': '0.30', 'lle': '3.56', 'sei': '11.47'}",CHEMBL3699998,,CHEMBL3699998,6.62,0,http://www.openphacts.org/units/Nanomolar,2577213,=,37,1,=,,IC50,nM,,240.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,240.0
,298671,16272155,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(F)(F)c1cnc2c(c1)N(C(=O)CN1C[C@@H](C)NC[C@@H]1CN1CCCC1=O)CC2(C)C,,,CHEMBL3639218,,2015,"{'bei': '16.26', 'le': '0.31', 'lle': '5.05', 'sei': '10.96'}",CHEMBL3700061,,CHEMBL3700061,7.54,0,http://www.openphacts.org/units/Nanomolar,2577277,=,37,1,=,,IC50,nM,,29.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,29.0
,298578,16272357,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cc(=O)n(Cc3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '17.72', 'le': '0.33', 'lle': '5.94', 'sei': '11.63'}",CHEMBL3699951,,CHEMBL3699951,7.77,0,http://www.openphacts.org/units/Nanomolar,2577166,=,37,1,=,,IC50,nM,,17.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,17.0
,273271,16272643,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)N[C@H]5CCC[C@@H]5c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)N[C@H]3CCC[C@@H]3c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699048,,CHEMBL3699048,,0,http://www.openphacts.org/units/Nanomolar,2576174,<,37,1,<,,IC50,nM,,3000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3000.0
,14160,16273452,[],CHEMBL3707504,"Fluorescence Polarization-Based Assays: An in vitro fluorescence polarization (FP) based binding assay was used to test the binding ability of the compounds of the present invention to certain IAP proteins (Nikolovska-Coleska et al., Anal. Biochem. 332:261-73 (2004)). he FP-based assay for XIAP BIR3 protein was described in detail previously (Nikolovska-Coleska et al., Anal. Biochem. 332:261-73 (2004)). Briefly, 5-carboxyfluorescein was coupled to the lysine side chain of a mutated Smac peptide with the sequence (AbuRPFK-Fam) and this fluorescently tagged peptide (named SM5F) was used as the fluorescent tracer in FP-based binding assay to XIAP BIR3.",B,,,BAO_0000190,BAO_0000357,single protein format,C=CC(C=C)c1cccc2[nH]c([C@@H]3CC[C@@H]4CCN(C(=O)CCCCCCCCCCC(=O)N5CC[C@H]6CC[C@@H](c7nc8c(-c9ccccc9)cccc8[nH]7)N6C(=O)[C@@H](NC(=O)[C@H](C)NC)C5)C[C@H](NC(=O)[C@H](C)NC)C(=O)N43)nc12,,,CHEMBL3639255,,2014,,CHEMBL3657134,,CHEMBL3657134,,0,http://www.openphacts.org/units/Nanomolar,2531444,<,37,1,<,,IC50,nM,,50.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,50.0
,298583,16273570,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(CC(C)C)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.75', 'le': '0.32', 'lle': '4.30', 'sei': '11.28'}",CHEMBL3699956,,CHEMBL3699956,6.51,0,http://www.openphacts.org/units/Nanomolar,2577171,=,37,1,=,,IC50,nM,,310.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,310.0
,298608,16273636,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(C#N)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.95', 'le': '0.32', 'lle': '5.17', 'sei': '7.44'}",CHEMBL3699984,,CHEMBL3699984,6.06,0,http://www.openphacts.org/units/Nanomolar,2577199,=,37,1,=,,IC50,nM,,870.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,870.0
,298561,16274725,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3cc(F)c(S(=O)(=O)N4CCCC4)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '12.28', 'le': '0.25', 'lle': '3.86', 'sei': '7.38'}",CHEMBL3696515,,CHEMBL3696515,5.39,0,http://www.openphacts.org/units/Nanomolar,2573359,=,37,1,=,,IC50,nM,,4100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4100.0
,273256,16274835,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(CCc3ccc(NC(=O)N4CC[C@H]5CC[C@@H](C(=O)NC(c6ccccc6)c6ccccc6)N5C(=O)[C@@H](NC(=O)[C@H](C)NC)C4)cc3)cc2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699033,,CHEMBL3699033,,0,http://www.openphacts.org/units/Nanomolar,2576159,<,37,1,<,,IC50,nM,,300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,300.0
,298678,16275027,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(C(C)(F)F)cc32)[C@@H](CN2CCc3cccnc32)CN1,,,CHEMBL3639218,,2015,"{'bei': '14.14', 'le': '0.27', 'lle': '3.91', 'sei': '10.61'}",CHEMBL3700087,,CHEMBL3700087,6.85,0,http://www.openphacts.org/units/Nanomolar,2577303,=,37,1,=,,IC50,nM,,140.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,140.0
,298656,16275400,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(c2cccnc2)c2ccc(Cc3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.27', 'le': '0.30', 'lle': '4.26', 'sei': '13.67'}",CHEMBL3700040,,CHEMBL3700040,7.89,0,http://www.openphacts.org/units/Nanomolar,2577256,=,37,1,=,,IC50,nM,,13.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,13.0
,298531,16275794,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3cc(F)ccc32)CCN1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3639218,,2015,,CHEMBL3696488,,CHEMBL3696488,,0,http://www.openphacts.org/units/Nanomolar,2573325,=,37,1,=,,IC50,nM,,170000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,170000.0
,298535,16275939,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3c(Cl)cccc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '14.82', 'le': '0.30', 'lle': '2.51', 'sei': '13.41'}",CHEMBL3696492,,CHEMBL3696492,4.77,0,http://www.openphacts.org/units/Nanomolar,2573331,=,37,1,=,,IC50,nM,,17000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,17000.0
,298581,16276181,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2ccc(S(=O)(=O)Cc3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '12.53', 'le': '0.24', 'lle': '3.50', 'sei': '7.71'}",CHEMBL3699954,,CHEMBL3699954,6.09,0,http://www.openphacts.org/units/Nanomolar,2577169,=,37,1,=,,IC50,nM,,820.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,820.0
,298607,16276216,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(N3CCCC3=O)cc21,,,CHEMBL3639218,,2015,"{'bei': '14.89', 'le': '0.28', 'lle': '5.05', 'sei': '7.93'}",CHEMBL3699983,,CHEMBL3699983,6.19,0,http://www.openphacts.org/units/Nanomolar,2577198,=,37,1,=,,IC50,nM,,650.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,650.0
,298609,16276571,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(C3=CCCCC3)cc21,,,CHEMBL3639218,,2015,"{'bei': '18.51', 'le': '0.35', 'lle': '4.67', 'sei': '13.24'}",CHEMBL3699987,,CHEMBL3699987,7.64,0,http://www.openphacts.org/units/Nanomolar,2577202,=,37,1,=,,IC50,nM,,23.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,23.0
,298642,16277776,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(c2ccccn2)c2ccc(Cc3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.34', 'le': '0.30', 'lle': '4.29', 'sei': '13.73'}",CHEMBL3700023,,CHEMBL3700023,7.92,0,http://www.openphacts.org/units/Nanomolar,2577239,=,37,1,=,,IC50,nM,,12.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,12.0
,298604,16278186,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Cc3ccc(OC)cc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.88', 'le': '0.32', 'lle': '5.03', 'sei': '11.41'}",CHEMBL3699979,,CHEMBL3699979,7.64,0,http://www.openphacts.org/units/Nanomolar,2577194,=,37,1,=,,IC50,nM,,23.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,23.0
,298588,16278504,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Cc3ccccc3Cl)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.31', 'le': '0.32', 'lle': '4.20', 'sei': '12.92'}",CHEMBL3699961,,CHEMBL3699961,7.46,0,http://www.openphacts.org/units/Nanomolar,2577176,=,37,1,=,,IC50,nM,,35.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,35.0
,298585,16279133,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(CCC(C)C)cc21,,,CHEMBL3639218,,2015,"{'bei': '19.36', 'le': '0.37', 'lle': '5.20', 'sei': '13.51'}",CHEMBL3699958,,CHEMBL3699958,7.80,0,http://www.openphacts.org/units/Nanomolar,2577173,=,37,1,=,,IC50,nM,,16.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,16.0
,273284,16279418,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)NC4Cc5ccccc5C4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)NC3Cc4ccccc4C3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699061,,CHEMBL3699061,,0,http://www.openphacts.org/units/Nanomolar,2576187,<,37,1,<,,IC50,nM,,10000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,10000.0
,298566,16279489,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2ccc(Cl)cc21,,,CHEMBL3639218,,2015,"{'bei': '14.98', 'le': '0.30', 'lle': '4.31', 'sei': '8.78'}",CHEMBL3696520,,CHEMBL3696520,5.68,0,http://www.openphacts.org/units/Nanomolar,2573364,=,37,1,=,,IC50,nM,,2100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2100.0
,298630,16279969,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Oc3c(C)cccc3Cl)cc21,,,CHEMBL3639218,,2015,"{'bei': '15.55', 'le': '0.30', 'lle': '3.59', 'sei': '10.99'}",CHEMBL3700009,,CHEMBL3700009,7.36,0,http://www.openphacts.org/units/Nanomolar,2577225,=,37,1,=,,IC50,nM,,44.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,44.0
,298641,16280021,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(c3ccccc3)c3ccc(C#N)cc32)[C@@H](Cn2cccn2)CN1,,,CHEMBL3639218,,2015,"{'bei': '14.74', 'le': '0.27', 'lle': '3.93', 'sei': '8.68'}",CHEMBL3700022,,CHEMBL3700022,6.70,0,http://www.openphacts.org/units/Nanomolar,2577238,=,37,1,=,,IC50,nM,,200.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,200.0
,273241,16280097,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCc2cccc(CNC(=O)N3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)c2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699018,,CHEMBL3699018,,0,http://www.openphacts.org/units/Nanomolar,2576144,<,37,1,<,,IC50,nM,,100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,100.0
,13520,16280359,[],CHEMBL3707504,"Fluorescence Polarization-Based Assays: An in vitro fluorescence polarization (FP) based binding assay was used to test the binding ability of the compounds of the present invention to certain IAP proteins (Nikolovska-Coleska et al., Anal. Biochem. 332:261-73 (2004)). he FP-based assay for XIAP BIR3 protein was described in detail previously (Nikolovska-Coleska et al., Anal. Biochem. 332:261-73 (2004)). Briefly, 5-carboxyfluorescein was coupled to the lysine side chain of a mutated Smac peptide with the sequence (AbuRPFK-Fam) and this fluorescently tagged peptide (named SM5F) was used as the fluorescent tracer in FP-based binding assay to XIAP BIR3.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CCCCOCCCCC(=O)N2CC[C@H]3CC[C@@H](c4nc5c(-c6ccccc6)cccc5[nH]4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CC[C@@H](c3nc4c(-c5ccccc5)cccc4[nH]3)N2C1=O,,,CHEMBL3639255,,2014,,CHEMBL3657131,,CHEMBL3657131,,0,http://www.openphacts.org/units/Nanomolar,2531440,<,37,1,<,,IC50,nM,,20.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,20.0
,298553,16281601,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3cc(F)c(S(=O)(=O)c4ccccc4)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '14.10', 'le': '0.28', 'lle': '4.05', 'sei': '8.44'}",CHEMBL3696508,,CHEMBL3696508,5.89,0,http://www.openphacts.org/units/Nanomolar,2573351,=,37,1,=,,IC50,nM,,1300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1300.0
,273276,16283416,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)N[C@H]5C[C@@H]5c5ccc(C(F)(F)F)c(F)c5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)N[C@H]3C[C@@H]3c3ccc(C(F)(F)F)c(F)c3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699053,,CHEMBL3699053,,0,http://www.openphacts.org/units/Nanomolar,2576179,<,37,1,<,,IC50,nM,,3000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3000.0
,298660,16283904,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(Cc4ccccc4)cc32)[C@@H](C(=O)N(C)C)CN1,,,CHEMBL3639218,,2015,"{'bei': '17.70', 'le': '0.33', 'lle': '5.91', 'sei': '11.57'}",CHEMBL3700047,,CHEMBL3700047,7.96,0,http://www.openphacts.org/units/Nanomolar,2577263,=,37,1,=,,IC50,nM,,11.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,11.0
,298677,16284162,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3cnc(Cc4ccc(F)cc4F)cc32)[C@@H](CN2CCCC2)CN1,,,CHEMBL3639218,,2015,"{'bei': '15.78', 'le': '0.30', 'lle': '4.52', 'sei': '15.19'}",CHEMBL3700085,,CHEMBL3700085,7.85,0,http://www.openphacts.org/units/Nanomolar,2577301,=,37,1,=,,IC50,nM,,14.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,14.0
,298542,16284868,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3cc(Br)c(S(=O)(=O)N(C)C)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '10.26', 'le': '0.24', 'lle': '3.69', 'sei': '6.26'}",CHEMBL3696497,,CHEMBL3696497,4.57,0,http://www.openphacts.org/units/Nanomolar,2573338,=,37,1,=,,IC50,nM,,27000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,27000.0
,298617,16285405,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2ccc(C#N)cc21,,,CHEMBL3639218,,2015,"{'bei': '17.25', 'le': '0.32', 'lle': '4.66', 'sei': '8.96'}",CHEMBL3699997,,CHEMBL3699997,6.15,0,http://www.openphacts.org/units/Nanomolar,2577212,=,37,1,=,,IC50,nM,,710.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,710.0
,298530,16285480,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2c(c1)N(C(=O)CN1CCN[C@H](C)C1)CC2,,,CHEMBL3639218,,2015,"{'bei': '14.71', 'le': '0.27', 'lle': '2.84', 'sei': '11.30'}",CHEMBL3600725,,CHEMBL3600725,4.02,0,http://www.openphacts.org/units/Nanomolar,2573324,=,37,1,=,,IC50,nM,,95000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,95000.0
,273280,16285919,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)N[C@H]4CCC[C@@H]4c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)N[C@H]3CCC[C@@H]3c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699057,,CHEMBL3699057,,0,http://www.openphacts.org/units/Nanomolar,2576183,<,37,1,<,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,273277,16286087,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(Cc3ccc(NC(=O)N4CC[C@H]5CC[C@@H](C(=O)N[C@H]6C[C@@H]6c6ccccc6)N5C(=O)[C@@H](NC(=O)[C@H](C)NC)C4)cc3)cc2)CC[C@H]2CCC(C(=O)N[C@H]3C[C@@H]3c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699054,,CHEMBL3699054,,0,http://www.openphacts.org/units/Nanomolar,2576180,<,37,1,<,,IC50,nM,,3000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3000.0
,273282,16286432,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)N[C@@H]4CCC[C@@H]4c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)N[C@@H]3CCC[C@@H]3c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699059,,CHEMBL3699059,,0,http://www.openphacts.org/units/Nanomolar,2576185,<,37,1,<,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,298606,16286584,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3cnc(Cc4ccccc4)cc32)[C@@H](C(=O)N2CCC2)CN1,,,CHEMBL3639218,,2015,"{'bei': '17.01', 'le': '0.32', 'lle': '5.66', 'sei': '11.42'}",CHEMBL3699981,,CHEMBL3699981,7.85,0,http://www.openphacts.org/units/Nanomolar,2577196,=,37,1,=,,IC50,nM,,14.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,14.0
,298584,16287836,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Oc3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.50', 'le': '0.31', 'lle': '4.19', 'sei': '10.47'}",CHEMBL3699957,,CHEMBL3699957,7.00,0,http://www.openphacts.org/units/Nanomolar,2577172,=,37,1,=,,IC50,nM,,99.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,99.0
,298657,16288673,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3cnc(Oc4ccccc4Cl)cc32)[C@@H](C(=O)N2CCOCC2)CN1,,,CHEMBL3639218,,2015,"{'bei': '14.87', 'le': '0.29', 'lle': '5.18', 'sei': '9.00'}",CHEMBL3700042,,CHEMBL3700042,7.85,0,http://www.openphacts.org/units/Nanomolar,2577258,=,37,1,=,,IC50,nM,,14.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,14.0
,298541,16289500,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CNS(=O)(=O)c1cc2c(cc1Br)CCN2C(=O)CN1CCN[C@H](C)C1,,,CHEMBL3639218,,2015,"{'bei': '9.79', 'le': '0.23', 'lle': '3.68', 'sei': '5.16'}",CHEMBL3696496,,CHEMBL3696496,4.22,0,http://www.openphacts.org/units/Nanomolar,2573337,=,37,1,=,,IC50,nM,,60000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,60000.0
,298602,16289541,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(C(=O)c3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.29', 'le': '0.30', 'lle': '4.86', 'sei': '9.51'}",CHEMBL3699977,,CHEMBL3699977,7.11,0,http://www.openphacts.org/units/Nanomolar,2577192,=,37,1,=,,IC50,nM,,77.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,77.0
,298534,16290118,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1ccc2c(c1)N(C(=O)CN1CCN[C@H](C)C1)CC2,,,CHEMBL3639218,,2015,"{'bei': '16.28', 'le': '0.31', 'lle': '4.51', 'sei': '8.35'}",CHEMBL3696490,,CHEMBL3696490,5.17,0,http://www.openphacts.org/units/Nanomolar,2573329,=,37,1,=,,IC50,nM,,6800.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,6800.0
,273252,16290872,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2cccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)c2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699029,,CHEMBL3699029,,0,http://www.openphacts.org/units/Nanomolar,2576155,<,37,1,<,,IC50,nM,,300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,300.0
,273273,16291696,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)N[C@H]5CCC[C@H]5c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)N[C@H]3CCC[C@H]3c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699050,,CHEMBL3699050,,0,http://www.openphacts.org/units/Nanomolar,2576176,<,37,1,<,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,298621,16292088,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3cnc(Cc4ccccc4)cc32)[C@@H](CF)CN1,,,CHEMBL3639218,,2015,"{'bei': '18.70', 'le': '0.35', 'lle': '4.75', 'sei': '15.84'}",CHEMBL3639988,,CHEMBL3639988,7.68,0,http://www.openphacts.org/units/Nanomolar,2577216,=,37,1,=,,IC50,nM,,21.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,21.0
,298634,16292157,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(c2ccccc2)c2ccc(C#N)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.06', 'le': '0.30', 'lle': '4.20', 'sei': '9.80'}",CHEMBL3700015,,CHEMBL3700015,6.72,0,http://www.openphacts.org/units/Nanomolar,2577231,=,37,1,=,,IC50,nM,,190.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,190.0
,298579,16293124,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2ccc(S(=O)(=O)N(C)C)cc21,,,CHEMBL3639218,,2015,"{'bei': '13.50', 'le': '0.27', 'lle': '5.05', 'sei': '7.20'}",CHEMBL3699952,,CHEMBL3699952,5.92,0,http://www.openphacts.org/units/Nanomolar,2577167,=,37,1,=,,IC50,nM,,1200.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1200.0
,298594,16293361,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(C(C)c3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '17.45', 'le': '0.33', 'lle': '4.45', 'sei': '13.21'}",CHEMBL3699968,,CHEMBL3699968,7.62,0,http://www.openphacts.org/units/Nanomolar,2577183,=,37,1,=,,IC50,nM,,24.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,24.0
,273257,16293602,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=S)Nc2ccc(Cc3ccc(NC(=S)N4CC[C@H]5CC[C@@H](C(=O)NC(c6ccccc6)c6ccccc6)N5C(=O)[C@@H](NC(=O)[C@H](C)NC)C4)cc3)cc2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699034,,CHEMBL3699034,,0,http://www.openphacts.org/units/Nanomolar,2576160,<,37,1,<,,IC50,nM,,300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,300.0
,298547,16294423,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3ccc(S(=O)(=O)c4ccccc4)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '13.57', 'le': '0.26', 'lle': '3.72', 'sei': '7.77'}",CHEMBL3696502,,CHEMBL3696502,5.42,0,http://www.openphacts.org/units/Nanomolar,2573344,=,37,1,=,,IC50,nM,,3800.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3800.0
,298600,16294560,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2ccc(Cc3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '18.63', 'le': '0.35', 'lle': '4.64', 'sei': '17.53'}",CHEMBL3699975,,CHEMBL3699975,7.85,0,http://www.openphacts.org/units/Nanomolar,2577190,=,37,1,=,,IC50,nM,,14.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,14.0
,298652,16295204,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2C[C@](C)(c3ccccc3)c3ccc(C#N)cc32)[C@@H](Cn2cccn2)CN1,,,CHEMBL3639218,,2015,"{'bei': '14.49', 'le': '0.26', 'lle': '3.82', 'sei': '8.53'}",CHEMBL3700033,,CHEMBL3700033,6.58,0,http://www.openphacts.org/units/Nanomolar,2577249,=,37,1,=,,IC50,nM,,260.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,260.0
,298558,16295505,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3c(Cl)cc(Cl)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '14.93', 'le': '0.32', 'lle': '2.41', 'sei': '14.95'}",CHEMBL3696512,,CHEMBL3696512,5.32,0,http://www.openphacts.org/units/Nanomolar,2573356,=,37,1,=,,IC50,nM,,4800.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4800.0
,273274,16295547,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)N[C@H]5C[C@@H]5c5ccc(C(F)(F)F)cc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)N[C@H]3C[C@@H]3c3ccc(C(F)(F)F)cc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699051,,CHEMBL3699051,,0,http://www.openphacts.org/units/Nanomolar,2576177,<,37,1,<,,IC50,nM,,3000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3000.0
,298550,16296720,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3ccc(S(=O)(=O)N4CCCC4)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '11.82', 'le': '0.23', 'lle': '3.99', 'sei': '6.36'}",CHEMBL3696505,,CHEMBL3696505,4.64,0,http://www.openphacts.org/units/Nanomolar,2573348,=,37,1,=,,IC50,nM,,23000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,23000.0
,298637,16297307,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1C[C@@](C)(c2ccccc2)c2ccc(C#N)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.06', 'le': '0.30', 'lle': '4.20', 'sei': '9.80'}",CHEMBL3700018,,CHEMBL3700018,6.72,0,http://www.openphacts.org/units/Nanomolar,2577234,=,37,1,=,,IC50,nM,,190.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,190.0
,298562,16297411,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC3(CCCC3)c3ccc(Cl)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '13.87', 'le': '0.27', 'lle': '2.03', 'sei': '13.56'}",CHEMBL3696516,,CHEMBL3696516,4.82,0,http://www.openphacts.org/units/Nanomolar,2573360,=,37,1,=,,IC50,nM,,15000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,15000.0
,273265,16297844,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)N[C@H]5C[C@H]5c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)N[C@H]3C[C@H]3c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699042,,CHEMBL3699042,,0,http://www.openphacts.org/units/Nanomolar,2576168,<,37,1,<,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,13517,16298112,[],CHEMBL3707504,"Fluorescence Polarization-Based Assays: An in vitro fluorescence polarization (FP) based binding assay was used to test the binding ability of the compounds of the present invention to certain IAP proteins (Nikolovska-Coleska et al., Anal. Biochem. 332:261-73 (2004)). he FP-based assay for XIAP BIR3 protein was described in detail previously (Nikolovska-Coleska et al., Anal. Biochem. 332:261-73 (2004)). Briefly, 5-carboxyfluorescein was coupled to the lysine side chain of a mutated Smac peptide with the sequence (AbuRPFK-Fam) and this fluorescently tagged peptide (named SM5F) was used as the fluorescent tracer in FP-based binding assay to XIAP BIR3.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CCCCCCC(=O)N2CC[C@H]3CC[C@@H](c4nc5c(-c6ccccc6)cccc5[nH]4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CC[C@@H](c3nc4c(-c5ccccc5)cccc4[nH]3)N2C1=O,,,CHEMBL3639255,,2014,,CHEMBL3657133,,CHEMBL3657133,,0,http://www.openphacts.org/units/Nanomolar,2531442,<,37,1,<,,IC50,nM,,20.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,20.0
,273248,16298437,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(S(=O)(=O)CCCCCCCCS(=O)(=O)N2CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699025,,CHEMBL3699025,,0,http://www.openphacts.org/units/Nanomolar,2576151,<,37,1,<,,IC50,nM,,100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,100.0
,298650,16299068,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2C[C@](C)(c3ccccc3)c3ccc(C#N)cc32)[C@@H](C(=O)N2CCOCC2)CN1,,,CHEMBL3639218,,2015,"{'bei': '13.94', 'le': '0.26', 'lle': '5.07', 'sei': '7.64'}",CHEMBL3700031,,CHEMBL3700031,6.80,0,http://www.openphacts.org/units/Nanomolar,2577247,=,37,1,=,,IC50,nM,,160.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,160.0
,273268,16299451,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)N[C@@H]5C[C@H]5c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)N[C@@H]3C[C@H]3c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699045,,CHEMBL3699045,,0,http://www.openphacts.org/units/Nanomolar,2576171,<,37,1,<,,IC50,nM,,3000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3000.0
,298664,16299902,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(C(C)(F)F)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.65', 'le': '0.32', 'lle': '4.47', 'sei': '11.44'}",CHEMBL3700053,,CHEMBL3700053,6.60,0,http://www.openphacts.org/units/Nanomolar,2577269,=,37,1,=,,IC50,nM,,250.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,250.0
,298643,16300047,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(-c3ccoc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.92', 'le': '0.32', 'lle': '4.47', 'sei': '9.52'}",CHEMBL3700024,,CHEMBL3700024,6.75,0,http://www.openphacts.org/units/Nanomolar,2577240,=,37,1,=,,IC50,nM,,180.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,180.0
,298554,16301334,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ccc(Cc4ccccc4)cc32)[C@@H](CO)CN1,,,CHEMBL3639218,,2015,"{'bei': '17.60', 'le': '0.33', 'lle': '4.61', 'sei': '12.85'}",CHEMBL3696509,,CHEMBL3696509,7.17,0,http://www.openphacts.org/units/Nanomolar,2573352,=,37,1,=,,IC50,nM,,67.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,67.0
,298684,16301563,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1COCCN1C[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2ncc(C(F)(F)CC)cc21,,,CHEMBL3639218,,2015,"{'bei': '15.91', 'le': '0.31', 'lle': '4.87', 'sei': '12.89'}",CHEMBL3700105,,CHEMBL3700105,7.85,0,http://www.openphacts.org/units/Nanomolar,2577322,=,37,1,=,,IC50,nM,,14.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,14.0
,298589,16302202,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(CC3CCCCC3)cc21,,,CHEMBL3639218,,2015,"{'bei': '17.74', 'le': '0.33', 'lle': '4.46', 'sei': '13.18'}",CHEMBL3699962,,CHEMBL3699962,7.60,0,http://www.openphacts.org/units/Nanomolar,2577177,=,37,1,=,,IC50,nM,,25.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,25.0
,298639,16302375,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cc(-c3nc(C)no3)c(Cl)cc21,,,CHEMBL3639218,,2015,"{'bei': '14.63', 'le': '0.29', 'lle': '3.92', 'sei': '7.83'}",CHEMBL3700020,,CHEMBL3700020,6.55,0,http://www.openphacts.org/units/Nanomolar,2577236,=,37,1,=,,IC50,nM,,280.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,280.0
,298527,16302948,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3ccc(N(C)c4ccccc4)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '11.26', 'le': '0.21', 'lle': '1.46', 'sei': '10.57'}",CHEMBL3696486,,CHEMBL3696486,4.10,0,http://www.openphacts.org/units/Nanomolar,2573320,=,37,1,=,,IC50,nM,,79000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,79000.0
,298592,16303494,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(N(C)c3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '13.45', 'le': '0.25', 'lle': '3.11', 'sei': '9.66'}",CHEMBL3699966,,CHEMBL3699966,5.89,0,http://www.openphacts.org/units/Nanomolar,2577181,=,37,1,=,,IC50,nM,,1300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1300.0
,298611,16303746,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ccc(Cl)cc32)[C@@H](C(=O)N2CCOCC2)CN1,,,CHEMBL3639218,,2015,"{'bei': '15.07', 'le': '0.30', 'lle': '5.06', 'sei': '10.06'}",CHEMBL3699989,,CHEMBL3699989,6.55,0,http://www.openphacts.org/units/Nanomolar,2577204,=,37,1,=,,IC50,nM,,280.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,280.0
,298563,16303831,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CCS(=O)(=O)c1cc2c(cc1F)C(C)(C)CN2C(=O)CN1CCN[C@H](C)C1,,,CHEMBL3639218,,2015,"{'bei': '13.82', 'le': '0.28', 'lle': '3.95', 'sei': '7.88'}",CHEMBL3696517,,CHEMBL3696517,5.50,0,http://www.openphacts.org/units/Nanomolar,2573361,=,37,1,=,,IC50,nM,,3200.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3200.0
,273279,16304530,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)N[C@@H]4CCCC[C@H]4c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)N[C@@H]3CCCC[C@H]3c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699056,,CHEMBL3699056,,0,http://www.openphacts.org/units/Nanomolar,2576182,<,37,1,<,,IC50,nM,,5000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,5000.0
,298601,16304633,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Cn3cccn3)cc21,,,CHEMBL3639218,,2015,"{'bei': '15.55', 'le': '0.29', 'lle': '4.15', 'sei': '9.30'}",CHEMBL3699976,,CHEMBL3699976,6.17,0,http://www.openphacts.org/units/Nanomolar,2577191,=,37,1,=,,IC50,nM,,680.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,680.0
,298590,16304695,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Cc3cccc(C#N)c3)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.72', 'le': '0.31', 'lle': '5.00', 'sei': '9.18'}",CHEMBL3699963,,CHEMBL3699963,7.48,0,http://www.openphacts.org/units/Nanomolar,2577178,=,37,1,=,,IC50,nM,,33.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,33.0
,298632,16304849,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cc(C)c(C#N)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.81', 'le': '0.32', 'lle': '4.43', 'sei': '9.08'}",CHEMBL3700013,,CHEMBL3700013,6.23,0,http://www.openphacts.org/units/Nanomolar,2577229,=,37,1,=,,IC50,nM,,590.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,590.0
,273285,16305359,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)NCCc4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)NCCc3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699062,,CHEMBL3699062,,0,http://www.openphacts.org/units/Nanomolar,2576188,<,37,1,<,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,298574,16306955,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Cl)cc21,,,CHEMBL3639218,,2015,"{'bei': '17.70', 'le': '0.35', 'lle': '4.82', 'sei': '11.26'}",CHEMBL3600735,,CHEMBL3600735,6.50,1,http://www.openphacts.org/units/Nanomolar,2577162,=,37,1,=,,IC50,nM,,320.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,320.0
,298557,16308245,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2ccc(Cl)cc21,,,CHEMBL3639218,,2015,"{'bei': '15.87', 'le': '0.32', 'lle': '4.48', 'sei': '9.64'}",CHEMBL3696511,,CHEMBL3696511,6.24,0,http://www.openphacts.org/units/Nanomolar,2573355,=,37,1,=,,IC50,nM,,580.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,580.0
,298638,16308560,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1C[C@](C)(c2ccccc2)c2ccc(C#N)cc21,,,CHEMBL3639218,,2015,"{'bei': '15.91', 'le': '0.29', 'lle': '4.14', 'sei': '9.70'}",CHEMBL3700019,,CHEMBL3700019,6.66,0,http://www.openphacts.org/units/Nanomolar,2577235,=,37,1,=,,IC50,nM,,220.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,220.0
,273240,16308593,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699017,,CHEMBL3699017,,0,http://www.openphacts.org/units/Nanomolar,2576143,<,37,1,<,,IC50,nM,,100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,100.0
,273239,16308722,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699016,,CHEMBL3699016,,0,http://www.openphacts.org/units/Nanomolar,2576142,<,37,1,<,,IC50,nM,,300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,300.0
,298674,16308759,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)C(F)(F)c1cc2c(cn1)C(C)(C)CN2C(=O)CN1C[C@@H](C)NC[C@@H]1CN1CCCC1=O,,,CHEMBL3639218,,2015,"{'bei': '16.03', 'le': '0.31', 'lle': '4.92', 'sei': '11.13'}",CHEMBL3700079,,CHEMBL3700079,7.66,0,http://www.openphacts.org/units/Nanomolar,2577295,=,37,1,=,,IC50,nM,,22.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,22.0
,298622,16309410,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3cnc(Cc4ccccc4)cc32)[C@@H](C(F)F)CN1,,,CHEMBL3639218,,2015,"{'bei': '17.59', 'le': '0.33', 'lle': '4.32', 'sei': '15.55'}",CHEMBL3700001,,CHEMBL3700001,7.54,0,http://www.openphacts.org/units/Nanomolar,2577217,=,37,1,=,,IC50,nM,,29.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,29.0
,298659,16310554,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1C[C@@](C)(COC)c2ccc(Br)cc21,,,CHEMBL3639218,,2015,"{'bei': '14.75', 'le': '0.33', 'lle': '4.48', 'sei': '12.02'}",CHEMBL3700046,,CHEMBL3700046,6.50,0,http://www.openphacts.org/units/Nanomolar,2577262,=,37,1,=,,IC50,nM,,320.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,320.0
,298648,16311030,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3cnc(Oc4ccccc4Cl)cc32)[C@@H](C(=O)N(C)C)CN1,,,CHEMBL3639218,,2015,"{'bei': '15.89', 'le': '0.31', 'lle': '4.82', 'sei': '9.90'}",CHEMBL3700029,,CHEMBL3700029,7.72,0,http://www.openphacts.org/units/Nanomolar,2577245,=,37,1,=,,IC50,nM,,19.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,19.0
,298571,16311170,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CCS(=O)(=O)c1ccc2c(c1)N(C(=O)CN1C[C@@H](C)NC[C@@H]1COC)CC2(C)C,,,CHEMBL3639218,,2015,"{'bei': '14.88', 'le': '0.30', 'lle': '4.89', 'sei': '7.98'}",CHEMBL3699946,,CHEMBL3699946,6.30,0,http://www.openphacts.org/units/Nanomolar,2577159,=,37,1,=,,IC50,nM,,500.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,500.0
,298565,16311619,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC3(CC3)c3ccc(Cl)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '15.66', 'le': '0.31', 'lle': '3.00', 'sei': '14.08'}",CHEMBL3696519,,CHEMBL3696519,5.01,0,http://www.openphacts.org/units/Nanomolar,2573363,=,37,1,=,,IC50,nM,,9800.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,9800.0
,298614,16311745,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CN(C(=O)CN2CCNC(CF)C2)c2cc(Cc3ccccc3)ncc21,,,CHEMBL3639218,,2015,"{'bei': '14.69', 'le': '0.27', 'lle': '3.28', 'sei': '12.02'}",CHEMBL3699994,,CHEMBL3699994,5.82,0,http://www.openphacts.org/units/Nanomolar,2577209,=,37,1,=,,IC50,nM,,1500.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1500.0
,298679,16312589,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(C(F)(F)C4CCC4)cc32)[C@@H](CN2CCCC2=O)CN1,,,CHEMBL3639218,,2015,"{'bei': '15.68', 'le': '0.30', 'lle': '4.80', 'sei': '11.16'}",CHEMBL3700089,,CHEMBL3700089,7.68,0,http://www.openphacts.org/units/Nanomolar,2577305,=,37,1,=,,IC50,nM,,21.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,21.0
,298646,16312806,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(c3ccccc3)c3ccc(C#N)cc32)[C@@H](C(=O)N2CCOCC2)CN1,,,CHEMBL3639218,,2015,"{'bei': '14.12', 'le': '0.26', 'lle': '5.16', 'sei': '7.74'}",CHEMBL3700027,,CHEMBL3700027,6.89,0,http://www.openphacts.org/units/Nanomolar,2577243,=,37,1,=,,IC50,nM,,130.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,130.0
,273287,16312821,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)N[C@H]4C[C@H](c5ccccc5)C4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)N[C@H]3C[C@H](c4ccccc4)C3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699064,,CHEMBL3699064,,0,http://www.openphacts.org/units/Nanomolar,2576190,<,37,1,<,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,298546,16313579,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3ccc(S(=O)(=O)N(C)C)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '11.58', 'le': '0.23', 'lle': '4.12', 'sei': '5.82'}",CHEMBL3696501,,CHEMBL3696501,4.24,0,http://www.openphacts.org/units/Nanomolar,2573343,=,37,1,=,,IC50,nM,,57000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,57000.0
,298682,16313639,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CC(F)(F)c1cnc2c(c1)N(C(=O)CN1C[C@@H](C)NC[C@@H]1CN1CCOCC1)CC2(C)C,,,CHEMBL3639218,,2015,"{'bei': '15.55', 'le': '0.30', 'lle': '4.84', 'sei': '12.60'}",CHEMBL3700094,,CHEMBL3700094,7.68,0,http://www.openphacts.org/units/Nanomolar,2577310,=,37,1,=,,IC50,nM,,21.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,21.0
,298575,16313908,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Cc3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '18.93', 'le': '0.35', 'lle': '5.39', 'sei': '13.86'}",CHEMBL3600717,,CHEMBL3600717,8.00,1,http://www.openphacts.org/units/Nanomolar,2577163,=,37,1,=,,IC50,nM,,10.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,10.0
,273249,16314235,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(Cc3ccc(NC(=O)N4CC[C@H]5CC[C@@H](C(=O)NC(c6ccccc6)c6ccccc6)N5C(=O)[C@@H](NC(=O)[C@H](C)NC)C4)cc3)cc2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699026,,CHEMBL3699026,,0,http://www.openphacts.org/units/Nanomolar,2576152,<,37,1,<,,IC50,nM,,100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,100.0
,298662,16316201,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1C[C@@](C)(c2cc(C)no2)c2ccc(Cc3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.29', 'le': '0.30', 'lle': '4.42', 'sei': '11.23'}",CHEMBL3700050,,CHEMBL3700050,7.96,0,http://www.openphacts.org/units/Nanomolar,2577266,=,37,1,=,,IC50,nM,,11.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,11.0
,298603,16316382,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Cc3cccc(F)c3)cc21,,,CHEMBL3639218,,2015,"{'bei': '17.64', 'le': '0.33', 'lle': '5.03', 'sei': '13.47'}",CHEMBL3699978,,CHEMBL3699978,7.77,0,http://www.openphacts.org/units/Nanomolar,2577193,=,37,1,=,,IC50,nM,,17.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,17.0
,298533,16316527,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc2c(c1)N(C(=O)CN1CCN[C@H](C)C1)CC2,,,CHEMBL3639218,,2015,"{'bei': '13.94', 'le': '0.26', 'lle': '2.21', 'sei': '11.81'}",CHEMBL3600726,,CHEMBL3600726,4.20,0,http://www.openphacts.org/units/Nanomolar,2573328,=,37,1,=,,IC50,nM,,63000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,63000.0
,298626,16316635,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(-c3ccsc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '17.04', 'le': '0.33', 'lle': '4.33', 'sei': '12.25'}",CHEMBL3700005,,CHEMBL3700005,7.07,0,http://www.openphacts.org/units/Nanomolar,2577221,=,37,1,=,,IC50,nM,,86.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,86.0
,298569,16316764,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3cc(F)c(S(=O)(=O)C4CC4)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '13.92', 'le': '0.28', 'lle': '4.02', 'sei': '8.17'}",CHEMBL3699944,,CHEMBL3699944,5.70,0,http://www.openphacts.org/units/Nanomolar,2577157,=,37,1,=,,IC50,nM,,2000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2000.0
,273278,16316891,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)N[C@H]4CCCC[C@@H]4c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)N[C@H]3CCCC[C@@H]3c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699055,,CHEMBL3699055,,0,http://www.openphacts.org/units/Nanomolar,2576181,<,37,1,<,,IC50,nM,,3000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3000.0
,273275,16318302,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)N[C@H]5C[C@@H]5c5ccc(C(F)(F)F)cc5F)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)N[C@H]3C[C@@H]3c3ccc(C(F)(F)F)cc3F)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699052,,CHEMBL3699052,,0,http://www.openphacts.org/units/Nanomolar,2576178,<,37,1,<,,IC50,nM,,3000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3000.0
,298538,16318745,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3ccc(C(F)(F)F)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '13.57', 'le': '0.26', 'lle': '2.55', 'sei': '12.49'}",CHEMBL3600730,,CHEMBL3600730,4.44,0,http://www.openphacts.org/units/Nanomolar,2573334,=,37,1,=,,IC50,nM,,36000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,36000.0
,298532,16319099,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1CN[C@H](C)CN1CC(=O)N1CCc2ccc(Br)cc21,,,CHEMBL3639218,,2015,"{'bei': '15.31', 'le': '0.35', 'lle': '3.16', 'sei': '16.37'}",CHEMBL3696489,,CHEMBL3696489,5.82,0,http://www.openphacts.org/units/Nanomolar,2573327,=,37,1,=,,IC50,nM,,1500.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1500.0
,273254,16319698,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(-c3ccc(NC(=O)N4CC[C@H]5CC[C@@H](C(=O)NC(c6ccccc6)c6ccccc6)N5C(=O)[C@@H](NC(=O)[C@H](C)NC)C4)c(C)c3)cc2C)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699031,,CHEMBL3699031,,0,http://www.openphacts.org/units/Nanomolar,2576157,<,37,1,<,,IC50,nM,,300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,300.0
,298663,16320485,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3cnc(Oc4ccccc4Cl)cc32)[C@@H](Cn2cc(F)cn2)CN1,,,CHEMBL3639218,,2015,"{'bei': '15.10', 'le': '0.29', 'lle': '3.89', 'sei': '10.26'}",CHEMBL3700051,,CHEMBL3700051,7.75,0,http://www.openphacts.org/units/Nanomolar,2577267,=,37,1,=,,IC50,nM,,18.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,18.0
,273283,16321294,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)N[C@H]4CCC[C@H]4c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)N[C@H]3CCC[C@H]3c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699060,,CHEMBL3699060,,0,http://www.openphacts.org/units/Nanomolar,2576186,<,37,1,<,,IC50,nM,,3000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3000.0
,298629,16322441,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C(=O)OC)c2ccc(Br)cc21,,,CHEMBL3639218,,2015,"{'bei': '13.91', 'le': '0.31', 'lle': '4.78', 'sei': '8.89'}",CHEMBL3700008,,CHEMBL3700008,6.32,0,http://www.openphacts.org/units/Nanomolar,2577224,=,37,1,=,,IC50,nM,,480.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,480.0
,298591,16322954,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Oc3ccccc3C)cc21,,,CHEMBL3639218,,2015,"{'bei': '15.87', 'le': '0.30', 'lle': '3.84', 'sei': '10.40'}",CHEMBL3699965,,CHEMBL3699965,6.96,0,http://www.openphacts.org/units/Nanomolar,2577180,=,37,1,=,,IC50,nM,,110.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,110.0
,298631,16322962,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(C(OC)c3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.23', 'le': '0.30', 'lle': '4.60', 'sei': '10.98'}",CHEMBL3700011,,CHEMBL3700011,7.35,0,http://www.openphacts.org/units/Nanomolar,2577227,=,37,1,=,,IC50,nM,,45.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,45.0
,298577,16323584,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cc(OC)ncc21,,,CHEMBL3639218,,2015,"{'bei': '16.24', 'le': '0.31', 'lle': '4.87', 'sei': '8.79'}",CHEMBL3699950,,CHEMBL3699950,5.89,0,http://www.openphacts.org/units/Nanomolar,2577165,=,37,1,=,,IC50,nM,,1300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1300.0
,298570,16324216,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cc(F)c(S(=O)(=O)c3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '15.01', 'le': '0.30', 'lle': '4.76', 'sei': '9.31'}",CHEMBL3699945,,CHEMBL3699945,7.35,0,http://www.openphacts.org/units/Nanomolar,2577158,=,37,1,=,,IC50,nM,,45.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,45.0
,273243,16324306,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)N[C@@H]5CCCc6ccccc65)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CCC(C(=O)N[C@@H]3CCCc4ccccc43)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699020,,CHEMBL3699020,,0,http://www.openphacts.org/units/Nanomolar,2576146,<,37,1,<,,IC50,nM,,100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,100.0
,273250,16325968,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(Cc3ccc(NC(=O)N4CC[C@H]5CC[C@@H](C(=O)N[C@@H]6CCCc7ccccc76)N5C(=O)[C@@H](NC(=O)[C@H](C)NC)C4)cc3)cc2)CC[C@H]2CCC(C(=O)N[C@@H]3CCCc4ccccc43)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699027,,CHEMBL3699027,,0,http://www.openphacts.org/units/Nanomolar,2576153,<,37,1,<,,IC50,nM,,100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,100.0
,298536,16326727,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ccc(Cl)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '16.88', 'le': '0.34', 'lle': '3.17', 'sei': '15.27'}",CHEMBL3600733,,CHEMBL3600733,5.43,1,http://www.openphacts.org/units/Nanomolar,2573332,=,37,1,=,,IC50,nM,,3700.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3700.0
,298529,16326880,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(c1)N(C(=O)CN1CCN[C@H](C)C1)CC2,,,CHEMBL3639218,,2015,"{'bei': '14.20', 'le': '0.27', 'lle': '3.23', 'sei': '9.17'}",CHEMBL3600724,,CHEMBL3600724,4.11,0,http://www.openphacts.org/units/Nanomolar,2573323,=,37,1,=,,IC50,nM,,78000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,78000.0
,298669,16327524,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(C(C)(F)F)cc32)[C@@H](CN2CCCC2=O)CN1,,,CHEMBL3639218,,2015,"{'bei': '16.46', 'le': '0.32', 'lle': '5.30', 'sei': '10.76'}",CHEMBL3700059,,CHEMBL3700059,7.40,0,http://www.openphacts.org/units/Nanomolar,2577275,=,37,1,=,,IC50,nM,,40.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,40.0
,273258,16328118,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(Sc3ccc(NC(=O)N4CC[C@H]5CC[C@@H](C(=O)NC(c6ccccc6)c6ccccc6)N5C(=O)[C@@H](NC(=O)[C@H](C)NC)C4)cc3)cc2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699035,,CHEMBL3699035,,0,http://www.openphacts.org/units/Nanomolar,2576161,<,37,1,<,,IC50,nM,,100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,100.0
,298548,16328462,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3cnc(Cl)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '15.94', 'le': '0.32', 'lle': '3.78', 'sei': '9.69'}",CHEMBL3600732,,CHEMBL3600732,4.70,1,http://www.openphacts.org/units/Nanomolar,2573345,=,37,1,=,,IC50,nM,,20000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,20000.0
,298627,16328730,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(COC)c2ccc(Br)cc21,,,CHEMBL3639218,,2015,"{'bei': '14.66', 'le': '0.33', 'lle': '4.45', 'sei': '11.95'}",CHEMBL3700006,,CHEMBL3700006,6.46,0,http://www.openphacts.org/units/Nanomolar,2577222,=,37,1,=,,IC50,nM,,350.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,350.0
,298615,16331432,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CN(C(=O)CN2CCN[C@H](CF)C2)c2cc(Cc3ccccc3)ncc21,,,CHEMBL3639218,,2015,"{'bei': '15.57', 'le': '0.29', 'lle': '3.63', 'sei': '12.74'}",CHEMBL3699995,,CHEMBL3699995,6.17,0,http://www.openphacts.org/units/Nanomolar,2577210,=,37,1,=,,IC50,nM,,670.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,670.0
,298666,16331817,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3cnc(C(C)(F)F)cc32)[C@@H](CN2CCCC2=O)CN1,,,CHEMBL3639218,,2015,"{'bei': '16.70', 'le': '0.32', 'lle': '5.41', 'sei': '10.92'}",CHEMBL3700055,,CHEMBL3700055,7.51,0,http://www.openphacts.org/units/Nanomolar,2577271,=,37,1,=,,IC50,nM,,31.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,31.0
,273261,16331901,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Oc2ccc(C(C)(C)c3ccc(OC(=O)N4CC[C@H]5CC[C@@H](C(=O)NC(c6ccccc6)c6ccccc6)N5C(=O)[C@@H](NC(=O)[C@H](C)NC)C4)cc3)cc2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699038,,CHEMBL3699038,,0,http://www.openphacts.org/units/Nanomolar,2576164,<,37,1,<,,IC50,nM,,300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,300.0
,298613,16332033,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Oc3ccccc3Cl)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.24', 'le': '0.32', 'lle': '4.00', 'sei': '11.14'}",CHEMBL3699991,,CHEMBL3699991,7.46,0,http://www.openphacts.org/units/Nanomolar,2577206,=,37,1,=,,IC50,nM,,35.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,35.0
,298636,16332181,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ccc(Cl)cc32)[C@@H](Cn2cccn2)CN1,,,CHEMBL3639218,,2015,"{'bei': '16.13', 'le': '0.32', 'lle': '3.96', 'sei': '12.14'}",CHEMBL3700017,,CHEMBL3700017,6.48,0,http://www.openphacts.org/units/Nanomolar,2577233,=,37,1,=,,IC50,nM,,330.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,330.0
,298543,16332954,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CNS(=O)(=O)c1ccc2c(c1)N(C(=O)CN1CCN[C@H](C)C1)CC2,,,CHEMBL3639218,,2015,"{'bei': '12.00', 'le': '0.24', 'lle': '4.45', 'sei': '5.17'}",CHEMBL3696498,,CHEMBL3696498,4.23,0,http://www.openphacts.org/units/Nanomolar,2573339,=,37,1,=,,IC50,nM,,59000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,59000.0
,298599,16333480,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C=C(c1ccccc1)c1cc2c(cn1)C(C)(C)CN2C(=O)CN1C[C@@H](C)NC[C@@H]1COC,,,CHEMBL3639218,,2015,"{'bei': '16.63', 'le': '0.31', 'lle': '4.15', 'sei': '12.53'}",CHEMBL3699974,,CHEMBL3699974,7.23,0,http://www.openphacts.org/units/Nanomolar,2577189,=,37,1,=,,IC50,nM,,59.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,59.0
,298551,16333679,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3cnc(-c4cc(Cl)ccc4F)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '14.60', 'le': '0.29', 'lle': '2.96', 'sei': '11.71'}",CHEMBL3696506,,CHEMBL3696506,5.68,0,http://www.openphacts.org/units/Nanomolar,2573349,=,37,1,=,,IC50,nM,,2100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2100.0
,273244,16334288,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCc2cccc(CNC(=O)N3CC[C@H]4CC[C@@H](C(=O)N[C@@H]5CCCc6ccccc65)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)c2)CC[C@H]2CCC(C(=O)N[C@@H]3CCCc4ccccc43)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699021,,CHEMBL3699021,,0,http://www.openphacts.org/units/Nanomolar,2576147,<,37,1,<,,IC50,nM,,100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,100.0
,298681,16334408,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(C(F)(F)CC4CC4)cc32)[C@@H](CN2CCOCC2)CN1,,,CHEMBL3639218,,2015,"{'bei': '16.32', 'le': '0.31', 'lle': '5.43', 'sei': '13.16'}",CHEMBL3700091,,CHEMBL3700091,8.02,0,http://www.openphacts.org/units/Nanomolar,2577307,=,37,1,=,,IC50,nM,,9.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,9.5
,298540,16334485,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3cc(F)c(-c4ccccc4)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '16.12', 'le': '0.30', 'lle': '3.02', 'sei': '16.02'}",CHEMBL3696495,,CHEMBL3696495,5.70,0,http://www.openphacts.org/units/Nanomolar,2573336,=,37,1,=,,IC50,nM,,2000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2000.0
,298559,16335726,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3cc(F)c(S(=O)(=O)c4ccccc4)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '14.38', 'le': '0.28', 'lle': '3.83', 'sei': '9.19'}",CHEMBL3696513,,CHEMBL3696513,6.41,0,http://www.openphacts.org/units/Nanomolar,2573357,=,37,1,=,,IC50,nM,,390.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,390.0
,298552,16335847,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ccc(Cl)cc32)[C@@H](CO)CN1,,,CHEMBL3639218,,2015,"{'bei': '17.30', 'le': '0.35', 'lle': '4.47', 'sei': '10.91'}",CHEMBL3696507,,CHEMBL3696507,6.09,0,http://www.openphacts.org/units/Nanomolar,2573350,=,37,1,=,,IC50,nM,,820.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,820.0
,298526,16336128,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3ccc(Br)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '13.00', 'le': '0.30', 'lle': '2.77', 'sei': '12.36'}",CHEMBL3600729,,CHEMBL3600729,4.40,0,http://www.openphacts.org/units/Nanomolar,2573319,=,37,1,=,,IC50,nM,,40000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,40000.0
,298616,16336192,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CN(C(=O)CN2CCN[C@@H](CF)C2)c2cc(Cc3ccccc3)ncc21,,,CHEMBL3639218,,2015,"{'bei': '14.43', 'le': '0.27', 'lle': '3.18', 'sei': '11.80'}",CHEMBL3699996,,CHEMBL3699996,5.72,0,http://www.openphacts.org/units/Nanomolar,2577211,=,37,1,=,,IC50,nM,,1900.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1900.0
,298549,16336495,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3cnc(Cc4ccccc4)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '17.17', 'le': '0.32', 'lle': '4.16', 'sei': '12.42'}",CHEMBL3696503,,CHEMBL3696503,6.02,0,http://www.openphacts.org/units/Nanomolar,2573346,=,37,1,=,,IC50,nM,,960.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,960.0
,298539,16336802,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC3(CCN(C(=O)OCc4ccccc4)CC3)c3ccc(Cl)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '9.98', 'le': '0.19', 'lle': '1.31', 'sei': '7.61'}",CHEMBL3696494,,CHEMBL3696494,4.96,0,http://www.openphacts.org/units/Nanomolar,2573335,=,37,1,=,,IC50,nM,,11000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,11000.0
,298647,16336827,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(-c3cc4ccccc4o3)cc21,,,CHEMBL3639218,,2015,"{'bei': '17.51', 'le': '0.33', 'lle': '4.42', 'sei': '11.09'}",CHEMBL3700028,,CHEMBL3700028,7.85,0,http://www.openphacts.org/units/Nanomolar,2577244,=,37,1,=,,IC50,nM,,14.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,14.0
,273245,16337113,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(S(=O)(=O)CC/C=C/CCS(=O)(=O)N2CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699022,,CHEMBL3699022,,0,http://www.openphacts.org/units/Nanomolar,2576148,<,37,1,<,,IC50,nM,,300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,300.0
,298635,16337879,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2ncc(Cc3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '18.59', 'le': '0.35', 'lle': '5.24', 'sei': '13.61'}",CHEMBL3700016,,CHEMBL3700016,7.85,0,http://www.openphacts.org/units/Nanomolar,2577232,=,37,1,=,,IC50,nM,,14.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,14.0
,298645,16338336,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(-c3ccc(C)s3)cc21,,,CHEMBL3639218,,2015,"{'bei': '17.14', 'le': '0.33', 'lle': '4.30', 'sei': '12.73'}",CHEMBL3700026,,CHEMBL3700026,7.35,0,http://www.openphacts.org/units/Nanomolar,2577242,=,37,1,=,,IC50,nM,,45.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,45.0
,273262,16339028,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(S(=O)(=O)c2cccc(S(=O)(=O)N3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)c2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699039,,CHEMBL3699039,,0,http://www.openphacts.org/units/Nanomolar,2576165,<,37,1,<,,IC50,nM,,300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,300.0
,298649,16339540,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2C[C@@](C)(c3ccccc3)c3ccc(C#N)cc32)[C@@H](C(=O)N2CCOCC2)CN1,,,CHEMBL3639218,,2015,"{'bei': '14.27', 'le': '0.26', 'lle': '5.23', 'sei': '7.83'}",CHEMBL3700030,,CHEMBL3700030,6.96,0,http://www.openphacts.org/units/Nanomolar,2577246,=,37,1,=,,IC50,nM,,110.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,110.0
,273288,16339742,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)N[C@H]4C[C@@H](c5ccccc5)C4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)N[C@H]3C[C@@H](c4ccccc4)C3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699065,,CHEMBL3699065,,0,http://www.openphacts.org/units/Nanomolar,2576191,<,37,1,<,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,298620,16339936,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC2(Cc3ccccc3C2)c2ccc(Cl)cc21,,,CHEMBL3639218,,2015,"{'bei': '15.39', 'le': '0.30', 'lle': '3.74', 'sei': '15.11'}",CHEMBL3700000,,CHEMBL3700000,6.77,0,http://www.openphacts.org/units/Nanomolar,2577215,=,37,1,=,,IC50,nM,,170.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,170.0
,298595,16340060,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Cc3cccc(OC)c3)cc21,,,CHEMBL3639218,,2015,"{'bei': '17.22', 'le': '0.32', 'lle': '5.19', 'sei': '11.65'}",CHEMBL3699970,,CHEMBL3699970,7.80,0,http://www.openphacts.org/units/Nanomolar,2577185,=,37,1,=,,IC50,nM,,16.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,16.0
,298597,16340214,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(Cc3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '18.99', 'le': '0.35', 'lle': '4.35', 'sei': '15.93'}",CHEMBL3699972,,CHEMBL3699972,7.72,0,http://www.openphacts.org/units/Nanomolar,2577187,=,37,1,=,,IC50,nM,,19.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,19.0
,273242,16340267,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)N[C@@H]4CCCc5ccccc54)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)N[C@@H]3CCCc4ccccc43)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699019,,CHEMBL3699019,,0,http://www.openphacts.org/units/Nanomolar,2576145,<,37,1,<,,IC50,nM,,100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,100.0
,298651,16340273,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2C[C@@](C)(c3ccccc3)c3ccc(C#N)cc32)[C@@H](Cn2cccn2)CN1,,,CHEMBL3639218,,2015,"{'bei': '14.89', 'le': '0.27', 'lle': '4.00', 'sei': '8.77'}",CHEMBL3700032,,CHEMBL3700032,6.77,0,http://www.openphacts.org/units/Nanomolar,2577248,=,37,1,=,,IC50,nM,,170.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,170.0
,13941,16340300,[],CHEMBL3707504,"Fluorescence Polarization-Based Assays: An in vitro fluorescence polarization (FP) based binding assay was used to test the binding ability of the compounds of the present invention to certain IAP proteins (Nikolovska-Coleska et al., Anal. Biochem. 332:261-73 (2004)). he FP-based assay for XIAP BIR3 protein was described in detail previously (Nikolovska-Coleska et al., Anal. Biochem. 332:261-73 (2004)). Briefly, 5-carboxyfluorescein was coupled to the lysine side chain of a mutated Smac peptide with the sequence (AbuRPFK-Fam) and this fluorescently tagged peptide (named SM5F) was used as the fluorescent tracer in FP-based binding assay to XIAP BIR3.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CCCCC(=O)N2CC[C@H]3CC[C@@H](c4nc5c(-c6ccccc6)cccc5[nH]4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CC[C@@H](c3nc4c(-c5ccccc5)cccc4[nH]3)N2C1=O,,,CHEMBL3639255,,2014,,CHEMBL3657132,,CHEMBL3657132,,0,http://www.openphacts.org/units/Nanomolar,2531441,<,37,1,<,,IC50,nM,,10.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,10.0
,298544,16340697,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3ccc(OC(F)(F)F)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '12.75', 'le': '0.25', 'lle': '2.61', 'sei': '9.77'}",CHEMBL3696499,,CHEMBL3696499,4.38,0,http://www.openphacts.org/units/Nanomolar,2573340,=,37,1,=,,IC50,nM,,42000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,42000.0
,298605,16341681,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3cnc(Cc4ccccc4)cc32)[C@@H](C(=O)N(C)C)CN1,,,CHEMBL3639218,,2015,"{'bei': '17.62', 'le': '0.33', 'lle': '5.87', 'sei': '11.52'}",CHEMBL3699980,,CHEMBL3699980,7.92,0,http://www.openphacts.org/units/Nanomolar,2577195,=,37,1,=,,IC50,nM,,12.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,12.0
,298582,16342085,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC2(CN(C(C)=O)C2)c2ccc(Cl)cc21,,,CHEMBL3639218,,2015,"{'bei': '14.89', 'le': '0.30', 'lle': '5.17', 'sei': '9.62'}",CHEMBL3699955,,CHEMBL3699955,6.27,0,http://www.openphacts.org/units/Nanomolar,2577170,=,37,1,=,,IC50,nM,,540.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,540.0
,298633,16342273,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CCC1(CC)CN(C(=O)CN2C[C@@H](C)NC[C@@H]2C(=O)N2CCOCC2)c2cc(Cl)ccc21,,,CHEMBL3639218,,2015,"{'bei': '15.34', 'le': '0.30', 'lle': '4.83', 'sei': '10.91'}",CHEMBL3700014,,CHEMBL3700014,7.10,0,http://www.openphacts.org/units/Nanomolar,2577230,=,37,1,=,,IC50,nM,,79.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,79.0
,273251,16342718,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699028,,CHEMBL3699028,,0,http://www.openphacts.org/units/Nanomolar,2576154,<,37,1,<,,IC50,nM,,300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,300.0
,298612,16342748,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC3(Cc4ccccc4C3)c3ccc(C#N)cc32)[C@@H](C(=O)N2CCOCC2)CN1,,,CHEMBL3639218,,2015,"{'bei': '13.66', 'le': '0.25', 'lle': '5.36', 'sei': '7.68'}",CHEMBL3699990,,CHEMBL3699990,6.82,0,http://www.openphacts.org/units/Nanomolar,2577205,=,37,1,=,,IC50,nM,,150.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,150.0
,298685,16342909,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(F)(F)c1cnc2c(c1)N(C(=O)CN1C[C@@H](C)NC[C@@H]1CN1CCOC[C@H]1COC)CC2(C)C,,,CHEMBL3639218,,2015,"{'bei': '14.95', 'le': '0.29', 'lle': '5.40', 'sei': '10.86'}",CHEMBL3700106,,CHEMBL3700106,7.62,0,http://www.openphacts.org/units/Nanomolar,2577323,=,37,1,=,,IC50,nM,,24.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,24.0
,298653,16343521,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(c2ccccn2)c2ccc(C#N)cc21,,,CHEMBL3639218,,2015,"{'bei': '14.03', 'le': '0.26', 'lle': '3.98', 'sei': '7.22'}",CHEMBL3700034,,CHEMBL3700034,5.89,0,http://www.openphacts.org/units/Nanomolar,2577250,=,37,1,=,,IC50,nM,,1300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1300.0
,273247,16343616,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(S(=O)(=O)CCCCCCS(=O)(=O)N2CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699024,,CHEMBL3699024,,0,http://www.openphacts.org/units/Nanomolar,2576150,<,37,1,<,,IC50,nM,,100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,100.0
,298687,16343641,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(Cc4ccc(F)cc4)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '18.63', 'le': '0.35', 'lle': '4.66', 'sei': '15.24'}",CHEMBL3700108,,CHEMBL3700108,7.39,0,http://www.openphacts.org/units/Nanomolar,2577325,=,37,1,=,,IC50,nM,,41.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,41.0
,298644,16343862,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(C(F)(F)c3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.94', 'le': '0.32', 'lle': '4.62', 'sei': '13.47'}",CHEMBL3700025,,CHEMBL3700025,7.77,0,http://www.openphacts.org/units/Nanomolar,2577241,=,37,1,=,,IC50,nM,,17.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,17.0
,298680,16344768,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(C(C)(F)F)cc32)[C@@H](CN2CCN(C)C(=O)C2)CN1,,,CHEMBL3639218,,2015,"{'bei': '15.92', 'le': '0.31', 'lle': '6.37', 'sei': '10.58'}",CHEMBL3700090,,CHEMBL3700090,7.62,0,http://www.openphacts.org/units/Nanomolar,2577306,=,37,1,=,,IC50,nM,,24.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,24.0
,298672,16344913,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN([C@@H](C)C(=O)N2CC(C)(C)c3ccc(C#N)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '13.81', 'le': '0.26', 'lle': '2.65', 'sei': '7.59'}",CHEMBL3700066,,CHEMBL3700066,4.51,0,http://www.openphacts.org/units/Nanomolar,2577282,=,37,1,=,,IC50,nM,,31000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,31000.0
,273267,16345169,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)N[C@H]5C[C@@H]5c5ccc(F)cc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)N[C@H]3C[C@@H]3c3ccc(F)cc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699044,,CHEMBL3699044,,0,http://www.openphacts.org/units/Nanomolar,2576170,<,37,1,<,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,298598,16345595,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(C3CCCC3)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.40', 'le': '0.31', 'lle': '3.90', 'sei': '11.38'}",CHEMBL3699973,,CHEMBL3699973,6.57,0,http://www.openphacts.org/units/Nanomolar,2577188,=,37,1,=,,IC50,nM,,270.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,270.0
,298560,16346113,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cc(F)c(S(=O)(=O)c3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '15.19', 'le': '0.30', 'lle': '3.83', 'sei': '10.32'}",CHEMBL3696514,,CHEMBL3696514,7.19,0,http://www.openphacts.org/units/Nanomolar,2573358,=,37,1,=,,IC50,nM,,64.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,64.0
,273260,16346400,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NC2CCC(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)CC2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699037,,CHEMBL3699037,,0,http://www.openphacts.org/units/Nanomolar,2576163,<,37,1,<,,IC50,nM,,300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,300.0
,298683,16346695,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1COCCN1C[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2ncc(C(C)(F)F)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.20', 'le': '0.31', 'lle': '5.18', 'sei': '12.75'}",CHEMBL3700104,,CHEMBL3700104,7.77,0,http://www.openphacts.org/units/Nanomolar,2577321,=,37,1,=,,IC50,nM,,17.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,17.0
,298556,16347284,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2ccc(Cl)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.91', 'le': '0.34', 'lle': '3.92', 'sei': '13.81'}",CHEMBL3600734,,CHEMBL3600734,6.19,1,http://www.openphacts.org/units/Nanomolar,2573354,=,37,1,=,,IC50,nM,,650.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,650.0
,14003,16347303,[],CHEMBL3707504,"Fluorescence Polarization-Based Assays: An in vitro fluorescence polarization (FP) based binding assay was used to test the binding ability of the compounds of the present invention to certain IAP proteins (Nikolovska-Coleska et al., Anal. Biochem. 332:261-73 (2004)). he FP-based assay for XIAP BIR3 protein was described in detail previously (Nikolovska-Coleska et al., Anal. Biochem. 332:261-73 (2004)). Briefly, 5-carboxyfluorescein was coupled to the lysine side chain of a mutated Smac peptide with the sequence (AbuRPFK-Fam) and this fluorescently tagged peptide (named SM5F) was used as the fluorescent tracer in FP-based binding assay to XIAP BIR3.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CCCCCCCCC(=O)N2CC[C@H]3CC[C@@H](c4nc5c(-c6ccccc6)cccc5[nH]4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CC[C@@H](c3nc4c(-c5ccccc5)cccc4[nH]3)N2C1=O,,,CHEMBL3639255,,2014,,CHEMBL3639385,,CHEMBL3639385,,0,http://www.openphacts.org/units/Nanomolar,2531443,<,37,1,<,,IC50,nM,,50.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,50.0
,298580,16347305,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2ccc(S(=O)(=O)NC(C)C)cc21,,,CHEMBL3639218,,2015,"{'bei': '12.93', 'le': '0.26', 'lle': '4.54', 'sei': '6.43'}",CHEMBL3699953,,CHEMBL3699953,5.85,0,http://www.openphacts.org/units/Nanomolar,2577168,=,37,1,=,,IC50,nM,,1400.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1400.0
,273253,16348079,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(Oc3ccc(NC(=O)N4CC[C@H]5CC[C@@H](C(=O)NC(c6ccccc6)c6ccccc6)N5C(=O)[C@@H](NC(=O)[C@H](C)NC)C4)cc3)cc2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699030,,CHEMBL3699030,,0,http://www.openphacts.org/units/Nanomolar,2576156,<,37,1,<,,IC50,nM,,300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,300.0
,298640,16348266,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC3(Cc4ccccc4C3)c3ccc(Cl)cc32)[C@@H](Cn2cccn2)CN1,,,CHEMBL3639218,,2015,"{'bei': '14.34', 'le': '0.27', 'lle': '3.54', 'sei': '12.78'}",CHEMBL3700021,,CHEMBL3700021,6.82,0,http://www.openphacts.org/units/Nanomolar,2577237,=,37,1,=,,IC50,nM,,150.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,150.0
,298667,16348315,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(F)(F)c1cnc2c(c1)N(C(=O)CN1C[C@@H](C)NC[C@@H]1CN1CCOC[C@H]1C)CC2(C)C,,,CHEMBL3639218,,2015,"{'bei': '16.59', 'le': '0.32', 'lle': '5.37', 'sei': '13.06'}",CHEMBL3700057,,CHEMBL3700057,7.96,0,http://www.openphacts.org/units/Nanomolar,2577273,=,37,1,=,,IC50,nM,,11.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,11.0
,273255,16348571,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=S)Nc2ccc(NC(=S)N3CC[C@H]4CC[C@@H](C(=O)NC(c5ccccc5)c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699032,,CHEMBL3699032,,0,http://www.openphacts.org/units/Nanomolar,2576158,<,37,1,<,,IC50,nM,,300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,300.0
,298596,16349302,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2cnc(C3=CCCC3)cc21,,,CHEMBL3639218,,2015,"{'bei': '17.82', 'le': '0.33', 'lle': '4.52', 'sei': '12.31'}",CHEMBL3699971,,CHEMBL3699971,7.10,0,http://www.openphacts.org/units/Nanomolar,2577186,=,37,1,=,,IC50,nM,,79.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,79.0
,298670,16349469,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3cnc(Oc4ccccc4Cl)cc32)[C@@H](CN2CCOC2=O)CN1,,,CHEMBL3639218,,2015,"{'bei': '15.28', 'le': '0.30', 'lle': '4.58', 'sei': '9.00'}",CHEMBL3700060,,CHEMBL3700060,7.85,0,http://www.openphacts.org/units/Nanomolar,2577276,=,37,1,=,,IC50,nM,,14.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,14.0
,298564,16349605,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)S(=O)(=O)c1cc2c(cc1F)C(C)(C)CN2C(=O)CN1CCN[C@H](C)C1,,,CHEMBL3639218,,2015,"{'bei': '13.61', 'le': '0.27', 'lle': '3.67', 'sei': '8.04'}",CHEMBL3696518,,CHEMBL3696518,5.60,0,http://www.openphacts.org/units/Nanomolar,2573362,=,37,1,=,,IC50,nM,,2500.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2500.0
,273266,16349752,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)N[C@H]5C[C@@H]5c5ccccc5F)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)N[C@H]3C[C@@H]3c3ccccc3F)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699043,,CHEMBL3699043,,0,http://www.openphacts.org/units/Nanomolar,2576169,<,37,1,<,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,273281,16350041,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)N[C@@H]4CCC[C@H]4c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)N[C@@H]3CCC[C@H]3c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699058,,CHEMBL3699058,,0,http://www.openphacts.org/units/Nanomolar,2576184,<,37,1,<,,IC50,nM,,3000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3000.0
,273286,16350522,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)N[C@H]4CC[C@@H]4c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)N[C@H]3CC[C@@H]3c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699063,,CHEMBL3699063,,0,http://www.openphacts.org/units/Nanomolar,2576189,<,37,1,<,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,298686,16351823,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2ccc(Cc3ccccc3)nc21,,,CHEMBL3639218,,2015,"{'bei': '14.60', 'le': '0.27', 'lle': '3.56', 'sei': '10.69'}",CHEMBL3700107,,CHEMBL3700107,6.17,0,http://www.openphacts.org/units/Nanomolar,2577324,=,37,1,=,,IC50,nM,,680.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,680.0
,298537,16351951,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ccccc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '15.90', 'le': '0.30', 'lle': '2.97', 'sei': '12.84'}",CHEMBL3696493,,CHEMBL3696493,4.57,0,http://www.openphacts.org/units/Nanomolar,2573333,=,37,1,=,,IC50,nM,,27000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,27000.0
,273269,16352615,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)N[C@H]5C[C@@H]5c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)N[C@H]3C[C@@H]3c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699046,,CHEMBL3699046,,0,http://www.openphacts.org/units/Nanomolar,2576172,<,37,1,<,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,298573,16352661,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CNS(=O)(=O)c1ccc2c(c1)N(C(=O)CN1C[C@@H](C)NC[C@@H]1COC)CC2(C)C,,,CHEMBL3639218,,2015,"{'bei': '13.65', 'le': '0.27', 'lle': '5.27', 'sei': '6.37'}",CHEMBL3699948,,CHEMBL3699948,5.80,0,http://www.openphacts.org/units/Nanomolar,2577161,=,37,1,=,,IC50,nM,,1600.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1600.0
,298625,16353470,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2ccc(CN3CCCC3=O)cc21,,,CHEMBL3639218,,2015,"{'bei': '14.32', 'le': '0.27', 'lle': '4.40', 'sei': '9.42'}",CHEMBL3700004,,CHEMBL3700004,6.14,0,http://www.openphacts.org/units/Nanomolar,2577220,=,37,1,=,,IC50,nM,,730.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,730.0
,298668,16353580,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(C(=O)c4ccccc4)cc32)[C@@H](CN2CCCC2=O)CN1,,,CHEMBL3639218,,2015,"{'bei': '15.31', 'le': '0.28', 'lle': '5.27', 'sei': '8.73'}",CHEMBL3700058,,CHEMBL3700058,7.50,0,http://www.openphacts.org/units/Nanomolar,2577274,=,37,1,=,,IC50,nM,,32.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,32.0
,298576,16354027,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2ccc(S(=O)(=O)CC(C)C)cc21,,,CHEMBL3639218,,2015,"{'bei': '15.18', 'le': '0.30', 'lle': '4.80', 'sei': '8.68'}",CHEMBL3699949,,CHEMBL3699949,6.85,0,http://www.openphacts.org/units/Nanomolar,2577164,=,37,1,=,,IC50,nM,,140.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,140.0
,298555,16354105,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ccc(S(=O)(=O)c4ccccc4)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '14.84', 'le': '0.29', 'lle': '3.91', 'sei': '9.10'}",CHEMBL3696510,,CHEMBL3696510,6.35,0,http://www.openphacts.org/units/Nanomolar,2573353,=,37,1,=,,IC50,nM,,450.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,450.0
,298545,16354768,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CCc3ccc(Cc4ccccc4)cc32)CCN1,,,CHEMBL3639218,,2015,"{'bei': '16.75', 'le': '0.31', 'lle': '3.39', 'sei': '16.45'}",CHEMBL3696500,,CHEMBL3696500,5.85,0,http://www.openphacts.org/units/Nanomolar,2573341,=,37,1,=,,IC50,nM,,1400.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1400.0
,273272,16355231,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)N[C@@H]5CCC[C@@H]5c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)N[C@@H]3CCC[C@@H]3c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699049,,CHEMBL3699049,,0,http://www.openphacts.org/units/Nanomolar,2576175,<,37,1,<,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,298610,16355326,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(Cc2ccccc2)c2ccc(Cl)cc21,,,CHEMBL3639218,,2015,"{'bei': '14.16', 'le': '0.28', 'lle': '2.76', 'sei': '13.97'}",CHEMBL3699988,,CHEMBL3699988,6.26,0,http://www.openphacts.org/units/Nanomolar,2577203,=,37,1,=,,IC50,nM,,550.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,550.0
,273270,16355544,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)Nc2ccc(NC(=O)N3CC[C@H]4CC[C@@H](C(=O)N[C@@H]5CCC[C@H]5c5ccccc5)N4C(=O)[C@@H](NC(=O)[C@H](C)NC)C3)cc2)CC[C@H]2CC[C@@H](C(=O)N[C@@H]3CCC[C@H]3c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699047,,CHEMBL3699047,,0,http://www.openphacts.org/units/Nanomolar,2576173,<,37,1,<,,IC50,nM,,3000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3000.0
,298586,16356894,[],CHEMBL3707783,"In vitro Competitive Displacement Binding Assays : Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC2(CN(C(C)=O)C2)c2ccc(Cc3ccccc3)cc21,,,CHEMBL3639218,,2015,"{'bei': '16.36', 'le': '0.30', 'lle': '5.77', 'sei': '11.97'}",CHEMBL3699959,,CHEMBL3699959,7.80,0,http://www.openphacts.org/units/Nanomolar,2577174,=,37,1,=,,IC50,nM,,16.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,16.0
,273263,16357045,[],CHEMBL3707980,"Fluorescence Polarization (FP) Based Competitive Assay: Binding affinities of the present compounds to XIAP linker-BIR2-BIR3 (residues 120-356), cIAP1-BIR3 (residues 253-363), and cIAP-2 BIR3 (residues 238-349) proteins were determined by fluorescence polarization (FP) based competitive assays. For cIAP-1 BIR3 and cIAP-2 BIR3 assays, a fluorescently labeled Smac mimetic (Smac-2F) was used as the fluorescent probe. The Kd values of Smac-2F to cIAP-1 BIR3 and cIAP-2 BIR3 were determined by monitoring the total fluorescence polarization of mixtures composed with the fluorescent probe at a fixed concentration and proteins with increasing concentrations up to full saturation. Fluorescence polarization values were measured using the Infinite M-1000 plate reader (Tecan U.S., Research Triangle Park, N.C.) in Microfluor 2 96-well, black, round-bottom plates (Thermo Scientific). To each well, 1 nM of SMAC-2F and increasing concentrations of protein were added to a final volume of 125 ul in the assay buffer (100 mM potassium phosphate, pH 7.5).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)NCCCCNC(=O)N2CC[C@H]3CC[C@@H](C(=O)NC(c4ccccc4)c4ccccc4)N3C(=O)[C@@H](NC(=O)[C@H](C)NC)C2)CC[C@H]2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL3639096,,2014,,CHEMBL3699040,,CHEMBL3699040,,0,http://www.openphacts.org/units/Nanomolar,2576166,<,37,1,<,,IC50,nM,,300.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,300.0
,273608,17655930,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CCC1(CC)Oc2nc(NC(=O)[C@H](C)N)ccc2N(c2ccc(Cl)cc2)C1=O,,,CHEMBL3886164,,2015,"{'bei': '15.63', 'le': '0.31', 'lle': '2.66', 'sei': '6.45'}",CHEMBL3893895,,CHEMBL3893895,6.30,0,http://www.openphacts.org/units/Nanomolar,2835909,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332892,17711240,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)N[C@@H](C)C(=O)N2,,,CHEMBL3886164,,2015,"{'bei': '16.18', 'le': '0.31', 'lle': '3.88', 'sei': '4.48'}",CHEMBL3922505,,CHEMBL3922505,4.26,0,http://www.openphacts.org/units/Nanomolar,2842756,=,37,1,=,,IC50,nM,,55000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,55000.0
,332893,17711241,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(c1)n(C)c(=O)n2C,,,CHEMBL3886164,,2015,"{'bei': '16.24', 'le': '0.31', 'lle': '3.84', 'sei': '6.26'}",CHEMBL3920196,,CHEMBL3920196,4.26,0,http://www.openphacts.org/units/Nanomolar,2842757,=,37,1,=,,IC50,nM,,55000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,55000.0
,332894,17711242,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)NCC(=O)N2,,,CHEMBL3886164,,2015,"{'bei': '17.09', 'le': '0.32', 'lle': '4.27', 'sei': '4.48'}",CHEMBL3890929,,CHEMBL3890929,4.26,0,http://www.openphacts.org/units/Nanomolar,2842758,=,37,1,=,,IC50,nM,,55000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,55000.0
,332895,17711243,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(C)C(=O)N2C,,,CHEMBL3886164,,2015,"{'bei': '18.97', 'le': '0.36', 'lle': '4.63', 'sei': '6.78'}",CHEMBL3894597,,CHEMBL3894597,5.26,0,http://www.openphacts.org/units/Nanomolar,2842759,=,37,1,=,,IC50,nM,,5500.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,5500.0
,332896,17711244,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CNC(=O)N2,,,CHEMBL3886164,,2015,"{'bei': '17.09', 'le': '0.32', 'lle': '4.00', 'sei': '4.48'}",CHEMBL3892789,,CHEMBL3892789,4.26,0,http://www.openphacts.org/units/Nanomolar,2842760,=,37,1,=,,IC50,nM,,55000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,55000.0
,332897,17711245,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(Cc1ccccc1)C(=O)N2c1ccccc1,,,CHEMBL3886164,,2015,"{'bei': '16.85', 'le': '0.31', 'lle': '3.10', 'sei': '9.02'}",CHEMBL3892200,,CHEMBL3892200,7.00,0,http://www.openphacts.org/units/Nanomolar,2842761,=,37,1,=,,IC50,nM,,100.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,100.0
,332898,17711246,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)OC(Cc1ccccc1)C(=O)N2,,,CHEMBL3886164,,2015,"{'bei': '18.50', 'le': '0.34', 'lle': '4.73', 'sei': '6.82'}",CHEMBL3897994,,CHEMBL3897994,6.30,0,http://www.openphacts.org/units/Nanomolar,2842762,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332899,17711247,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CNC(=O)N2c1ccccc1,,,CHEMBL3886164,,2015,"{'bei': '19.35', 'le': '0.36', 'lle': '4.31', 'sei': '7.29'}",CHEMBL3969247,,CHEMBL3969247,6.30,0,http://www.openphacts.org/units/Nanomolar,2842763,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332900,17711248,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(c1ccc(Cl)cc1)C(=O)N2c1ccc(Cl)cc1,,,CHEMBL3886164,,2015,"{'bei': '13.39', 'le': '0.27', 'lle': '1.09', 'sei': '8.12'}",CHEMBL3970450,,CHEMBL3970450,6.30,0,http://www.openphacts.org/units/Nanomolar,2842764,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332901,17711249,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CNC(=O)N2c1ccc(Cl)cc1,,,CHEMBL3886164,,2015,"{'bei': '17.50', 'le': '0.34', 'lle': '3.66', 'sei': '7.29'}",CHEMBL3954799,,CHEMBL3954799,6.30,0,http://www.openphacts.org/units/Nanomolar,2842765,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332902,17711250,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(c1ccccc1)C(=O)N2c1ccccc1,,,CHEMBL3886164,,2015,"{'bei': '15.68', 'le': '0.29', 'lle': '2.39', 'sei': '8.12'}",CHEMBL3983433,,CHEMBL3983433,6.30,0,http://www.openphacts.org/units/Nanomolar,2842766,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332903,17711251,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(c1cccc(Cl)c1)C(=O)N2c1cccc(Cl)c1,,,CHEMBL3886164,,2015,"{'bei': '13.39', 'le': '0.27', 'lle': '1.09', 'sei': '8.12'}",CHEMBL3946108,,CHEMBL3946108,6.30,0,http://www.openphacts.org/units/Nanomolar,2842767,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332904,17711252,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(C)C(=O)N2c1ccc(Cl)cc1,,,CHEMBL3886164,,2015,"{'bei': '16.84', 'le': '0.33', 'lle': '3.32', 'sei': '8.12'}",CHEMBL3940762,,CHEMBL3940762,6.30,0,http://www.openphacts.org/units/Nanomolar,2842768,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332905,17711253,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)OCC(=O)N2c1ccc(Cl)cc1,,,CHEMBL3886164,,2015,"{'bei': '17.45', 'le': '0.34', 'lle': '3.96', 'sei': '7.54'}",CHEMBL3902848,,CHEMBL3902848,6.30,0,http://www.openphacts.org/units/Nanomolar,2842769,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332906,17711254,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(c1cc(Cl)ccc1F)C(=O)N2c1ccccc1,,,CHEMBL3886164,,2015,"{'bei': '13.87', 'le': '0.27', 'lle': '1.60', 'sei': '8.12'}",CHEMBL3970314,,CHEMBL3970314,6.30,0,http://www.openphacts.org/units/Nanomolar,2842770,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332907,17711255,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)OC(C)(C)C(=O)N2c1ccc(Cl)cc1,,,CHEMBL3886164,,2015,"{'bei': '16.19', 'le': '0.32', 'lle': '3.18', 'sei': '7.54'}",CHEMBL3903476,,CHEMBL3903476,6.30,0,http://www.openphacts.org/units/Nanomolar,2842771,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332908,17711256,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CCCN1Cc2nc(NC(=O)[C@H](C)NC)ccc2N(c2ccccc2)C1=O,,,CHEMBL3886164,,2015,"{'bei': '17.14', 'le': '0.32', 'lle': '3.19', 'sei': '8.12'}",CHEMBL3931762,,CHEMBL3931762,6.30,0,http://www.openphacts.org/units/Nanomolar,2842772,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332909,17711257,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(C1CCCCC1)C(=O)N2c1ccc(Cl)cc1,,,CHEMBL3886164,,2015,"{'bei': '14.25', 'le': '0.28', 'lle': '1.61', 'sei': '8.12'}",CHEMBL3955844,,CHEMBL3955844,6.30,0,http://www.openphacts.org/units/Nanomolar,2842773,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332910,17711258,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(C1CCCC1)C(=O)N2c1ccc(Cl)cc1,,,CHEMBL3886164,,2015,"{'bei': '14.71', 'le': '0.29', 'lle': '2.00', 'sei': '8.12'}",CHEMBL3907712,,CHEMBL3907712,6.30,0,http://www.openphacts.org/units/Nanomolar,2842774,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332911,17711259,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(C(C)C)C(=O)N2c1ccc(Cl)cc1,,,CHEMBL3886164,,2015,"{'bei': '15.67', 'le': '0.31', 'lle': '2.54', 'sei': '8.12'}",CHEMBL3932160,,CHEMBL3932160,6.30,0,http://www.openphacts.org/units/Nanomolar,2842775,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332912,17711260,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(CCc1ccccc1)C(=O)N2c1ccc(Cl)cc1,,,CHEMBL3886164,,2015,"{'bei': '13.57', 'le': '0.26', 'lle': '1.70', 'sei': '8.12'}",CHEMBL3904793,,CHEMBL3904793,6.30,0,http://www.openphacts.org/units/Nanomolar,2842776,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332913,17711261,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(C(C)C)C(=O)N2c1cccc(Cl)c1,,,CHEMBL3886164,,2015,"{'bei': '15.67', 'le': '0.31', 'lle': '2.54', 'sei': '8.12'}",CHEMBL3895249,,CHEMBL3895249,6.30,0,http://www.openphacts.org/units/Nanomolar,2842777,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332914,17711262,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(C(C)C)C(=O)N2,,,CHEMBL3886164,,2015,"{'bei': '18.05', 'le': '0.34', 'lle': '3.88', 'sei': '6.09'}",CHEMBL3923214,,CHEMBL3923214,5.26,0,http://www.openphacts.org/units/Nanomolar,2842778,=,37,1,=,,IC50,nM,,5500.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,5500.0
,332915,17711263,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CCC1(CC)Oc2nc(NC(=O)[C@@H](C)NC)ccc2N(c2ccc(Cl)cc2)C1=O,,,CHEMBL3886164,,2015,"{'bei': '15.10', 'le': '0.30', 'lle': '2.40', 'sei': '7.54'}",CHEMBL4111272,,CHEMBL4111272,6.30,0,http://www.openphacts.org/units/Nanomolar,2842779,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332916,17711264,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)OC1(CCCC1)C(=O)N2c1ccc(Cl)cc1,,,CHEMBL3886164,,2015,"{'bei': '15.18', 'le': '0.30', 'lle': '2.65', 'sei': '7.54'}",CHEMBL3975382,,CHEMBL3975382,6.30,0,http://www.openphacts.org/units/Nanomolar,2842780,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332917,17711265,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(C(C)CC(C)C)C(=O)N2c1ccc(Cl)cc1,,,CHEMBL3886164,,2015,"{'bei': '14.18', 'le': '0.28', 'lle': '1.51', 'sei': '8.12'}",CHEMBL3969310,,CHEMBL3969310,6.30,0,http://www.openphacts.org/units/Nanomolar,2842781,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332918,17711266,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)OC1(Cc3ccccc3C1)C(=O)N2c1ccc(Cl)cc1,,,CHEMBL3886164,,2015,"{'bei': '13.60', 'le': '0.26', 'lle': '2.42', 'sei': '7.54'}",CHEMBL3964665,,CHEMBL3964665,6.30,0,http://www.openphacts.org/units/Nanomolar,2842782,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332919,17711267,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(C1CCC(C)(C)CC1)C(=O)N2c1cccc(Cl)c1,,,CHEMBL3886164,,2015,"{'bei': '13.40', 'le': '0.26', 'lle': '0.98', 'sei': '8.12'}",CHEMBL3917778,,CHEMBL3917778,6.30,0,http://www.openphacts.org/units/Nanomolar,2842783,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332920,17711268,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)OC(C)(C)C(=O)N2c1cccc(Cl)c1,,,CHEMBL3886164,,2015,"{'bei': '16.19', 'le': '0.32', 'lle': '3.18', 'sei': '7.54'}",CHEMBL3925194,,CHEMBL3925194,6.30,0,http://www.openphacts.org/units/Nanomolar,2842784,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332921,17711269,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)O[C@@](C)(c1ccccc1)C(=O)N2c1ccc(Cl)cc1,,,CHEMBL3886164,,2015,"{'bei': '13.96', 'le': '0.27', 'lle': '2.05', 'sei': '7.54'}",CHEMBL3896796,,CHEMBL3896796,6.30,0,http://www.openphacts.org/units/Nanomolar,2842785,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332922,17711270,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(Cc1cscn1)C(=O)N2c1ccc(Cl)cc1,,,CHEMBL3886164,,2015,"{'bei': '13.78', 'le': '0.28', 'lle': '2.29', 'sei': '6.96'}",CHEMBL3900529,,CHEMBL3900529,6.30,0,http://www.openphacts.org/units/Nanomolar,2842786,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332923,17711271,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(C(C)C(C)C)C(=O)N2c1cccc(Cl)c1,,,CHEMBL3886164,,2015,"{'bei': '14.65', 'le': '0.29', 'lle': '1.90', 'sei': '8.12'}",CHEMBL3979152,,CHEMBL3979152,6.30,0,http://www.openphacts.org/units/Nanomolar,2842787,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332924,17711272,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)OC1(CCCCC1)C(=O)N2c1ccc(Cl)cc1,,,CHEMBL3886164,,2015,"{'bei': '14.68', 'le': '0.29', 'lle': '2.26', 'sei': '7.54'}",CHEMBL3906876,,CHEMBL3906876,6.30,0,http://www.openphacts.org/units/Nanomolar,2842788,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332925,17711273,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)OC(C)(Cc1ccccc1)C(=O)N2c1cccc(Cl)c1,,,CHEMBL3886164,,2015,"{'bei': '13.54', 'le': '0.26', 'lle': '1.96', 'sei': '7.54'}",CHEMBL3951508,,CHEMBL3951508,6.30,0,http://www.openphacts.org/units/Nanomolar,2842789,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332926,17711274,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)OC(C)(CC(C)C)C(=O)N2c1cccc(Cl)c1,,,CHEMBL3886164,,2015,"{'bei': '14.61', 'le': '0.29', 'lle': '2.16', 'sei': '7.54'}",CHEMBL3917879,,CHEMBL3917879,6.30,0,http://www.openphacts.org/units/Nanomolar,2842790,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332927,17711275,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)OC(C)(C1CCCC1)C(=O)N2c1cccc(Cl)c1,,,CHEMBL3886164,,2015,"{'bei': '14.22', 'le': '0.28', 'lle': '2.01', 'sei': '7.54'}",CHEMBL3912475,,CHEMBL3912475,6.30,0,http://www.openphacts.org/units/Nanomolar,2842791,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332928,17711276,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(C(C)C1CCC1)C(=O)N2c1cccc(Cl)c1,,,CHEMBL3886164,,2015,"{'bei': '14.25', 'le': '0.28', 'lle': '1.76', 'sei': '8.12'}",CHEMBL3908827,,CHEMBL3908827,6.30,0,http://www.openphacts.org/units/Nanomolar,2842792,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332929,17711277,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(CC1CCCC1)C(=O)N2c1cccc(Cl)c1,,,CHEMBL3886164,,2015,"{'bei': '14.25', 'le': '0.28', 'lle': '1.75', 'sei': '8.12'}",CHEMBL3978734,,CHEMBL3978734,6.30,0,http://www.openphacts.org/units/Nanomolar,2842793,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332930,17711278,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(C1CCN(C(C)=O)CC1)C(=O)N2c1cccc(Cl)c1,,,CHEMBL3886164,,2015,"{'bei': '12.98', 'le': '0.25', 'lle': '2.93', 'sei': '6.43'}",CHEMBL3970943,,CHEMBL3970943,6.30,0,http://www.openphacts.org/units/Nanomolar,2842794,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332931,17711279,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(c1cc(Cl)cc(Cl)c1)C(=O)N2c1cc(Cl)cc(Cl)c1,,,CHEMBL3886164,,2015,"{'bei': '11.68', 'le': '0.25', 'lle': '-0.22', 'sei': '8.12'}",CHEMBL3978606,,CHEMBL3978606,6.30,0,http://www.openphacts.org/units/Nanomolar,2842795,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332932,17711280,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1ccc2c(n1)OC(C)(CCC(C)N)C(=O)N2c1ccccc1,,,CHEMBL3886164,,2015,"{'bei': '15.30', 'le': '0.29', 'lle': '3.73', 'sei': '5.75'}",CHEMBL4109627,,CHEMBL4109627,6.30,0,http://www.openphacts.org/units/Nanomolar,2842796,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332933,17711281,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2c(n1)CN(C(C)CC(C)(C)C)C(=O)N2c1cccc(Cl)c1,,,CHEMBL3886164,,2015,"{'bei': '13.75', 'le': '0.27', 'lle': '1.12', 'sei': '8.12'}",CHEMBL3896283,,CHEMBL3896283,6.30,0,http://www.openphacts.org/units/Nanomolar,2842797,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,332934,17711282,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc2[nH]c(=O)n(Cc3ccccc3)c2n1,,,CHEMBL3886164,,2015,"{'bei': '13.09', 'le': '0.24', 'lle': '2.94', 'sei': '4.64'}",CHEMBL3917272,,CHEMBL3917272,4.26,0,http://www.openphacts.org/units/Nanomolar,2842798,=,37,1,=,,IC50,nM,,55000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,55000.0
,332935,17711283,[],CHEMBL3887095,"In Vitro Competitive Displacement Binding Assay: Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, cIAP-1 or cIAP-2. BIR3 domains of cIAP-1, cIAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50 mM Hepes pH 7.5, 0.025% Tween-20, 0.01% BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and cIAP-2) or 3 hrs (cIAP-1) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485 nm, 520 nm, 520 nm).",B,,,BAO_0000190,BAO_0000357,single protein format,CCC1(CC)Oc2nc(NC(=O)[C@H](C)N)ccc2N(c2ccc(Cl)cc2)C1=O,,,CHEMBL3886164,,2015,"{'bei': '15.63', 'le': '0.31', 'lle': '2.66', 'sei': '6.45'}",CHEMBL3893895,,CHEMBL3893895,6.30,0,http://www.openphacts.org/units/Nanomolar,2835909,=,37,1,=,,IC50,nM,,505.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,505.0
,363777,17739151,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ncnc3c(C)nn(C)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '18.75', 'le': '0.36', 'lle': '6.42', 'sei': '6.45'}",CHEMBL3935993,,CHEMBL3935993,9.00,0,http://www.openphacts.org/units/Nanomolar,2860633,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363778,17739152,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ncnc3c(C)nn(C)c23)cc(NC(=O)c2cc3c(cn2)COC3)n1,,,CHEMBL3886507,,2016,"{'bei': '17.84', 'le': '0.33', 'lle': '6.74', 'sei': '5.84'}",CHEMBL3898998,,CHEMBL3898998,8.70,0,http://www.openphacts.org/units/Nanomolar,2860634,=,37,1,=,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,363779,17739153,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)noc2C)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '19.87', 'le': '0.39', 'lle': '5.32', 'sei': '6.98'}",CHEMBL3927049,,CHEMBL3927049,8.52,0,http://www.openphacts.org/units/Nanomolar,2860635,=,37,1,=,,IC50,nM,,3.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3.0
,363780,17739154,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ccncc2C#N)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '17.33', 'le': '0.33', 'lle': '4.69', 'sei': '5.69'}",CHEMBL3926020,,CHEMBL3926020,7.55,0,http://www.openphacts.org/units/Nanomolar,2860636,=,37,1,=,,IC50,nM,,28.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,28.0
,363781,17739155,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ncnc2C)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '18.87', 'le': '0.37', 'lle': '5.30', 'sei': '6.82'}",CHEMBL3929299,,CHEMBL3929299,8.30,0,http://www.openphacts.org/units/Nanomolar,2860637,=,37,1,=,,IC50,nM,,5.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,5.0
,363782,17739156,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)nc3ccccn23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '17.24', 'le': '0.33', 'lle': '4.45', 'sei': '7.06'}",CHEMBL3955142,,CHEMBL3955142,8.00,0,http://www.openphacts.org/units/Nanomolar,2860638,=,37,1,=,,IC50,nM,,10.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,10.0
,363783,17739157,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2cccc3cnn(C)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '18.37', 'le': '0.35', 'lle': '5.04', 'sei': '7.49'}",CHEMBL3951871,,CHEMBL3951871,8.52,0,http://www.openphacts.org/units/Nanomolar,2860639,=,37,1,=,,IC50,nM,,3.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3.0
,363784,17739158,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2nccc3cccc(C)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '18.95', 'le': '0.36', 'lle': '4.55', 'sei': '8.26'}",CHEMBL3975889,,CHEMBL3975889,9.00,0,http://www.openphacts.org/units/Nanomolar,2860640,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363785,17739159,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2nccc3cccc(C)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '18.95', 'le': '0.36', 'lle': '4.55', 'sei': '8.26'}",CHEMBL3975889,,CHEMBL3975889,9.00,0,http://www.openphacts.org/units/Nanomolar,2860640,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363786,17739160,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)nc3cccc(C)n23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '17.06', 'le': '0.33', 'lle': '4.29', 'sei': '7.20'}",CHEMBL3971543,,CHEMBL3971543,8.15,0,http://www.openphacts.org/units/Nanomolar,2860641,=,37,1,=,,IC50,nM,,7.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,7.0
,363787,17739161,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2cccc3nc(C)c(C)n23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '18.83', 'le': '0.36', 'lle': '5.14', 'sei': '7.94'}",CHEMBL3932853,,CHEMBL3932853,9.00,0,http://www.openphacts.org/units/Nanomolar,2860642,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363788,17739162,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2cccc3nn(C)c(C)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '17.83', 'le': '0.34', 'lle': '4.73', 'sei': '7.49'}",CHEMBL3960445,,CHEMBL3960445,8.52,0,http://www.openphacts.org/units/Nanomolar,2860643,=,37,1,=,,IC50,nM,,3.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3.0
,363789,17739163,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2cccc3c2c(C)nn3C)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '18.20', 'le': '0.35', 'lle': '4.91', 'sei': '7.64'}",CHEMBL3932969,,CHEMBL3932969,8.70,0,http://www.openphacts.org/units/Nanomolar,2860644,=,37,1,=,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,363790,17739164,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ncnc3cccc(F)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '18.75', 'le': '0.36', 'lle': '5.32', 'sei': '7.39'}",CHEMBL3946504,,CHEMBL3946504,9.00,0,http://www.openphacts.org/units/Nanomolar,2860645,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363791,17739165,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ncnc3oc(C)c(C)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '18.75', 'le': '0.36', 'lle': '5.25', 'sei': '6.67'}",CHEMBL3916269,,CHEMBL3916269,9.00,0,http://www.openphacts.org/units/Nanomolar,2860646,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363792,17739166,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ncnc3nc(C)n(C)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '18.75', 'le': '0.36', 'lle': '6.42', 'sei': '6.45'}",CHEMBL3915777,,CHEMBL3915777,9.00,0,http://www.openphacts.org/units/Nanomolar,2860647,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363793,17739167,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2nn(C)c3ncnc(N)c23)cc(NC(=O)c2ccccn2)n1,,,CHEMBL3886507,,2016,"{'bei': '15.73', 'le': '0.29', 'lle': '5.82', 'sei': '4.24'}",CHEMBL3943738,,CHEMBL3943738,7.02,0,http://www.openphacts.org/units/Nanomolar,2860648,=,37,1,=,,IC50,nM,,95.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,95.0
,363794,17739168,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2cnc3cccc(Cl)n23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '18.58', 'le': '0.37', 'lle': '5.10', 'sei': '7.94'}",CHEMBL3928237,,CHEMBL3928237,9.00,0,http://www.openphacts.org/units/Nanomolar,2860649,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363795,17739169,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(OC)ccc3ccccc23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '13.57', 'le': '0.26', 'lle': '1.89', 'sei': '6.32'}",CHEMBL3952463,,CHEMBL3952463,6.65,0,http://www.openphacts.org/units/Nanomolar,2860650,=,37,1,=,,IC50,nM,,225.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,225.0
,363796,17739170,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(OC)ccc3nccnc23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '14.84', 'le': '0.28', 'lle': '3.75', 'sei': '5.57'}",CHEMBL3901338,,CHEMBL3901338,7.30,0,http://www.openphacts.org/units/Nanomolar,2860651,=,37,1,=,,IC50,nM,,50.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,50.0
,363797,17739171,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2nc(C)nc3c(C)nn(C)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '18.22', 'le': '0.35', 'lle': '6.11', 'sei': '6.45'}",CHEMBL3929287,,CHEMBL3929287,9.00,0,http://www.openphacts.org/units/Nanomolar,2860652,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363798,17739172,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ncnc3cccc(Cl)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '18.13', 'le': '0.36', 'lle': '4.81', 'sei': '7.39'}",CHEMBL3906797,,CHEMBL3906797,9.00,0,http://www.openphacts.org/units/Nanomolar,2860653,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363799,17739173,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ccnc3cc(F)cc(F)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '16.29', 'le': '0.32', 'lle': '3.68', 'sei': '7.44'}",CHEMBL3938332,,CHEMBL3938332,8.10,0,http://www.openphacts.org/units/Nanomolar,2860654,=,37,1,=,,IC50,nM,,8.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,8.0
,363800,17739174,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(OC)ccc3nccc(C)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '17.82', 'le': '0.34', 'lle': '4.54', 'sei': '7.62'}",CHEMBL3923542,,CHEMBL3923542,9.00,0,http://www.openphacts.org/units/Nanomolar,2860655,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363801,17739175,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ccnc3cc(F)cc(F)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '14.75', 'le': '0.29', 'lle': '2.91', 'sei': '6.73'}",CHEMBL3938332,,CHEMBL3938332,7.33,0,http://www.openphacts.org/units/Nanomolar,2860654,=,37,1,=,,IC50,nM,,47.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,47.0
,363802,17739176,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)nc(C)c3c(=O)n(C)n(C)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '17.21', 'le': '0.33', 'lle': '6.20', 'sei': '6.63'}",CHEMBL3975877,,CHEMBL3975877,9.00,0,http://www.openphacts.org/units/Nanomolar,2860656,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363803,17739177,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(Cl)c(C)nc3cc(Cl)cc(Cl)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '13.39', 'le': '0.29', 'lle': '1.33', 'sei': '7.11'}",CHEMBL3946563,,CHEMBL3946563,7.75,0,http://www.openphacts.org/units/Nanomolar,2860657,=,37,1,=,,IC50,nM,,18.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,18.0
,363804,17739178,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2cc3c(cn2)COC3)n1,,,CHEMBL3886507,,2016,"{'bei': '15.56', 'le': '0.28', 'lle': '3.68', 'sei': '6.36'}",CHEMBL3983891,,CHEMBL3983891,7.51,0,http://www.openphacts.org/units/Nanomolar,2860658,=,37,1,=,,IC50,nM,,31.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,31.0
,363805,17739179,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2ccc(C)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '16.62', 'le': '0.30', 'lle': '3.44', 'sei': '6.94'}",CHEMBL3958644,,CHEMBL3958644,7.55,0,http://www.openphacts.org/units/Nanomolar,2860659,=,37,1,=,,IC50,nM,,28.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,28.0
,363806,17739180,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2ccc(C#N)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '15.99', 'le': '0.29', 'lle': '3.77', 'sei': '5.61'}",CHEMBL3959727,,CHEMBL3959727,7.44,0,http://www.openphacts.org/units/Nanomolar,2860660,=,37,1,=,,IC50,nM,,36.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,36.0
,363807,17739181,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2ncc3ccccc3n2)n1,,,CHEMBL3886507,,2016,"{'bei': '14.82', 'le': '0.27', 'lle': '2.93', 'sei': '5.98'}",CHEMBL3932220,,CHEMBL3932220,7.28,0,http://www.openphacts.org/units/Nanomolar,2860661,=,37,1,=,,IC50,nM,,52.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,52.0
,363808,17739182,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2ccc(F)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '15.87', 'le': '0.29', 'lle': '3.34', 'sei': '6.68'}",CHEMBL3978628,,CHEMBL3978628,7.28,0,http://www.openphacts.org/units/Nanomolar,2860662,=,37,1,=,,IC50,nM,,53.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,53.0
,363809,17739183,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2ccc(OC)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '15.36', 'le': '0.28', 'lle': '3.42', 'sei': '6.12'}",CHEMBL3937728,,CHEMBL3937728,7.23,0,http://www.openphacts.org/units/Nanomolar,2860663,=,37,1,=,,IC50,nM,,59.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,59.0
,363810,17739184,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2cnc(C)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '15.33', 'le': '0.28', 'lle': '3.48', 'sei': '5.73'}",CHEMBL3941154,,CHEMBL3941154,6.98,0,http://www.openphacts.org/units/Nanomolar,2860664,=,37,1,=,,IC50,nM,,104.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,104.0
,363811,17739185,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2cc3ccccc3cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '14.02', 'le': '0.25', 'lle': '1.93', 'sei': '6.32'}",CHEMBL3913142,,CHEMBL3913142,6.88,0,http://www.openphacts.org/units/Nanomolar,2860665,=,37,1,=,,IC50,nM,,132.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,132.0
,363812,17739186,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2ccc3ccccc3n2)n1,,,CHEMBL3886507,,2016,"{'bei': '13.80', 'le': '0.25', 'lle': '1.82', 'sei': '6.22'}",CHEMBL3957993,,CHEMBL3957993,6.77,0,http://www.openphacts.org/units/Nanomolar,2860666,=,37,1,=,,IC50,nM,,170.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,170.0
,363813,17739187,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2ccncn2)n1,,,CHEMBL3886507,,2016,"{'bei': '14.42', 'le': '0.26', 'lle': '3.18', 'sei': '5.23'}",CHEMBL3983236,,CHEMBL3983236,6.37,0,http://www.openphacts.org/units/Nanomolar,2860667,=,37,1,=,,IC50,nM,,428.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,428.0
,363814,17739188,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2cc3ccccc3o2)n1,,,CHEMBL3886507,,2016,"{'bei': '13.11', 'le': '0.24', 'lle': '1.14', 'sei': '5.76'}",CHEMBL3945899,,CHEMBL3945899,6.29,0,http://www.openphacts.org/units/Nanomolar,2860668,=,37,1,=,,IC50,nM,,514.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,514.0
,363815,17739189,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2ccccn2)n1,,,CHEMBL3886507,,2016,"{'bei': '14.20', 'le': '0.26', 'lle': '2.46', 'sei': '5.75'}",CHEMBL3975253,,CHEMBL3975253,6.26,0,http://www.openphacts.org/units/Nanomolar,2860669,=,37,1,=,,IC50,nM,,553.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,553.0
,363816,17739190,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2cccc(C)n2)n1,,,CHEMBL3886507,,2016,"{'bei': '13.69', 'le': '0.25', 'lle': '2.11', 'sei': '5.71'}",CHEMBL3986011,,CHEMBL3986011,6.22,0,http://www.openphacts.org/units/Nanomolar,2860670,=,37,1,=,,IC50,nM,,598.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,598.0
,363817,17739191,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2ccn(C)n2)n1,,,CHEMBL3886507,,2016,"{'bei': '13.87', 'le': '0.25', 'lle': '3.01', 'sei': '5.41'}",CHEMBL3970113,,CHEMBL3970113,6.15,0,http://www.openphacts.org/units/Nanomolar,2860671,=,37,1,=,,IC50,nM,,703.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,703.0
,363818,17739192,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2cc(Cl)ccn2)n1,,,CHEMBL3886507,,2016,"{'bei': '12.48', 'le': '0.24', 'lle': '1.48', 'sei': '5.44'}",CHEMBL3931529,,CHEMBL3931529,5.93,0,http://www.openphacts.org/units/Nanomolar,2860672,=,37,1,=,,IC50,nM,,1187.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1187.0
,363819,17739193,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2cccnn2)n1,,,CHEMBL3886507,,2016,"{'bei': '12.65', 'le': '0.23', 'lle': '2.39', 'sei': '4.59'}",CHEMBL3959026,,CHEMBL3959026,5.58,0,http://www.openphacts.org/units/Nanomolar,2860673,=,37,1,=,,IC50,nM,,2603.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2603.0
,363820,17739194,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2ccc3cnccc3c2)n1,,,CHEMBL3886507,,2016,"{'bei': '11.20', 'le': '0.20', 'lle': '0.55', 'sei': '5.05'}",CHEMBL3924954,,CHEMBL3924954,5.50,0,http://www.openphacts.org/units/Nanomolar,2860674,=,37,1,=,,IC50,nM,,3189.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3189.0
,363821,17739195,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2cn(C)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '11.96', 'le': '0.22', 'lle': '2.17', 'sei': '4.66'}",CHEMBL3949256,,CHEMBL3949256,5.31,0,http://www.openphacts.org/units/Nanomolar,2860675,=,37,1,=,,IC50,nM,,4939.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4939.0
,363822,17739196,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(C)ccc3ncccc23)cc(NC(=O)c2cc(-c3ccccc3)on2)n1,,,CHEMBL3886507,,2016,"{'bei': '10.26', 'le': '0.19', 'lle': '0.14', 'sei': '4.26'}",CHEMBL3929533,,CHEMBL3929533,5.20,0,http://www.openphacts.org/units/Nanomolar,2860676,=,37,1,=,,IC50,nM,,6334.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,6334.0
,363823,17739197,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ccncc2C)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '18.29', 'le': '0.35', 'lle': '4.47', 'sei': '7.13'}",CHEMBL3959673,,CHEMBL3959673,7.77,0,http://www.openphacts.org/units/Nanomolar,2860677,=,37,1,=,,IC50,nM,,17.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,17.0
,363824,17739198,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2cccc3nc(C)c(C)n23)cc(NC(=O)c2cc3c(cn2)COC3)n1,,,CHEMBL3886507,,2016,"{'bei': '18.54', 'le': '0.34', 'lle': '5.76', 'sei': '7.34'}",CHEMBL3923211,,CHEMBL3923211,9.00,0,http://www.openphacts.org/units/Nanomolar,2860678,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363825,17739199,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2cccc3nc(C)c(C)n23)cc(NC(=O)Cc2ccccc2)n1,,,CHEMBL3886507,,2016,"{'bei': '11.55', 'le': '0.21', 'lle': '1.53', 'sei': '5.25'}",CHEMBL3963989,,CHEMBL3963989,5.27,0,http://www.openphacts.org/units/Nanomolar,2860679,=,37,1,=,,IC50,nM,,5346.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,5346.0
,363826,17739200,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2cccc3nc(C)c(C)n23)cc(NC(=O)c2cc3ccccc3[nH]2)n1,,,CHEMBL3886507,,2016,"{'bei': '13.41', 'le': '0.25', 'lle': '2.17', 'sei': '5.56'}",CHEMBL3889562,,CHEMBL3889562,6.46,0,http://www.openphacts.org/units/Nanomolar,2860680,=,37,1,=,,IC50,nM,,348.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,348.0
,363827,17739201,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2cccc3nc(C)c(C)n23)cc(NC(=O)c2ccc(OC)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '19.01', 'le': '0.35', 'lle': '5.78', 'sei': '7.34'}",CHEMBL3946388,,CHEMBL3946388,9.00,0,http://www.openphacts.org/units/Nanomolar,2860681,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363828,17739202,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2cncc3ccn(C)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '19.40', 'le': '0.37', 'lle': '5.52', 'sei': '7.91'}",CHEMBL3937672,,CHEMBL3937672,9.00,0,http://www.openphacts.org/units/Nanomolar,2860682,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363829,17739203,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2cccc3cncc(C)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '18.95', 'le': '0.36', 'lle': '4.55', 'sei': '8.26'}",CHEMBL3967322,,CHEMBL3967322,9.00,0,http://www.openphacts.org/units/Nanomolar,2860683,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363830,17739204,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2c(Cl)cnc3ccccc23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '16.07', 'le': '0.32', 'lle': '3.16', 'sei': '7.31'}",CHEMBL3936420,,CHEMBL3936420,7.96,0,http://www.openphacts.org/units/Nanomolar,2860684,=,37,1,=,,IC50,nM,,11.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,11.0
,363831,17739205,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc2ccn(-c3cc(NC(=O)c4ccc(Cl)cn4)nc(NC(=O)C(C)N)c3)c12,,,CHEMBL3886507,,2016,"{'bei': '16.37', 'le': '0.31', 'lle': '3.43', 'sei': '6.39'}",CHEMBL3969548,,CHEMBL3969548,7.35,0,http://www.openphacts.org/units/Nanomolar,2860685,=,37,1,=,,IC50,nM,,45.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,45.0
,363832,17739206,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(N)C(=O)Nc1cc(Cl)cc(NC(=O)c2ccccn2)n1,,,CHEMBL3886507,,2016,"{'bei': '16.69', 'le': '0.33', 'lle': '3.67', 'sei': '4.85'}",CHEMBL3957995,,CHEMBL3957995,5.34,0,http://www.openphacts.org/units/Nanomolar,2860686,=,37,1,=,,IC50,nM,,4597.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4597.0
,363833,17739207,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(C(=O)Nc2cccc(NC(=O)C(C)N)n2)nc1,,,CHEMBL3886507,,2016,"{'bei': '21.30', 'le': '0.40', 'lle': '5.06', 'sei': '5.80'}",CHEMBL3930490,,CHEMBL3930490,6.38,0,http://www.openphacts.org/units/Nanomolar,2860687,=,37,1,=,,IC50,nM,,421.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,421.0
,363834,17739208,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2nccc3c(=O)n(C)n(C)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '17.22', 'le': '0.33', 'lle': '6.34', 'sei': '6.27'}",CHEMBL3969043,,CHEMBL3969043,8.52,0,http://www.openphacts.org/units/Nanomolar,2860688,=,37,1,=,,IC50,nM,,3.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3.0
,363835,17739209,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2nc(C)nc3c(C)c(C)n(C)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '17.75', 'le': '0.34', 'lle': '5.20', 'sei': '7.10'}",CHEMBL3935909,,CHEMBL3935909,9.00,0,http://www.openphacts.org/units/Nanomolar,2860689,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363836,17739210,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2nc(C)nc3c(C)nn(C)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '15.12', 'le': '0.29', 'lle': '4.58', 'sei': '5.35'}",CHEMBL3929287,,CHEMBL3929287,7.47,0,http://www.openphacts.org/units/Nanomolar,2860652,=,37,1,=,,IC50,nM,,34.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,34.0
,363837,17739211,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ncnc3c(C)nn(C)c23)cc(NC(=O)c2ncc(Cl)cc2C)n1,,,CHEMBL3886507,,2016,"{'bei': '18.22', 'le': '0.35', 'lle': '6.11', 'sei': '6.45'}",CHEMBL3944851,,CHEMBL3944851,9.00,0,http://www.openphacts.org/units/Nanomolar,2860690,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363838,17739212,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2nc(C)nc3c(C)nn(C)c23)cc(NC(=O)c2ncc(Cl)cc2F)n1,,,CHEMBL3886507,,2016,"{'bei': '17.58', 'le': '0.34', 'lle': '5.97', 'sei': '6.45'}",CHEMBL3953439,,CHEMBL3953439,9.00,0,http://www.openphacts.org/units/Nanomolar,2860691,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,363839,17739213,[],CHEMBL3887924,"DELFIA Assay: R3 domains of human XIAP (covering amino acids 241 to 356; XIAP BIR3) and cIAPl (covering amino acids 256 to 363; cIAPl BIR3) were expressed and purified from Ecoli as GST-fusion proteins. Peptide AVPIAQKSE-Lys(Biotin), representing the N-terminus of mature human SMAC (SMAC peptide), was used as interaction partner in the protein- peptide interaction assay.BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonXlOO) for one hour at room temperature in the presence of inhibitiory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-Nl- antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluoresecence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2nc(OC)nc3c(C)nn(C)c23)cc(NC(=O)c2ccc(Cl)cn2)n1,,,CHEMBL3886507,,2016,"{'bei': '14.24', 'le': '0.28', 'lle': '4.67', 'sei': '4.88'}",CHEMBL3929227,,CHEMBL3929227,7.26,0,http://www.openphacts.org/units/Nanomolar,2860692,=,37,1,=,,IC50,nM,,55.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,55.0
,375192,17749416,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2ncnc3c(C)nn(C)c23)cc(C#Cc2ccc3c(cnn3C)c2)n1,,,CHEMBL3886594,,2016,"{'bei': '18.77', 'le': '0.34', 'lle': '6.43', 'sei': '7.80'}",CHEMBL4115565,,CHEMBL4115565,9.00,0,http://www.openphacts.org/units/Nanomolar,2867720,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375193,17749417,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2ncnc3c(C)nn(C)c23)cc(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886594,,2016,"{'bei': '18.35', 'le': '0.33', 'lle': '5.46', 'sei': '8.14'}",CHEMBL4114897,,CHEMBL4114897,9.00,0,http://www.openphacts.org/units/Nanomolar,2867721,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375194,17749418,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2ncnc3c(C)nn(C)c23)cc(C#Cc2cc(C)nc3c(F)cccc23)n1,,,CHEMBL3886594,,2016,"{'bei': '17.70', 'le': '0.32', 'lle': '5.32', 'sei': '8.14'}",CHEMBL4115526,,CHEMBL4115526,9.00,0,http://www.openphacts.org/units/Nanomolar,2867722,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375195,17749419,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2ncnc3c(C)nn(C)c23)cc(C#Cc2ccn3c(C)ncc3c2)n1,,,CHEMBL3886594,,2016,"{'bei': '18.77', 'le': '0.34', 'lle': '6.36', 'sei': '7.83'}",CHEMBL4115207,,CHEMBL4115207,9.00,0,http://www.openphacts.org/units/Nanomolar,2867723,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375196,17749420,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2c(OC)ccc3nc(C)ccc23)cc(C#Cc2ccccc2)n1,,,CHEMBL3886594,,2016,"{'bei': '16.05', 'le': '0.29', 'lle': '2.67', 'sei': '9.49'}",CHEMBL4109172,,CHEMBL4109172,7.23,0,http://www.openphacts.org/units/Nanomolar,2867724,=,37,1,=,,IC50,nM,,59.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,59.0
,375197,17749421,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2ncnc3cnn(C)c23)cc(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886594,,2016,"{'bei': '18.89', 'le': '0.34', 'lle': '5.77', 'sei': '8.14'}",CHEMBL4106485,,CHEMBL4106485,9.00,0,http://www.openphacts.org/units/Nanomolar,2867725,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375198,17749422,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2ncnc3cnn(C)c23)cc(C#Cc2ccccc2)n1,,,CHEMBL3886594,,2016,"{'bei': '21.14', 'le': '0.38', 'lle': '6.33', 'sei': '8.91'}",CHEMBL4107160,,CHEMBL4107160,8.70,0,http://www.openphacts.org/units/Nanomolar,2867726,=,37,1,=,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,375199,17749423,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2ncnc3cnn(C)c23)cc(C#Cc2ccc3c(ccc(=O)n3C)c2)n1,,,CHEMBL3886594,,2016,"{'bei': '18.27', 'le': '0.33', 'lle': '6.78', 'sei': '7.52'}",CHEMBL4108098,,CHEMBL4108098,9.00,0,http://www.openphacts.org/units/Nanomolar,2867727,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375200,17749424,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2ncnc3cnn(C)c23)cc(C#Cc2ccc(-n3cnc(C)c3)cc2)n1,,,CHEMBL3886594,,2016,"{'bei': '17.70', 'le': '0.32', 'lle': '5.83', 'sei': '7.54'}",CHEMBL4115656,,CHEMBL4115656,8.70,0,http://www.openphacts.org/units/Nanomolar,2867728,=,37,1,=,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,375201,17749425,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2ncnc3oc(C)c(C)c23)cc(C#Cc2ccccc2)n1,,,CHEMBL3886594,,2016,"{'bei': '20.44', 'le': '0.37', 'lle': '4.85', 'sei': '9.36'}",CHEMBL4112542,,CHEMBL4112542,8.70,0,http://www.openphacts.org/units/Nanomolar,2867729,=,37,1,=,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,375202,17749426,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2cccc3nc(C)c(C)n23)cc(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886594,,2016,"{'bei': '18.42', 'le': '0.33', 'lle': '4.18', 'sei': '10.69'}",CHEMBL4115218,,CHEMBL4115218,9.00,0,http://www.openphacts.org/units/Nanomolar,2867730,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375203,17749427,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2cccc3cnn(C)c23)cc(C#Cc2ccc3c(c2)CC(=O)N3C)n1,,,CHEMBL3886594,,2016,"{'bei': '16.63', 'le': '0.30', 'lle': '4.86', 'sei': '8.64'}",CHEMBL4114456,,CHEMBL4114456,7.96,0,http://www.openphacts.org/units/Nanomolar,2867731,=,37,1,=,,IC50,nM,,11.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,11.0
,375204,17749428,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2cnc3cccc(C)n23)cc(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886594,,2016,"{'bei': '18.96', 'le': '0.34', 'lle': '4.49', 'sei': '10.69'}",CHEMBL4108099,,CHEMBL4108099,9.00,0,http://www.openphacts.org/units/Nanomolar,2867732,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375205,17749429,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2c(C)nc(C)c3c(=O)n(C)n(C)c23)cc(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886594,,2016,"{'bei': '16.87', 'le': '0.31', 'lle': '5.25', 'sei': '8.43'}",CHEMBL4110909,,CHEMBL4110909,9.00,0,http://www.openphacts.org/units/Nanomolar,2867733,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375206,17749430,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2nc(C)nc3c(C)nn(C)c23)cc(C#Cc2ccc3c(ccc(=O)n3C)c2)n1,,,CHEMBL3886594,,2016,"{'bei': '17.29', 'le': '0.32', 'lle': '6.16', 'sei': '7.52'}",CHEMBL4115053,,CHEMBL4115053,9.00,0,http://www.openphacts.org/units/Nanomolar,2867734,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375207,17749431,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2nc(C)nc3c(C)nn(C)c23)cc(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886594,,2016,"{'bei': '17.84', 'le': '0.32', 'lle': '5.16', 'sei': '8.14'}",CHEMBL4110049,,CHEMBL4110049,9.00,0,http://www.openphacts.org/units/Nanomolar,2867735,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375208,17749432,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2nc(C)nc3c(C)nn(C)c23)cc(C#Cc2ccc3c(cnn3C)c2)n1,,,CHEMBL3886594,,2016,"{'bei': '18.23', 'le': '0.33', 'lle': '6.12', 'sei': '7.80'}",CHEMBL4108709,,CHEMBL4108709,9.00,0,http://www.openphacts.org/units/Nanomolar,2867736,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375209,17749433,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2nc(C)nc3nn(C)c(C)c23)cc(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886594,,2016,"{'bei': '17.84', 'le': '0.32', 'lle': '5.16', 'sei': '8.14'}",CHEMBL4113127,,CHEMBL4113127,9.00,0,http://www.openphacts.org/units/Nanomolar,2867737,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375210,17749434,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2nc(C)nc3nn(C)c(C)c23)cc(C#Cc2ccc3c(ccc(=O)n3C)c2)n1,,,CHEMBL3886594,,2016,"{'bei': '16.71', 'le': '0.30', 'lle': '5.86', 'sei': '7.27'}",CHEMBL4107814,,CHEMBL4107814,8.70,0,http://www.openphacts.org/units/Nanomolar,2867738,=,37,1,=,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,375211,17749435,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2nc(C)nc3nn(C)c(C)c23)cc(C#Cc2ccc3c(cnn3C)c2)n1,,,CHEMBL3886594,,2016,"{'bei': '18.23', 'le': '0.33', 'lle': '6.12', 'sei': '7.80'}",CHEMBL4107425,,CHEMBL4107425,9.00,0,http://www.openphacts.org/units/Nanomolar,2867739,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375212,17749436,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2nc(C)nc3nn(C)c(C)c23)cc(C#Cc2cnc(-n3cnc(C)c3)nc2)n1,,,CHEMBL3886594,,2016,"{'bei': '17.25', 'le': '0.32', 'lle': '6.73', 'sei': '6.37'}",CHEMBL4110268,,CHEMBL4110268,9.00,0,http://www.openphacts.org/units/Nanomolar,2867740,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375213,17749437,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2nc(C)nc3nn(C)c(C)c23)cc(C#Cc2cccs2)n1,,,CHEMBL3886594,,2016,"{'bei': '20.20', 'le': '0.38', 'lle': '5.95', 'sei': '9.22'}",CHEMBL4110057,,CHEMBL4110057,9.00,0,http://www.openphacts.org/units/Nanomolar,2867741,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375214,17749438,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2cccc3cnn(C)c23)c(Cl)c(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886594,,2016,"{'bei': '15.56', 'le': '0.29', 'lle': '2.83', 'sei': '9.35'}",CHEMBL4107271,,CHEMBL4107271,7.92,0,http://www.openphacts.org/units/Nanomolar,2867742,=,37,1,=,,IC50,nM,,12.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,12.0
,375215,17749439,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2cccc3cnn(C)c23)c(Cl)c(C#Cc2ccc3c(ccc(=O)n3C)c2)n1,,,CHEMBL3886594,,2016,"{'bei': '15.24', 'le': '0.29', 'lle': '3.91', 'sei': '8.53'}",CHEMBL4111060,,CHEMBL4111060,8.00,0,http://www.openphacts.org/units/Nanomolar,2867761,=,37,1,=,,IC50,nM,,10.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,10.0
,375216,17749440,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2cccc3cnn(C)c23)c(OC)c(C#Cc2ccccc2)n1,,,CHEMBL3886594,,2016,"{'bei': '18.02', 'le': '0.33', 'lle': '4.33', 'sei': '9.77'}",CHEMBL4112689,,CHEMBL4112689,7.92,0,http://www.openphacts.org/units/Nanomolar,2867743,=,37,1,=,,IC50,nM,,12.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,12.0
,375217,17749441,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2cccc3ncccc23)c(OC)c(C#Cc2ccccc2)n1,,,CHEMBL3886594,,2016,"{'bei': '15.73', 'le': '0.28', 'lle': '2.62', 'sei': '9.02'}",CHEMBL4115311,,CHEMBL4115311,6.87,0,http://www.openphacts.org/units/Nanomolar,2867744,=,37,1,=,,IC50,nM,,136.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,136.0
,375218,17749442,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2ccncc2)cc(C#Cc2ccccc2)n1,,,CHEMBL3886594,,2016,"{'bei': '18.38', 'le': '0.33', 'lle': '3.46', 'sei': '9.79'}",CHEMBL4112194,,CHEMBL4112194,6.55,0,http://www.openphacts.org/units/Nanomolar,2867745,=,37,1,=,,IC50,nM,,282.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,282.0
,375219,17749443,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2cncc(F)c2)cc(C#Cc2ccccc2)n1,,,CHEMBL3886594,,2016,"{'bei': '18.42', 'le': '0.34', 'lle': '3.67', 'sei': '10.31'}",CHEMBL4109659,,CHEMBL4109659,6.90,0,http://www.openphacts.org/units/Nanomolar,2867746,=,37,1,=,,IC50,nM,,127.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,127.0
,375220,17749444,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2ccc(C(F)(F)F)nc2)cc(C#Cc2ccccc2)n1,,,CHEMBL3886594,,2016,"{'bei': '15.20', 'le': '0.28', 'lle': '2.34', 'sei': '9.64'}",CHEMBL4106789,,CHEMBL4106789,6.45,0,http://www.openphacts.org/units/Nanomolar,2867747,=,37,1,=,,IC50,nM,,352.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,352.0
,375221,17749445,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2ccc(OC)nc2)cc(C#Cc2ccccc2)n1,,,CHEMBL3886594,,2016,"{'bei': '16.79', 'le': '0.31', 'lle': '3.39', 'sei': '8.52'}",CHEMBL4113639,,CHEMBL4113639,6.49,0,http://www.openphacts.org/units/Nanomolar,2867748,=,37,1,=,,IC50,nM,,325.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,325.0
,375222,17749446,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2ccccc2F)cc(C#Cc2ccccc2)n1,,,CHEMBL3886594,,2016,"{'bei': '14.45', 'le': '0.26', 'lle': '1.57', 'sei': '9.99'}",CHEMBL4106575,,CHEMBL4106575,5.40,0,http://www.openphacts.org/units/Nanomolar,2867749,=,37,1,=,,IC50,nM,,4010.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4010.0
,375223,17749447,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2ccccc2)cc(C#Cc2ccccc2)n1,,,CHEMBL3886594,,2016,"{'bei': '15.69', 'le': '0.28', 'lle': '1.89', 'sei': '10.33'}",CHEMBL4111793,,CHEMBL4111793,5.58,0,http://www.openphacts.org/units/Nanomolar,2867750,=,37,1,=,,IC50,nM,,2642.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2642.0
,375224,17749448,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)C(=O)Nc1cc(-c2cccnc2)cc(C#Cc2ccccc2)n1,,,CHEMBL3886594,,2016,"{'bei': '18.52', 'le': '0.33', 'lle': '3.51', 'sei': '9.87'}",CHEMBL4112887,,CHEMBL4112887,6.60,0,http://www.openphacts.org/units/Nanomolar,2867751,=,37,1,=,,IC50,nM,,250.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,250.0
,375225,17749449,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ccncc2)c(-c2cncnc2)c(C#Cc2ccccc2)n1,,,CHEMBL3886594,,2016,"{'bei': '15.19', 'le': '0.27', 'lle': '3.05', 'sei': '7.12'}",CHEMBL3931465,,CHEMBL3931465,6.60,0,http://www.openphacts.org/units/Nanomolar,2867752,=,37,1,=,,IC50,nM,,250.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,250.0
,375226,17749450,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2cccnc2)c(-c2cncnc2)c(C#Cc2ccccc2)n1,,,CHEMBL3886594,,2016,"{'bei': '15.57', 'le': '0.28', 'lle': '3.21', 'sei': '7.30'}",CHEMBL3903484,,CHEMBL3903484,6.76,0,http://www.openphacts.org/units/Nanomolar,2867753,=,37,1,=,,IC50,nM,,172.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,172.0
,375227,17749451,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNC(CC)C(=O)Nc1cc(-c2ncnc3c(C)nn(C)c23)cc(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886594,,2016,"{'bei': '15.85', 'le': '0.29', 'lle': '3.90', 'sei': '7.44'}",CHEMBL3940501,,CHEMBL3940501,8.22,0,http://www.openphacts.org/units/Nanomolar,2867754,=,37,1,=,,IC50,nM,,6.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,6.0
,375228,17749452,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ncnc3c(C)nn(C)c23)cc(C#Cc2ccc3nc(C)ccc3c2)n1,,,CHEMBL3886594,,2016,"{'bei': '18.35', 'le': '0.33', 'lle': '5.46', 'sei': '8.14'}",CHEMBL3909016,,CHEMBL3909016,9.00,0,http://www.openphacts.org/units/Nanomolar,2867755,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375229,17749453,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ncnc3c(C)nn(C)c23)cc(C#Cc2cc(C)nc(C)c2)n1,,,CHEMBL3886594,,2016,"{'bei': '19.80', 'le': '0.36', 'lle': '6.31', 'sei': '8.14'}",CHEMBL3935487,,CHEMBL3935487,9.00,0,http://www.openphacts.org/units/Nanomolar,2867756,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375230,17749454,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ncnc3c(C)nn(C)c23)cc(C#Cc2cc(F)cc(F)c2)n1,,,CHEMBL3886594,,2016,"{'bei': '19.50', 'le': '0.36', 'lle': '6.04', 'sei': '9.22'}",CHEMBL3917949,,CHEMBL3917949,9.00,0,http://www.openphacts.org/units/Nanomolar,2867757,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375231,17749455,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ncnc3c(C)nn(C)c23)cc(C#Cc2ccc(-n3cnc(C)c3)cc2)n1,,,CHEMBL3886594,,2016,"{'bei': '17.80', 'le': '0.32', 'lle': '5.83', 'sei': '7.80'}",CHEMBL3926762,,CHEMBL3926762,9.00,0,http://www.openphacts.org/units/Nanomolar,2867758,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375232,17749456,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ncnc3c(C)nn(C)c23)cc(C#Cc2cc(F)c3ncccc3c2)n1,,,CHEMBL3886594,,2016,"{'bei': '18.20', 'le': '0.33', 'lle': '5.63', 'sei': '8.14'}",CHEMBL3963948,,CHEMBL3963948,9.00,0,http://www.openphacts.org/units/Nanomolar,2867759,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,375233,17749457,[],CHEMBL3888131,"XIAP BIR3 & cIAP1 BIR3 Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% TritonX100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a strepatvidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes. Time resolved Europium fluorescence was measured in a Wallac Victor using Standard assay settings.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)C(=O)Nc1cc(-c2ncnc3c(C)nn(C)c23)cc(C#Cc2cnc3c(cnn3C)c2)n1,,,CHEMBL3886594,,2016,"{'bei': '18.73', 'le': '0.34', 'lle': '7.04', 'sei': '7.01'}",CHEMBL3898413,,CHEMBL3898413,9.00,0,http://www.openphacts.org/units/Nanomolar,2867760,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,441789,17801533,[],CHEMBL3889229,"Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a streptavidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc(-c2c(-c3cccnc3OC)nc3cc(C)ccn23)c(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886996,,2016,"{'bei': '15.47', 'le': '0.28', 'lle': '3.42', 'sei': '8.46'}",CHEMBL3895473,,CHEMBL3895473,9.00,0,http://www.openphacts.org/units/Nanomolar,2901287,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,441790,17801534,[],CHEMBL3889229,"Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a streptavidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc(-c2c(-c3ccnc(C)c3)nc3cc(C)ccn23)c(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886996,,2016,"{'bei': '15.91', 'le': '0.29', 'lle': '3.12', 'sei': '9.27'}",CHEMBL3911035,,CHEMBL3911035,9.00,0,http://www.openphacts.org/units/Nanomolar,2901288,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,441791,17801535,[],CHEMBL3889229,"Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a streptavidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc(-c2c(-c3cnn(C)c3)nc3cc(C)ccn23)c(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886996,,2016,"{'bei': '16.23', 'le': '0.29', 'lle': '4.09', 'sei': '8.82'}",CHEMBL3981054,,CHEMBL3981054,9.00,0,http://www.openphacts.org/units/Nanomolar,2901289,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,441792,17801536,[],CHEMBL3889229,"Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a streptavidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc(-c2c(-c3cncn3C)nc3cc(C)ccn23)c(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886996,,2016,"{'bei': '16.23', 'le': '0.29', 'lle': '4.09', 'sei': '8.82'}",CHEMBL3905467,,CHEMBL3905467,9.00,0,http://www.openphacts.org/units/Nanomolar,2901290,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,441793,17801537,[],CHEMBL3889229,"Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a streptavidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc(-c2c(-c3cccnc3C)nc3cc(C)ccn23)c(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886996,,2016,"{'bei': '15.38', 'le': '0.28', 'lle': '2.82', 'sei': '8.96'}",CHEMBL3973040,,CHEMBL3973040,8.70,0,http://www.openphacts.org/units/Nanomolar,2901291,=,37,1,=,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,441794,17801538,[],CHEMBL3889229,"Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a streptavidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc(-c2c(-c3ccc(C)nc3)nc3cc(C)ccn23)c(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886996,,2016,"{'bei': '15.91', 'le': '0.29', 'lle': '3.12', 'sei': '9.27'}",CHEMBL3896543,,CHEMBL3896543,9.00,0,http://www.openphacts.org/units/Nanomolar,2901292,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,441795,17801539,[],CHEMBL3889229,"Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a streptavidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc(-c2c(-c3cnc(C)nc3)nc3cc(C)ccn23)c(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886996,,2016,"{'bei': '15.88', 'le': '0.29', 'lle': '3.73', 'sei': '8.18'}",CHEMBL3967713,,CHEMBL3967713,9.00,0,http://www.openphacts.org/units/Nanomolar,2901293,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,441796,17801540,[],CHEMBL3889229,"Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a streptavidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc(-c2c(-c3ccnc(OC)c3)nc3cc(C)ccn23)c(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886996,,2016,"{'bei': '15.47', 'le': '0.28', 'lle': '3.42', 'sei': '8.46'}",CHEMBL3928571,,CHEMBL3928571,9.00,0,http://www.openphacts.org/units/Nanomolar,2901294,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,441797,17801541,[],CHEMBL3889229,"Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a streptavidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc(-c2c(-c3ccc(OC)nc3)nc3cc(C)ccn23)c(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886996,,2016,"{'bei': '15.47', 'le': '0.28', 'lle': '3.42', 'sei': '8.46'}",CHEMBL3964219,,CHEMBL3964219,9.00,0,http://www.openphacts.org/units/Nanomolar,2901295,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,441798,17801542,[],CHEMBL3889229,"Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a streptavidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc(-c2c(-c3cccnc3OC)nc3cc(C)ccn23)c(C#Cc2ccc3c(ccc(=O)n3C)c2)n1,,,CHEMBL3886996,,2016,"{'bei': '15.06', 'le': '0.27', 'lle': '4.43', 'sei': '7.80'}",CHEMBL3930510,,CHEMBL3930510,9.00,0,http://www.openphacts.org/units/Nanomolar,2901296,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,441799,17801543,[],CHEMBL3889229,"Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a streptavidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc(-c2c(-c3ccnc(C)c3)nc3cc(C)ccn23)c(C#Cc2ccccc2)n1,,,CHEMBL3886996,,2016,"{'bei': '17.98', 'le': '0.32', 'lle': '3.98', 'sei': '10.69'}",CHEMBL3958007,,CHEMBL3958007,9.00,0,http://www.openphacts.org/units/Nanomolar,2901297,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,441800,17801544,[],CHEMBL3889229,"Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a streptavidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc(-c2c(-c3cnc(C)nc3)nc3cc(C)ccn23)c(C#Cc2ccc3c(ccc(=O)n3C)c2)n1,,,CHEMBL3886996,,2016,"{'bei': '14.93', 'le': '0.27', 'lle': '4.43', 'sei': '7.30'}",CHEMBL3935923,,CHEMBL3935923,8.70,0,http://www.openphacts.org/units/Nanomolar,2901298,=,37,1,=,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,441801,17801545,[],CHEMBL3889229,"Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a streptavidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc(-c2c(-c3ccnc(OC)c3)nc3cc(C)ccn23)c(C#Cc2ccc3c(ccc(=O)n3C)c2)n1,,,CHEMBL3886996,,2016,"{'bei': '15.06', 'le': '0.27', 'lle': '4.43', 'sei': '7.80'}",CHEMBL3969059,,CHEMBL3969059,9.00,0,http://www.openphacts.org/units/Nanomolar,2901299,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,441802,17801546,[],CHEMBL3889229,"Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a streptavidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc(-c2c(-c3ccc(OC)nc3)nc3cc(C)ccn23)c(C#Cc2ccc3c(ccc(=O)n3C)c2)n1,,,CHEMBL3886996,,2016,"{'bei': '15.06', 'le': '0.27', 'lle': '4.43', 'sei': '7.80'}",CHEMBL3929505,,CHEMBL3929505,9.00,0,http://www.openphacts.org/units/Nanomolar,2901300,=,37,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,441803,17801547,[],CHEMBL3889229,"Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a streptavidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc(-c2c(-c3cccnc3OC)nc3cc(Cl)ccn23)c(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886996,,2016,"{'bei': '14.45', 'le': '0.27', 'lle': '2.78', 'sei': '8.18'}",CHEMBL3974300,,CHEMBL3974300,8.70,0,http://www.openphacts.org/units/Nanomolar,2901301,=,37,1,=,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,441804,17801548,[],CHEMBL3889229,"Binding Assays (DELFIA): BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for one hour at room temperature in the presence of inhibitory compounds. The assay mixture was transferred to a streptavidin coated plate and incubated for one hour at room temperature to allow binding of the biotinylated peptide and associated BIR3 domains to the plate. After several washing steps Eu labeled anti-GST antibody (e.g. Perkin Elmer DELFIA Eu-N1-antiGST AD0250) was added to detect BIR3 domain-SMAC peptide interactions according to Perkin Elmer's instructions. Briefly, the antibody was added (dilution 1:5000 in Perkin Elmer DELFIA Assay Buffer 2013-01) and incubated for one hour. After 3 washing steps using Delfia Washing Buffer (Perkin Elmer DELFIA Wash 2013-05), Enhancement Solution (Perkin Elmer Enhancement Asolution 2013-02) was added and incubation continued for 10 minutes.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)Nc1ccc(-c2c(-c3cccnc3OC)nc3ccccn23)c(C#Cc2ccc3c(C)nccc3c2)n1,,,CHEMBL3886996,,2016,"{'bei': '15.32', 'le': '0.28', 'lle': '3.43', 'sei': '8.18'}",CHEMBL3956933,,CHEMBL3956933,8.70,0,http://www.openphacts.org/units/Nanomolar,2901302,=,37,1,=,,IC50,nM,,2.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.0
,,18073575,[],CHEMBL4015839,Inhibition of SMAC-derived peptide abuRPFK (5 and 6FAM)-amide interaction with cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)O,,,CHEMBL4014324,J Med Chem,2017,"{'bei': '23.83', 'le': '0.46', 'lle': '9.41', 'sei': '6.69'}",CHEMBL234346,,CHEMBL234346,9.49,0,http://www.openphacts.org/units/Nanomolar,2995793,=,1,1,=,,IC50,nM,,0.32,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,0.32
,,18073576,[],CHEMBL4015839,Inhibition of SMAC-derived peptide abuRPFK (5 and 6FAM)-amide interaction with cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CN[C@H](C)CN1CC(=O)N1CC(C)(C)c2ncc(Cc3ccccc3)cc21,,,CHEMBL4014324,J Med Chem,2017,"{'bei': '18.59', 'le': '0.35', 'lle': '5.24', 'sei': '13.61'}",CHEMBL3700016,,CHEMBL3700016,7.85,1,http://www.openphacts.org/units/Nanomolar,2995773,=,1,1,=,,IC50,nM,,14.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,14.0
,,18084851,[],CHEMBL4018350,Inhibition of SMAC derived peptide abuRPF-K(5-Fam)-NH2 interaction with recombinant human C-terminal 6His-tagged cIAP1 BIR3 domain (245 to 357 residues) expressed in Escherichia coli BL21(DE3) incubated for 15 mins measured after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNC(=O)c1ccccc1)CC[C@H]2C(=O)N[C@H](C(=O)NCCN(Cc1ccccn1)Cc1ccccn1)c1ccccc1,,,CHEMBL4017482,Bioorg Med Chem Lett,2017,"{'bei': '11.18', 'le': '0.21', 'lle': '5.83', 'sei': '5.04'}",CHEMBL4098982,,CHEMBL4098982,8.96,0,http://www.openphacts.org/units/Nanomolar,2998496,=,1,1,=,,IC50,nM,,1.09,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.09
,,18084852,[],CHEMBL4018350,Inhibition of SMAC derived peptide abuRPF-K(5-Fam)-NH2 interaction with recombinant human C-terminal 6His-tagged cIAP1 BIR3 domain (245 to 357 residues) expressed in Escherichia coli BL21(DE3) incubated for 15 mins measured after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNC(=O)c1ccccc1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL4017482,Bioorg Med Chem Lett,2017,"{'bei': '14.51', 'le': '0.27', 'lle': '5.28', 'sei': '7.40'}",CHEMBL4084120,,CHEMBL4084120,8.85,0,http://www.openphacts.org/units/Nanomolar,2998497,=,1,1,=,,IC50,nM,,1.42,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.42
,,18084853,[],CHEMBL4018350,Inhibition of SMAC derived peptide abuRPF-K(5-Fam)-NH2 interaction with recombinant human C-terminal 6His-tagged cIAP1 BIR3 domain (245 to 357 residues) expressed in Escherichia coli BL21(DE3) incubated for 15 mins measured after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNC(=O)CN(Cc1ccccn1)Cc1ccccn1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL4017482,Bioorg Med Chem Lett,2017,"{'bei': '11.84', 'le': '0.22', 'lle': '5.07', 'sei': '5.93'}",CHEMBL4091245,,CHEMBL4091245,8.82,0,http://www.openphacts.org/units/Nanomolar,2998498,=,1,1,=,,IC50,nM,,1.52,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.52
,,18084854,[],CHEMBL4018350,Inhibition of SMAC derived peptide abuRPF-K(5-Fam)-NH2 interaction with recombinant human C-terminal 6His-tagged cIAP1 BIR3 domain (245 to 357 residues) expressed in Escherichia coli BL21(DE3) incubated for 15 mins measured after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNC(=O)CCNC(=O)CN(Cc1ccccn1)Cc1ccccn1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL4017482,Bioorg Med Chem Lett,2017,"{'bei': '10.87', 'le': '0.20', 'lle': '5.61', 'sei': '4.99'}",CHEMBL4070316,,CHEMBL4070316,8.87,0,http://www.openphacts.org/units/Nanomolar,2998499,=,1,1,=,,IC50,nM,,1.35,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.35
,,18084855,[],CHEMBL4018350,Inhibition of SMAC derived peptide abuRPF-K(5-Fam)-NH2 interaction with recombinant human C-terminal 6His-tagged cIAP1 BIR3 domain (245 to 357 residues) expressed in Escherichia coli BL21(DE3) incubated for 15 mins measured after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNC(=O)CCCCCCCCCCNC(=O)CN(Cc1ccccn1)Cc1ccccn1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL4017482,Bioorg Med Chem Lett,2017,"{'bei': '8.85', 'le': '0.17', 'lle': '1.84', 'sei': '4.62'}",CHEMBL4079500,,CHEMBL4079500,8.22,0,http://www.openphacts.org/units/Nanomolar,2998500,=,1,1,=,,IC50,nM,,6.08,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,6.08
,,18084856,[],CHEMBL4018350,Inhibition of SMAC derived peptide abuRPF-K(5-Fam)-NH2 interaction with recombinant human C-terminal 6His-tagged cIAP1 BIR3 domain (245 to 357 residues) expressed in Escherichia coli BL21(DE3) incubated for 15 mins measured after 3 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@H](NC)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNC(=O)COCCOCCNC(=O)CN(Cc1ccccn1)Cc1ccccn1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1,,,CHEMBL4017482,Bioorg Med Chem Lett,2017,"{'bei': '9.86', 'le': '0.18', 'lle': '5.88', 'sei': '4.47'}",CHEMBL4097534,,CHEMBL4097534,8.78,0,http://www.openphacts.org/units/Nanomolar,2998501,=,1,1,=,,IC50,nM,,1.66,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.66
,Not Determined,18327398,[],CHEMBL4135557,Inhibition of recombinant human His-tagged cIAP1 (Leu250 to Gly350 residues) expressed in Escherichia coli by TR-FRET assay,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,,,CHEMBL4130523,ACS Med Chem Lett,2017,,CHEMBL483847,,CHEMBL483847,,0,,3043017,,1,0,,,IC50,,,,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,,,,
,Not Determined,18327399,[],CHEMBL4135557,Inhibition of recombinant human His-tagged cIAP1 (Leu250 to Gly350 residues) expressed in Escherichia coli by TR-FRET assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(NCCO)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,,,CHEMBL4130523,ACS Med Chem Lett,2017,,CHEMBL1257423,,CHEMBL1257423,,0,,3043018,,1,0,,,IC50,,,,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,,,,
,Not Determined,18327400,[],CHEMBL4135557,Inhibition of recombinant human His-tagged cIAP1 (Leu250 to Gly350 residues) expressed in Escherichia coli by TR-FRET assay,B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)C1CCN(c2ncc(C(=O)Nc3ccc(OC(F)(F)Cl)cc3)cc2-c2ccn[nH]2)C1,,,CHEMBL4130523,ACS Med Chem Lett,2017,,CHEMBL4162041,,CHEMBL4162041,,0,,3043019,,1,0,,,IC50,,,,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,,,,
,,18327401,[],CHEMBL4135557,Inhibition of recombinant human His-tagged cIAP1 (Leu250 to Gly350 residues) expressed in Escherichia coli by TR-FRET assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2cccc(OC)c2)cs1)C1CCCCC1,,,CHEMBL4130523,ACS Med Chem Lett,2017,"{'bei': '16.23', 'le': '0.32', 'lle': '4.60', 'sei': '8.27'}",CHEMBL4164385,,CHEMBL4164385,8.32,0,http://www.openphacts.org/units/Nanomolar,3043020,=,1,1,=,,IC50,nM,,4.8,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4.8
,,18327402,[],CHEMBL4135557,Inhibition of recombinant human His-tagged cIAP1 (Leu250 to Gly350 residues) expressed in Escherichia coli by TR-FRET assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2cccc(OCCOCCOCCNC(=O)c3cccc(-c4cc(Nc5ccc(OC(F)(F)F)cc5)ncn4)c3)c2)cs1)C1CCCCC1,,,CHEMBL4130523,ACS Med Chem Lett,2017,"{'bei': '6.74', 'le': '0.13', 'lle': '-0.99', 'sei': '3.41'}",CHEMBL4172268,,CHEMBL4172268,6.66,0,http://www.openphacts.org/units/Nanomolar,3043021,=,1,1,=,,IC50,nM,,220.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,220.0
,,18327403,[],CHEMBL4135557,Inhibition of recombinant human His-tagged cIAP1 (Leu250 to Gly350 residues) expressed in Escherichia coli by TR-FRET assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2cccc(OCCOCCOCCNC(=O)C3CCN(c4ncc(C(=O)Nc5ccc(OC(F)(F)Cl)cc5)cc4-c4ccn[nH]4)C3)c2)cs1)C1CCCCC1,,,CHEMBL4130523,ACS Med Chem Lett,2017,"{'bei': '6.48', 'le': None, 'lle': None, 'sei': None}",CHEMBL4160980,,CHEMBL4160980,7.07,0,http://www.openphacts.org/units/Nanomolar,3043022,=,1,1,=,,IC50,nM,,86.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,86.0
,,18327404,[],CHEMBL4135557,Inhibition of recombinant human His-tagged cIAP1 (Leu250 to Gly350 residues) expressed in Escherichia coli by TR-FRET assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N(C)[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2cccc(OCCOCCOCCNC(=O)C3CCN(c4ncc(C(=O)Nc5ccc(OC(F)(F)Cl)cc5)cc4-c4ccn[nH]4)C3)c2)cs1)C1CCCCC1,,,CHEMBL4130523,ACS Med Chem Lett,2017,,CHEMBL4168907,,CHEMBL4168907,,0,http://www.openphacts.org/units/Nanomolar,3043023,>,1,1,>,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,,18441538,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(Cc4ccc(F)cc4)cc32)[C@@H](CN2CCOC[C@H]2C)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '18.63', 'le': '0.35', 'lle': '6.67', 'sei': '15.58'}",CHEMBL4064619,,CHEMBL4064619,9.49,0,http://www.openphacts.org/units/Nanomolar,3060486,=,1,1,=,,IC50,nM,,0.32,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,0.32
,,18441573,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3c2cc(Cc2ccc(F)cc2)c(=O)n3C)[C@@H](CN2[C@H](C)COC[C@H]2C)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '17.60', 'le': '0.33', 'lle': '7.23', 'sei': '13.91'}",CHEMBL4169478,,CHEMBL4169478,9.74,0,http://www.openphacts.org/units/Nanomolar,3060504,=,1,1,=,,IC50,nM,,0.18,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,0.18
,,18441577,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3cc(=O)n(Cc4ccc(F)cc4)cc32)[C@@H](CN2[C@H](C)COC[C@H]2C)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '16.96', 'le': '0.32', 'lle': '6.72', 'sei': '13.07'}",CHEMBL4177336,,CHEMBL4177336,9.15,0,http://www.openphacts.org/units/Nanomolar,3060505,=,1,1,=,,IC50,nM,,0.7,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,0.7
,,18441583,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nc(CO)c(Cc4ccc(F)cc4)cc32)[C@@H](CN2[C@H](C)COC[C@H]2C)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '18.06', 'le': '0.34', 'lle': '7.30', 'sei': '12.32'}",CHEMBL4166057,,CHEMBL4166057,10.00,0,http://www.openphacts.org/units/Nanomolar,3060506,=,1,1,=,,IC50,nM,,0.1,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,0.1
,,18441597,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nc(CO)c(Cc4ccc(F)cc4)cc32)[C@@H](CN2CCOC[C@H]2C)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '17.89', 'le': '0.34', 'lle': '7.35', 'sei': '11.90'}",CHEMBL4173974,ASTX-660,CHEMBL4173974,9.66,0,http://www.openphacts.org/units/Nanomolar,3060507,=,1,1,=,,IC50,nM,,0.22,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,0.22
,,18441612,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3[nH]c(=O)c(Cc4ccc(F)cc4)cc32)[C@@H](CN2[C@H](C)COC[C@H]2C)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '18.32', 'le': '0.35', 'lle': '7.39', 'sei': '12.22'}",CHEMBL4167141,,CHEMBL4167141,9.89,0,http://www.openphacts.org/units/Nanomolar,3060503,=,1,1,=,,IC50,nM,,0.13,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,0.13
,,18441618,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(Cc4ccc(F)cc4O)cc32)[C@@H](CN2[C@H](C)COC[C@H]2C)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '17.10', 'le': '0.32', 'lle': '6.32', 'sei': '11.37'}",CHEMBL4159232,,CHEMBL4159232,9.23,0,http://www.openphacts.org/units/Nanomolar,3060502,=,1,1,=,,IC50,nM,,0.59,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,0.59
,,18441625,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc([C@@H](O)c4ccc(F)cc4)cc32)[C@@H](CN2[C@H](C)COC[C@H]2C)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '15.67', 'le': '0.30', 'lle': '5.76', 'sei': '10.42'}",CHEMBL4170539,,CHEMBL4170539,8.46,0,http://www.openphacts.org/units/Nanomolar,3060501,=,1,1,=,,IC50,nM,,3.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3.5
,,18441633,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc([C@H](O)c4ccc(F)cc4)cc32)[C@@H](CN2[C@H](C)COC[C@H]2C)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '16.01', 'le': '0.30', 'lle': '5.94', 'sei': '10.64'}",CHEMBL4162607,,CHEMBL4162607,8.64,0,http://www.openphacts.org/units/Nanomolar,3060500,=,1,1,=,,IC50,nM,,2.3,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.3
,,18441640,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nnc(Cc4ccc(F)cc4F)cc32)[C@@H](CN2Cc3ccc(C#N)cc3C2=O)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '15.02', 'le': '0.28', 'lle': '5.64', 'sei': '8.34'}",CHEMBL4159806,,CHEMBL4159806,8.80,0,http://www.openphacts.org/units/Nanomolar,3060499,=,1,1,=,,IC50,nM,,1.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.6
,,18441646,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nnc(Cc4ccc(F)cc4F)cc32)[C@@H](CN2Cc3cc(C#N)ccc3C2=O)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '15.37', 'le': '0.29', 'lle': '5.84', 'sei': '8.53'}",CHEMBL4167717,,CHEMBL4167717,9.00,0,http://www.openphacts.org/units/Nanomolar,3060498,=,1,1,=,,IC50,nM,,1.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.0
,,18441652,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nnc(Cc4ccc(F)cc4F)cc32)[C@@H](CN2Cc3ccc(F)cc3C2=O)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '15.78', 'le': '0.30', 'lle': '5.70', 'sei': '11.18'}",CHEMBL4174922,,CHEMBL4174922,9.13,0,http://www.openphacts.org/units/Nanomolar,3060497,=,1,1,=,,IC50,nM,,0.74,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,0.74
,,18441658,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nnc(Cc4ccc(F)cc4F)cc32)[C@@H](CN2Cc3cc(F)ccc3C2=O)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '16.76', 'le': '0.32', 'lle': '6.27', 'sei': '11.88'}",CHEMBL4164271,,CHEMBL4164271,9.70,0,http://www.openphacts.org/units/Nanomolar,3060496,=,1,1,=,,IC50,nM,,0.2,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,0.2
,,18441664,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nnc(Cc4ccc(F)cc4F)cc32)[C@@H](CN2Cc3c(F)cccc3C2=O)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '16.88', 'le': '0.32', 'lle': '6.34', 'sei': '11.96'}",CHEMBL4171490,,CHEMBL4171490,9.77,0,http://www.openphacts.org/units/Nanomolar,3060495,=,1,1,=,,IC50,nM,,0.17,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,0.17
,,18441672,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nnc(Cc4ccc(F)cc4F)cc32)[C@@H](CN2Cc3ccccc3C2=O)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '16.89', 'le': '0.32', 'lle': '6.18', 'sei': '11.59'}",CHEMBL4160872,,CHEMBL4160872,9.47,0,http://www.openphacts.org/units/Nanomolar,3060494,=,1,1,=,,IC50,nM,,0.34,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,0.34
,,18441679,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nnc(Cc4ccc(F)cc4)cc32)[C@@H](CN2Cc3ccccc3C2=O)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '15.85', 'le': '0.29', 'lle': '5.45', 'sei': '10.53'}",CHEMBL4168144,,CHEMBL4168144,8.60,0,http://www.openphacts.org/units/Nanomolar,3060493,=,1,1,=,,IC50,nM,,2.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2.5
,,18441684,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(Cc4ccc(F)cc4)cc32)[C@@H](CN2Cc3ccccc3C2=O)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '16.40', 'le': '0.30', 'lle': '5.14', 'sei': '12.92'}",CHEMBL4175992,,CHEMBL4175992,8.89,0,http://www.openphacts.org/units/Nanomolar,3060492,=,1,1,=,,IC50,nM,,1.3,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1.3
,,18441689,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC1=C(C)C(=O)N(C[C@H]2CN[C@H](C)CN2CC(=O)N2CC(C)(C)c3ncc(Cc4ccc(F)cc4)cc32)C1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '16.20', 'le': '0.30', 'lle': '5.14', 'sei': '12.24'}",CHEMBL4173890,,CHEMBL4173890,8.42,0,http://www.openphacts.org/units/Nanomolar,3060491,=,1,1,=,,IC50,nM,,3.8,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,3.8
,,18441694,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(Cc4ccc(F)cc4)cc32)[C@@H](CN2C[C@@H](C)OCC2=O)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '15.63', 'le': '0.29', 'lle': '5.84', 'sei': '10.49'}",CHEMBL4172596,,CHEMBL4172596,8.19,0,http://www.openphacts.org/units/Nanomolar,3060490,=,1,1,=,,IC50,nM,,6.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,6.5
,,18441699,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(Cc4ccc(F)cc4)cc32)[C@@H](CN2[C@H](C)COC[C@@H]2C)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '17.58', 'le': '0.33', 'lle': '6.00', 'sei': '15.11'}",CHEMBL4168197,,CHEMBL4168197,9.21,0,http://www.openphacts.org/units/Nanomolar,3060489,=,1,1,=,,IC50,nM,,0.62,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,0.62
,,18441704,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(Cc4ccc(F)cc4)cc32)[C@@H](CN2[C@H](C)COC[C@H]2C)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '18.56', 'le': '0.35', 'lle': '6.51', 'sei': '15.95'}",CHEMBL4166607,,CHEMBL4166607,9.72,0,http://www.openphacts.org/units/Nanomolar,3060488,=,1,1,=,,IC50,nM,,0.19,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,0.19
,,18441709,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(Cc4ccc(F)cc4)cc32)[C@@H](CN2C[C@@H](C)OC[C@H]2C)CN1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '16.00', 'le': '0.30', 'lle': '5.17', 'sei': '13.75'}",CHEMBL4159855,,CHEMBL4159855,8.38,0,http://www.openphacts.org/units/Nanomolar,3060487,=,1,1,=,,IC50,nM,,4.2,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4.2
,,18441713,[],CHEMBL4157561,Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1,,,CHEMBL4152349,J Med Chem,2018,"{'bei': '18.77', 'le': '0.37', 'lle': '5.55', 'sei': '10.28'}",CHEMBL2431768,LCL-161,CHEMBL2431768,9.40,0,http://www.openphacts.org/units/Nanomolar,3060485,=,1,1,=,,IC50,nM,,0.4,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,0.4
,,18709901,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](Cc1ccc(CP(=O)(O)O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,,CHEMBL4251755,J Med Chem,2018,"{'bei': '11.41', 'le': '0.22', 'lle': '6.50', 'sei': '3.51'}",CHEMBL4291176,,CHEMBL4291176,6.70,0,http://www.openphacts.org/units/Nanomolar,3107473,=,1,1,=,,IC50,nM,,197.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,197.6
,,18709902,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](Cc1ccc(S(=O)(=O)O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,,CHEMBL4251755,J Med Chem,2018,"{'bei': '11.93', 'le': '0.23', 'lle': '7.07', 'sei': '3.64'}",CHEMBL4283320,,CHEMBL4283320,6.84,0,http://www.openphacts.org/units/Nanomolar,3107474,=,1,1,=,,IC50,nM,,143.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,143.5
,,18709903,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](Cc1ccc(S(=O)(=O)O)cc1)C(=O)N1CCC[C@H]1C(=O)NC1Cc2ccccc2C1,,,CHEMBL4251755,J Med Chem,2018,,CHEMBL4291444,,CHEMBL4291444,,0,http://www.openphacts.org/units/Nanomolar,3107493,>,1,1,>,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,,18709904,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](Cc1ccc(S(=O)(=O)O)cc1)C(=O)N1CCC[C@@H]1c1cncc(Cc2ccccc2)n1,,,CHEMBL4251755,J Med Chem,2018,,CHEMBL4283597,,CHEMBL4283597,,0,http://www.openphacts.org/units/Nanomolar,3107494,>,1,1,>,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,,18709905,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](Cc1ccc(C(F)(F)F)c(Cl)c1)C(=O)N1CCC[C@@H]1c1cncc(Cc2ccccc2)n1,,,CHEMBL4251755,J Med Chem,2018,"{'bei': '11.24', 'le': '0.22', 'lle': '1.71', 'sei': '7.40'}",CHEMBL4288043,,CHEMBL4288043,6.45,0,http://www.openphacts.org/units/Nanomolar,3107495,=,1,1,=,,IC50,nM,,352.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,352.6
,,18709906,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](CCN)C(=O)N1CCCC1c1nc2ccccc2[nH]1,,,CHEMBL4251755,J Med Chem,2018,,CHEMBL4280144,,CHEMBL4280144,,0,http://www.openphacts.org/units/Nanomolar,3107496,>,1,1,>,,IC50,nM,,16000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,16000.0
,,18709907,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](Cc1ccc(N=C(N)N)cc1)C(=O)N1CCCC1c1nc2ccccc2[nH]1,,,CHEMBL4251755,J Med Chem,2018,,CHEMBL4284657,,CHEMBL4284657,,0,http://www.openphacts.org/units/Nanomolar,3107497,>,1,1,>,,IC50,nM,,5000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,5000.0
,,18709908,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](CCN)C(=O)N1CCC[C@@H]1C(=O)N[C@@H]1CCc2c(F)cccc21,,,CHEMBL4251755,J Med Chem,2018,"{'bei': '17.91', 'le': '0.34', 'lle': '7.40', 'sei': '6.66'}",CHEMBL4276715,,CHEMBL4276715,7.76,0,http://www.openphacts.org/units/Nanomolar,3107498,=,1,1,=,,IC50,nM,,17.2,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,17.2
,,18709909,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](Cc1ccc(CP(=O)(O)O)cc1)C(=O)N1CCC[C@@H]1C(=O)NC1Cc2ccccc2C1,,,CHEMBL4251755,J Med Chem,2018,"{'bei': '10.64', 'le': '0.21', 'lle': '4.65', 'sei': '4.00'}",CHEMBL4281250,,CHEMBL4281250,5.92,0,http://www.openphacts.org/units/Nanomolar,3107499,=,1,1,=,,IC50,nM,,1203.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1203.0
,,18709910,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](Cc1ccc(CP(=O)(O)O)cc1)C(=O)N1CCC[C@@H]1c1cncc(Cc2ccccc2)n1,,,CHEMBL4251755,J Med Chem,2018,,CHEMBL4291873,,CHEMBL4291873,,0,http://www.openphacts.org/units/Nanomolar,3107500,>,1,1,>,,IC50,nM,,2000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,2000.0
,,18709911,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCc2c(F)cccc21,,,CHEMBL4251755,J Med Chem,2018,"{'bei': '14.50', 'le': '0.27', 'lle': '5.46', 'sei': '5.70'}",CHEMBL4277802,,CHEMBL4277802,7.62,0,http://www.openphacts.org/units/Nanomolar,3107501,=,1,1,=,,IC50,nM,,23.9,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,23.9
,,18709912,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](Cc1ccc(S(=O)(=O)O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCc2c(F)cccc21,,,CHEMBL4251755,J Med Chem,2018,"{'bei': '13.67', 'le': '0.27', 'lle': '6.16', 'sei': '5.29'}",CHEMBL4288451,,CHEMBL4288451,7.66,0,http://www.openphacts.org/units/Nanomolar,3107502,=,1,1,=,,IC50,nM,,21.7,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,21.7
,,18709913,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](Cc1cc(C)c(C(F)(F)F)cc1F)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCc2c(F)cccc21,,,CHEMBL4251755,J Med Chem,2018,"{'bei': '14.38', 'le': '0.28', 'lle': '4.63', 'sei': '9.22'}",CHEMBL4288478,,CHEMBL4288478,8.35,0,http://www.openphacts.org/units/Nanomolar,3107503,=,1,1,=,,IC50,nM,,4.5,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,4.5
,,18709914,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1ccc(S(=O)(=O)F)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,,CHEMBL4251755,J Med Chem,2018,"{'bei': '10.90', 'le': '0.21', 'lle': '7.37', 'sei': '3.42'}",CHEMBL4277819,,CHEMBL4277819,6.74,0,http://www.openphacts.org/units/Nanomolar,3107504,=,1,1,=,,IC50,nM,,181.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,181.0
,,18709915,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1cccc(S(=O)(=O)F)c1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,,CHEMBL4251755,J Med Chem,2018,"{'bei': '10.63', 'le': '0.21', 'lle': '7.21', 'sei': '3.34'}",CHEMBL4291896,,CHEMBL4291896,6.58,0,http://www.openphacts.org/units/Nanomolar,3107505,=,1,1,=,,IC50,nM,,264.1,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,264.1
,,18709916,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1ccc(S(=O)(=O)F)cc1)C(=O)N1CCC[C@@H]1c1cncc(Cc2cccc(F)c2)n1,,,CHEMBL4251755,J Med Chem,2018,,CHEMBL4281278,,CHEMBL4281278,,0,http://www.openphacts.org/units/Nanomolar,3107506,>,1,1,>,,IC50,nM,,200.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,200.0
,,18709917,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1ccc(S(=O)(=O)F)cc1)C(=O)N1CCC[C@H]1c1cncc(Cc2cccc(F)c2)n1,,,CHEMBL4251755,J Med Chem,2018,,CHEMBL4276740,,CHEMBL4276740,,0,http://www.openphacts.org/units/Nanomolar,3107507,>,1,1,>,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
,,18709918,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1)C1CCCCC1,,,CHEMBL4251755,J Med Chem,2018,"{'bei': '16.01', 'le': '0.31', 'lle': '5.17', 'sei': '6.86'}",CHEMBL2063869,GDC-0152,CHEMBL2063869,7.98,0,http://www.openphacts.org/units/Nanomolar,3107508,=,1,1,=,,IC50,nM,,10.4,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,10.4
,,18709919,[],CHEMBL4256814,Displacement of AVPIAQKSEK-biotin from cIAP1 BIR3 (unknown origin) after 1 hr by DELFIA,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C,,,CHEMBL4251755,J Med Chem,2018,"{'bei': '16.42', 'le': '0.31', 'lle': '7.38', 'sei': '5.48'}",CHEMBL4280168,,CHEMBL4280168,7.32,0,http://www.openphacts.org/units/Nanomolar,3107509,=,1,1,=,,IC50,nM,,48.2,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,48.2
,,18997184,[],CHEMBL4342753,Inhibition of CIAP1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nc(CO)c(Cc4ccc(F)cc4)cc32)[C@@H](CN2CCOC[C@H]2C)CN1,,,CHEMBL4342405,Eur J Med Chem,2019,"{'bei': '14.68', 'le': '0.28', 'lle': '5.61', 'sei': '9.76'}",CHEMBL4173974,ASTX-660,CHEMBL4173974,7.92,0,http://www.openphacts.org/units/Nanomolar,3169842,=,1,1,=,,IC50,nM,,12.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,12.0
,,19036977,[],CHEMBL4351161,Binding affinity to cIAP1-BIR3 domain (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1ccc(S(=O)(=O)F)cc1)C(=O)N1CCC[C@@H]1c1cncc(Cc2ccc(F)cc2)n1,,,CHEMBL4350953,J Med Chem,2019,,CHEMBL4452928,,CHEMBL4452928,,0,http://www.openphacts.org/units/Nanomolar,3176139,>,1,1,>,,IC50,nM,,200.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,200.0
,,19036998,[],CHEMBL4351161,Binding affinity to cIAP1-BIR3 domain (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H]1c2ccccc2C[C@H]1OCC#CC#CCO[C@@H]1Cc2ccccc2[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)C(C)(C)C,,,CHEMBL4350953,J Med Chem,2019,"{'bei': '8.12', 'le': '0.15', 'lle': '4.97', 'sei': '3.92'}",CHEMBL3108931,,CHEMBL3108931,7.82,0,http://www.openphacts.org/units/Nanomolar,3176146,=,1,1,=,,IC50,nM,,15.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,15.0
,,19309662,[],CHEMBL4416032,Inhibition of N-terminal 6x-His-tagged recombinant human cIAP1-BIR3 (258 to 363 residues) expressed in Escherichia coli incubated for 2 hrs after 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)NC(Cc1cc(C)c(C(F)(F)F)cc1F)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCc2c(OS(=O)(=O)F)cccc21,,,CHEMBL4414592,J Med Chem,2019,"{'bei': '11.84', 'le': '0.24', 'lle': '4.64', 'sei': '5.84'}",CHEMBL4552412,,CHEMBL4552412,7.82,0,http://www.openphacts.org/units/Nanomolar,3224377,=,1,1,=,,IC50,nM,,15.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,15.0
,,19309663,[],CHEMBL4416032,Inhibition of N-terminal 6x-His-tagged recombinant human cIAP1-BIR3 (258 to 363 residues) expressed in Escherichia coli incubated for 2 hrs after 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCc2c(OS(=O)(=O)F)cccc21)C1CCCCC1,,,CHEMBL4414592,J Med Chem,2019,"{'bei': '14.21', 'le': '0.28', 'lle': '5.80', 'sei': '5.87'}",CHEMBL4581366,,CHEMBL4581366,7.85,0,http://www.openphacts.org/units/Nanomolar,3224376,=,1,1,=,,IC50,nM,,14.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,14.0
,,19309664,[],CHEMBL4416032,Inhibition of N-terminal 6x-His-tagged recombinant human cIAP1-BIR3 (258 to 363 residues) expressed in Escherichia coli incubated for 2 hrs after 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@@H](Cc1ccc(OS(=O)(=O)F)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCc2c(F)cccc21,,,CHEMBL4414592,J Med Chem,2019,"{'bei': '13.31', 'le': '0.26', 'lle': '5.85', 'sei': '5.75'}",CHEMBL4437401,,CHEMBL4437401,7.70,0,http://www.openphacts.org/units/Nanomolar,3224375,=,1,1,=,,IC50,nM,,20.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,20.0
,,19309665,[],CHEMBL4416032,Inhibition of N-terminal 6x-His-tagged recombinant human cIAP1-BIR3 (258 to 363 residues) expressed in Escherichia coli incubated for 2 hrs after 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CC(C)C)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL4414592,J Med Chem,2019,"{'bei': '13.27', 'le': '0.25', 'lle': '4.84', 'sei': '6.73'}",CHEMBL2158051,XEVINAPANT,CHEMBL2158051,7.46,0,http://www.openphacts.org/units/Nanomolar,3224374,=,1,1,=,,IC50,nM,,35.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,35.0
,,19309666,[],CHEMBL4416032,Inhibition of N-terminal 6x-His-tagged recombinant human cIAP1-BIR3 (258 to 363 residues) expressed in Escherichia coli incubated for 2 hrs after 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1,,,CHEMBL4414592,J Med Chem,2019,"{'bei': '15.34', 'le': '0.30', 'lle': '3.83', 'sei': '8.40'}",CHEMBL2431768,LCL-161,CHEMBL2431768,7.68,0,http://www.openphacts.org/units/Nanomolar,3224373,=,1,1,=,,IC50,nM,,21.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,21.0
,,19309667,[],CHEMBL4416031,Inhibition of N-terminal 6x-His-tagged recombinant human cIAP1-BIR3 (258 to 363 residues) expressed in Escherichia coli incubated for 2 hrs without 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)NC(Cc1cc(C)c(C(F)(F)F)cc1F)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCc2c(OS(=O)(=O)F)cccc21,,,CHEMBL4414592,J Med Chem,2019,"{'bei': '11.05', 'le': '0.22', 'lle': '4.12', 'sei': '5.45'}",CHEMBL4552412,,CHEMBL4552412,7.30,0,http://www.openphacts.org/units/Nanomolar,3224377,=,1,1,=,,IC50,nM,,50.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,50.0
,,19309668,[],CHEMBL4416031,Inhibition of N-terminal 6x-His-tagged recombinant human cIAP1-BIR3 (258 to 363 residues) expressed in Escherichia coli incubated for 2 hrs without 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCc2c(OS(=O)(=O)F)cccc21)C1CCCCC1,,,CHEMBL4414592,J Med Chem,2019,"{'bei': '13.76', 'le': '0.27', 'lle': '5.55', 'sei': '5.68'}",CHEMBL4581366,,CHEMBL4581366,7.60,0,http://www.openphacts.org/units/Nanomolar,3224376,=,1,1,=,,IC50,nM,,25.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,25.0
,,19309669,[],CHEMBL4416031,Inhibition of N-terminal 6x-His-tagged recombinant human cIAP1-BIR3 (258 to 363 residues) expressed in Escherichia coli incubated for 2 hrs without 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@@H](Cc1ccc(OS(=O)(=O)F)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCc2c(F)cccc21,,,CHEMBL4414592,J Med Chem,2019,"{'bei': '13.17', 'le': '0.26', 'lle': '5.77', 'sei': '5.69'}",CHEMBL4437401,,CHEMBL4437401,7.62,0,http://www.openphacts.org/units/Nanomolar,3224375,=,1,1,=,,IC50,nM,,24.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,24.0
,,19309670,[],CHEMBL4416031,Inhibition of N-terminal 6x-His-tagged recombinant human cIAP1-BIR3 (258 to 363 residues) expressed in Escherichia coli incubated for 2 hrs without 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CC(C)C)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,,,CHEMBL4414592,J Med Chem,2019,"{'bei': '13.30', 'le': '0.25', 'lle': '4.85', 'sei': '6.74'}",CHEMBL2158051,XEVINAPANT,CHEMBL2158051,7.47,0,http://www.openphacts.org/units/Nanomolar,3224374,=,1,1,=,,IC50,nM,,34.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,34.0
,,19309671,[],CHEMBL4416031,Inhibition of N-terminal 6x-His-tagged recombinant human cIAP1-BIR3 (258 to 363 residues) expressed in Escherichia coli incubated for 2 hrs without 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1,,,CHEMBL4414592,J Med Chem,2019,"{'bei': '15.44', 'le': '0.30', 'lle': '3.88', 'sei': '8.46'}",CHEMBL2431768,LCL-161,CHEMBL2431768,7.73,0,http://www.openphacts.org/units/Nanomolar,3224373,=,1,1,=,,IC50,nM,,18.6,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,18.6
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24667585,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5098729,Antagonist activity at N-terminal His-tagged cIAP1-BIR3 domain (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate incubated for 2 hrs by DELFIA assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,,CHEMBL5096205,J Med Chem,2021,"{'bei': '15.81', 'le': '0.30', 'lle': '7.14', 'sei': '4.62'}",CHEMBL5186855,,CHEMBL5186855,6.82,0,http://www.openphacts.org/units/Nanomolar,3843975,=,1,1,=,,IC50,nM,,150.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,150.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24667586,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5098729,Antagonist activity at N-terminal His-tagged cIAP1-BIR3 domain (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate incubated for 2 hrs by DELFIA assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1,,,CHEMBL5096205,J Med Chem,2021,"{'bei': '15.30', 'le': '0.30', 'lle': '3.81', 'sei': '8.38'}",CHEMBL2431768,LCL-161,CHEMBL2431768,7.66,0,http://www.openphacts.org/units/Nanomolar,3843976,=,1,1,=,,IC50,nM,,22.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,22.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24667587,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5098729,Antagonist activity at N-terminal His-tagged cIAP1-BIR3 domain (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate incubated for 2 hrs by DELFIA assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1ccc(S(=O)(=O)F)c(OC)c1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,,CHEMBL5096205,J Med Chem,2021,"{'bei': '10.55', 'le': '0.21', 'lle': '7.46', 'sei': '3.32'}",CHEMBL5181541,,CHEMBL5181541,6.84,0,http://www.openphacts.org/units/Nanomolar,3843977,=,1,1,=,,IC50,nM,,144.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,144.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24667588,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5098729,Antagonist activity at N-terminal His-tagged cIAP1-BIR3 domain (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate incubated for 2 hrs by DELFIA assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1cc(S(=O)(=O)F)ccc1OC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,,CHEMBL5096205,J Med Chem,2021,"{'bei': '10.51', 'le': '0.21', 'lle': '7.44', 'sei': '3.31'}",CHEMBL5175233,,CHEMBL5175233,6.82,0,http://www.openphacts.org/units/Nanomolar,3843978,=,1,1,=,,IC50,nM,,153.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,153.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24667589,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5098729,Antagonist activity at N-terminal His-tagged cIAP1-BIR3 domain (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate incubated for 2 hrs by DELFIA assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1cc(S(=O)(=O)F)ccc1OC)C(=O)N1CCCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,,CHEMBL5096205,J Med Chem,2021,"{'bei': '9.25', 'le': '0.18', 'lle': '6.36', 'sei': '2.97'}",CHEMBL5169527,,CHEMBL5169527,6.13,0,http://www.openphacts.org/units/Nanomolar,3843979,=,1,1,=,,IC50,nM,,745.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,745.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24667590,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5098729,Antagonist activity at N-terminal His-tagged cIAP1-BIR3 domain (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate incubated for 2 hrs by DELFIA assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1cc(S(=O)(=O)F)ccc1OC)C(=O)N1Cc2ccccc2C[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,,CHEMBL5096205,J Med Chem,2021,"{'bei': '9.41', 'le': '0.18', 'lle': '6.35', 'sei': '3.25'}",CHEMBL5193194,,CHEMBL5193194,6.69,0,http://www.openphacts.org/units/Nanomolar,3843980,=,1,1,=,,IC50,nM,,205.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,205.0
,,24667591,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5098729,Antagonist activity at N-terminal His-tagged cIAP1-BIR3 domain (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate incubated for 2 hrs by DELFIA assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1cccc(S(=O)(=O)F)c1)C(=O)N1CCC[C@H]1C(=O)NC1Cc2ccccc2C1,,,CHEMBL5096205,J Med Chem,2021,,CHEMBL5200297,,CHEMBL5200297,,0,http://www.openphacts.org/units/Nanomolar,3843981,>,1,1,>,,IC50,nM,,1000.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,1000.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24667592,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5098729,Antagonist activity at N-terminal His-tagged cIAP1-BIR3 domain (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate incubated for 2 hrs by DELFIA assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1cc(S(=O)(=O)F)ccc1OC)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCc2c(F)cccc21,,,CHEMBL5096205,J Med Chem,2021,"{'bei': '10.91', 'le': '0.22', 'lle': '5.83', 'sei': '4.25'}",CHEMBL5191180,,CHEMBL5191180,6.94,0,http://www.openphacts.org/units/Nanomolar,3843982,=,1,1,=,,IC50,nM,,116.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,116.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24667593,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5098729,Antagonist activity at N-terminal His-tagged cIAP1-BIR3 domain (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate incubated for 2 hrs by DELFIA assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1cc(S(=O)(=O)F)ccc1OC)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCc2ccccc21,,,CHEMBL5096205,J Med Chem,2021,"{'bei': '11.98', 'le': '0.23', 'lle': '6.43', 'sei': '4.54'}",CHEMBL5174454,,CHEMBL5174454,7.40,0,http://www.openphacts.org/units/Nanomolar,3843983,=,1,1,=,,IC50,nM,,40.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,40.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24667594,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5098729,Antagonist activity at N-terminal His-tagged cIAP1-BIR3 domain (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate incubated for 2 hrs by DELFIA assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1cc(S(=O)(=O)F)ccc1OC)C(=O)N1CCCC[C@H]1C(=O)N[C@@H]1CCc2ccccc21,,,CHEMBL5096205,J Med Chem,2021,"{'bei': '10.80', 'le': '0.21', 'lle': '5.46', 'sei': '4.18'}",CHEMBL5203019,,CHEMBL5203019,6.82,0,http://www.openphacts.org/units/Nanomolar,3843984,=,1,1,=,,IC50,nM,,151.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,151.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24667595,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5098729,Antagonist activity at N-terminal His-tagged cIAP1-BIR3 domain (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate incubated for 2 hrs by DELFIA assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1cc(S(=O)(=O)F)ccc1OC)C(=O)N1Cc2ccccc2C[C@H]1C(=O)N[C@@H]1CCc2ccccc21,,,CHEMBL5096205,J Med Chem,2021,"{'bei': '10.44', 'le': '0.20', 'lle': '5.17', 'sei': '4.35'}",CHEMBL5170823,,CHEMBL5170823,7.10,0,http://www.openphacts.org/units/Nanomolar,3843985,=,1,1,=,,IC50,nM,,80.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,80.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24667596,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5098729,Antagonist activity at N-terminal His-tagged cIAP1-BIR3 domain (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate incubated for 2 hrs by DELFIA assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1cc(S(=O)(=O)O)ccc1OC)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCc2ccccc21,,,CHEMBL5096205,J Med Chem,2021,"{'bei': '10.68', 'le': '0.21', 'lle': '6.02', 'sei': '3.59'}",CHEMBL5195146,,CHEMBL5195146,6.58,0,http://www.openphacts.org/units/Nanomolar,3843986,=,1,1,=,,IC50,nM,,266.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,266.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24667615,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5098733,Antagonist activity at N-terminal His-tagged cIAP1-BIR3 domain (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate preincubated for 2 hrs with protein followed by substrate addition measured after 2 hrs by DELFIA assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1cc(S(=O)(=O)O)ccc1OC)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCc2ccccc21,,,CHEMBL5096205,J Med Chem,2021,"{'bei': '10.45', 'le': '0.20', 'lle': '5.87', 'sei': '3.51'}",CHEMBL5195146,,CHEMBL5195146,6.43,0,http://www.openphacts.org/units/Nanomolar,3843986,=,1,1,=,,IC50,nM,,370.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,370.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24667616,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5098733,Antagonist activity at N-terminal His-tagged cIAP1-BIR3 domain (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate preincubated for 2 hrs with protein followed by substrate addition measured after 2 hrs by DELFIA assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1cc(S(=O)(=O)F)ccc1OC)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCc2ccccc21,,,CHEMBL5096205,J Med Chem,2021,"{'bei': '11.38', 'le': '0.22', 'lle': '6.06', 'sei': '4.31'}",CHEMBL5174454,,CHEMBL5174454,7.03,0,http://www.openphacts.org/units/Nanomolar,3843983,=,1,1,=,,IC50,nM,,94.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,94.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24667617,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5098733,Antagonist activity at N-terminal His-tagged cIAP1-BIR3 domain (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate preincubated for 2 hrs with protein followed by substrate addition measured after 2 hrs by DELFIA assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1,,,CHEMBL5096205,J Med Chem,2021,"{'bei': '15.57', 'le': '0.30', 'lle': '3.95', 'sei': '8.53'}",CHEMBL2431768,LCL-161,CHEMBL2431768,7.80,0,http://www.openphacts.org/units/Nanomolar,3843976,=,1,1,=,,IC50,nM,,16.0,CHEMBL5462,Homo sapiens,Baculoviral IAP repeat-containing protein 2,9606,,,IC50,nM,UO_0000065,,16.0
